Medical Properties Trust (MPW) 10-K 3 Mar 14 2013 FY Annual report Financial data

Document_and_Entity_Informatio

Document and Entity Information (USD $)	12 Months Ended
	Dec. 31, 2013	Feb. 28, 2014	Jun. 28, 2013
Document Information [Line Items]	'	'	'
Document Type	'10-K	'	'
Amendment Flag	'false	'	'
Document Period End Date	31-Dec-13	'	'
Document Fiscal Year Focus	'2013	'	'
Document Fiscal Period Focus	'FY	'	'
Trading Symbol	'MPW	'	'
Entity Registrant Name	'MEDICAL PROPERTIES TRUST INC	'	'
Entity Central Index Key	'0001287865	'	'
Current Fiscal Year End Date	'--12-31	'	'
Entity Well-known Seasoned Issuer	'Yes	'	'
Entity Current Reporting Status	'Yes	'	'
Entity Voluntary Filers	'No	'	'
Entity Filer Category	'Large Accelerated Filer	'	'
Entity Common Stock, Shares Outstanding	'	162,550,162	'
Entity Public Float	'	'	$2,149,029,766
MPT Operating Partnership, L.P. [Member]	'	'	'
Document Information [Line Items]	'	'	'
Document Type	'10-K	'	'
Amendment Flag	'false	'	'
Document Period End Date	31-Dec-13	'	'
Document Fiscal Year Focus	'2013	'	'
Document Fiscal Period Focus	'FY	'	'
Entity Registrant Name	'MPT Operating Partnership, L.P.	'	'
Entity Central Index Key	'0001524607	'	'
Current Fiscal Year End Date	'--12-31	'	'
Entity Filer Category	'Non-accelerated Filer	'	'

Consolidated_Balance_Sheets

Consolidated Balance Sheets (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Real estate assets	'	'
Land	$154,858	$108,456
Buildings and improvements	1,578,336	1,052,479
Construction in progress and other	41,771	38,339
Intangible lease assets	90,490	51,966
Real estate held for sale	'	25,537
Net investment in direct financing leases	431,024	314,412
Mortgage loans	388,650	368,650
Gross investment in real estate assets	2,685,129	1,959,839
Accumulated depreciation	-144,235	-110,888	[1]
Accumulated amortization	-15,541	-11,908
Net investment in real estate assets	2,525,353	1,837,043
Cash and cash equivalents	45,979	37,311
Interest and rent receivables	58,499	45,289
Straight-line rent receivables	45,829	35,860
Other loans	160,990	159,243
Other assets	67,920	64,140
Total Assets	2,904,570	2,178,886
Liabilities	'	'
Debt, net	1,421,681	1,025,160
Accounts payable and accrued expenses	94,311	65,961
Deferred revenue	23,787	20,609
Lease deposits and other obligations to tenants	20,583	17,342
Total liabilities	1,560,362	1,129,072
Commitments and Contingencies	'	'
Equity / Capital	'	'
Preferred stock, $0.001 par value. Authorized 10,000 shares; no shares outstanding	'	'
Common stock, $0.001 par value. Authorized 250,000 shares; issued and outstanding - 161,310 shares at December 31, 2013 and 136,335 shares at December 31, 2012	161	136
Limited Partners:	'	'
Additional paid-in capital	1,618,054	1,295,916
Distributions in excess of net income	-264,804	-233,494
Accumulated other comprehensive loss	-8,941	-12,482
Treasury shares, at cost	-262	-262
Total Equity / Capital	1,344,208	1,049,814
Total Liabilities and Equity	2,904,570	2,178,886
MPT Operating Partnership, L.P. [Member]	'	'
Real estate assets	'	'
Land	154,858	108,456
Buildings and improvements	1,578,336	1,052,479
Construction in progress and other	41,771	38,339
Intangible lease assets	90,490	51,966
Real estate held for sale	'	25,537
Net investment in direct financing leases	431,024	314,412
Mortgage loans	388,650	368,650
Gross investment in real estate assets	2,685,129	1,959,839
Accumulated depreciation	-144,235	-110,888
Accumulated amortization	-15,541	-11,908
Net investment in real estate assets	2,525,353	1,837,043
Cash and cash equivalents	45,979	37,311
Interest and rent receivables	58,499	45,289
Straight-line rent receivables	45,829	35,860
Other loans	160,990	159,243
Other assets	67,920	64,140
Total Assets	2,904,570	2,178,886
Liabilities	'	'
Debt, net	1,421,681	1,025,160
Accounts payable and accrued expenses	58,559	38,177
Deferred revenue	23,787	20,609
Lease deposits and other obligations to tenants	20,583	17,342
Payable due to Medical Properties Trust, Inc.	35,362	27,394
Total liabilities	1,559,972	1,128,682
Commitments and Contingencies	'	'
Limited Partners:	'	'
Accumulated other comprehensive loss	-8,941	-12,482
Total Equity / Capital	1,344,598	1,050,204
Total Liabilities and Equity	2,904,570	2,178,886
MPT Operating Partnership, L.P. [Member] | Common Units [Member]	'	'
Limited Partners:	'	'
Limited Partners Capital	1,339,998	1,052,056
MPT Operating Partnership, L.P. [Member] | General Partner [Member]	'	'
Equity / Capital	'	'
General partner - issued and outstanding - 1,608 units at December 31, 2013 and 1,357 units at December 31, 2012	13,541	10,630
MPT Operating Partnership, L.P. [Member] | LTIP Units [Member]	'	'
Limited Partners:	'	'
Limited Partners Capital	'	'
[1]	Includes in accumulated depreciation in real estate held for sale of $3,511 for 2012. Excludes accumulated amortization related to intangible lease assets that are included in real estate held for sale of $426 for 2012.

Consolidated_Balance_Sheets_Pa

Consolidated Balance Sheets (Parenthetical) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Preferred stock, par value	$0.00	$0.00
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, shares outstanding	'	'
Common stock, par value	$0.00	$0.00
Common stock, shares authorized	250,000,000	250,000,000
Common stock, shares issued	136,335,000	136,335,000
Common stock, shares outstanding	136,335,000	136,335,000
MPT Operating Partnership, L.P. [Member] | General Partner [Member]	'	'
General partner, units issued	1,608,000	1,357,000
General partner, units outstanding	1,357,000	1,357,000
MPT Operating Partnership, L.P. [Member] | LTIP Units [Member]	'	'
LTIP Units, shares issued	292,000	221,000
LTIP Units, shares outstanding	292,000	221,000
MPT Operating Partnership, L.P. [Member] | Common Units [Member]	'	'
Limited Partners, units issued	159,702,000	134,978,000
Limited Partners, units outstanding	159,702,000	134,978,000

Consolidated_Statements_of_Inc

Consolidated Statements of Income (USD $)	12 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Revenues	'	'	'
Rent billed	$132,578	$119,883	$105,688
Straight-line rent	10,706	7,911	5,277
Income from direct financing leases	40,830	21,728	'
Interest and fee income	58,409	48,603	21,357
Total revenues	242,523	198,125	132,322
Expenses	'	'	'
Real estate depreciation and amortization	36,978	32,815	30,147
Property-related	2,450	1,477	724
Acquisition expenses	19,494	5,420	4,184
General and administrative	30,063	28,562	27,091
Total operating expense	88,985	68,274	62,146
Operating income	153,538	129,851	70,176
Other income (expense)	'	'	'
Interest and other (expense) income	-319	-1,662	18
Earnings from equity and other interests	3,554	2,943	78
Debt refinancing expense	'	'	-14,214
Interest expense	-66,746	-58,243	-43,810
Income tax expense	-726	-19	-128
Net other expenses	-64,237	-56,981	-58,056
Income from continuing operations	89,301	72,870	12,120
Income from discontinued operations	7,914	17,207	14,594
Net income	97,215	90,077	26,714
Net income attributable to non-controlling interests	-224	-177	-178
Net income attributable to MPT common stockholders	96,991	89,900	26,536
Earnings per share (unit) - basic	'	'	'
Income from continuing operations attributable to MPT common stockholders (Operating Partnership partners)	$0.59	$0.54	$0.10
Income from discontinued operations attributable to MPT common stockholders (Operating Partnership partners)	$0.05	$0.13	$0.13
Net income attributable to MPT common stockholders (Operating Partnership partners)	$0.64	$0.67	$0.23
Weighted average shares (units) outstanding - basic	151,439	132,331	110,623
Earnings per share (unit) - diluted	'	'	'
Income from continuing operations attributable to MPT common stockholders (Operating Partnership partners)	$0.58	$0.54	$0.10
Income from discontinued operations attributable to MPT common stockholders / Operating Partnership partners	$0.05	$0.13	$0.13
Net income attributable to MPT common stockholders (Operating Partnership partners)	$0.63	$0.67	$0.23
Weighted average shares (units) outstanding - diluted	152,598	132,333	110,629
MPT Operating Partnership, L.P. [Member]	'	'	'
Revenues	'	'	'
Rent billed	132,578	119,883	105,688
Straight-line rent	10,706	7,911	5,277
Income from direct financing leases	40,830	21,728	'
Interest and fee income	58,409	48,603	21,357
Total revenues	242,523	198,125	132,322
Expenses	'	'	'
Real estate depreciation and amortization	36,978	32,815	30,147
Property-related	2,450	1,477	724
Acquisition expenses	19,494	5,420	4,184
General and administrative	30,063	28,562	27,074
Total operating expense	88,985	68,274	62,129
Operating income	153,538	129,851	70,193
Other income (expense)	'	'	'
Interest and other (expense) income	-319	-1,662	18
Earnings from equity and other interests	3,554	2,943	78
Debt refinancing expense	'	'	-14,214
Interest expense	-66,746	-58,243	-43,810
Income tax expense	-726	-19	-128
Net other expenses	-64,237	-56,981	-58,056
Income from continuing operations	89,301	72,870	12,137
Income from discontinued operations	7,914	17,207	14,594
Net income	97,215	90,077	26,731
Net income attributable to non-controlling interests	-224	-177	-178
Net income attributable to MPT common stockholders	$96,991	$89,900	$26,553
Earnings per share (unit) - basic	'	'	'
Income from continuing operations attributable to MPT common stockholders (Operating Partnership partners)	$0.59	$0.54	$0.10
Income from discontinued operations attributable to MPT common stockholders (Operating Partnership partners)	$0.05	$0.13	$0.13
Net income attributable to MPT common stockholders (Operating Partnership partners)	$0.64	$0.67	$0.23
Weighted average shares (units) outstanding - basic	151,439	132,331	110,623
Earnings per share (unit) - diluted	'	'	'
Income from continuing operations attributable to MPT common stockholders (Operating Partnership partners)	$0.58	$0.54	$0.10
Income from discontinued operations attributable to MPT common stockholders / Operating Partnership partners	$0.05	$0.13	$0.13
Net income attributable to MPT common stockholders (Operating Partnership partners)	$0.63	$0.67	$0.23
Weighted average shares (units) outstanding - diluted	152,598	132,333	110,629

Consolidated_Statements_of_Com

Consolidated Statements of Comprehensive Income (Loss) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Net income	$97,215	$90,077	$26,714
Other comprehensive income (loss):	'	'	'
Unrealized gain (loss) on interest rate swap	3,474	-251	-8,590
Foreign currency translation gain	67	'	'
Total comprehensive income	100,756	89,826	18,124
Comprehensive income attributable to non-controlling interests	-224	-177	-178
Comprehensive income attributable to MPT common stockholders (Operating Partnership partners)	100,532	89,649	17,946
MPT Operating Partnership, L.P. [Member]	'	'	'
Net income	97,215	90,077	26,731
Other comprehensive income (loss):	'	'	'
Unrealized gain (loss) on interest rate swap	3,474	-251	-8,590
Foreign currency translation gain	67	'	'
Total comprehensive income	100,756	89,826	18,141
Comprehensive income attributable to non-controlling interests	-224	-177	-178
Comprehensive income attributable to MPT common stockholders (Operating Partnership partners)	$100,532	$89,649	$17,963

Consolidated_Statements_of_Equ

Consolidated Statements of Equity / Capital (USD $)

Total

Additional Paid-in Capital [Member]

Distributions in Excess of Net Income [Member]

Treasury Stock [Member]

Common Par Value [Member]

Accumulated Other Comprehensive Loss [Member]

Non- Controlling Interests [Member]

MPT Operating Partnership, L.P. [Member]

MPT Operating Partnership, L.P. [Member]

MPT Operating Partnership, L.P. [Member]

MPT Operating Partnership, L.P. [Member]

MPT Operating Partnership, L.P. [Member]

MPT Operating Partnership, L.P. [Member]

In Thousands

Accumulated Other Comprehensive Loss [Member]

Non- Controlling Interests [Member]

General Partner [Member]

Limited Partner [Member]

Limited Partner [Member]

Common Par Value [Member]

Long Term Incentive Plan [Member]

Beginning balance at Dec. 31, 2010

$899,576

$1,051,785

($148,530)

($262)

$110

($3,641)

$114

$899,949

($3,641)

$114

$9,035

$894,441

'

Beginning balance (in shares) at Dec. 31, 2010

'

'

'

'

110,225

'

'

'

'

'

1,102

109,123

94

Net income

26,714

'

26,536

'

'

'

178

26,731

'

178

265

26,020

268

Unrealized gain ( loss) on interest rate swaps

-8,590

'

'

'

'

-8,590

'

-8,590

-8,590

'

'

'

'

Stock (Unit) vesting and amortization of stock (unit)-based compensation

6,983

6,982

'

'

1

'

'

6,984

'

'

69

6,915

'

Stock (Unit) vesting and amortization of stock (unit)-based compensation (shares)

'

'

'

'

561

'

'

'

'

'

5

556

56

Purchase of non-controlling interest

-524

-441

'

'

'

'

-83

-525

'

-83

'

-442

'

Extinguishment of convertible debt

-5,501

-3,070

-2,431

'

'

'

'

-5,501

'

'

-55

-5,446

'

Distributions to non-controlling interests

-209

'

'

'

'

'

-209

-209

'

-209

'

'

'

Dividends (Distributions) declared ($0.80 in 2011, $0.80 in 2012 and $0.81 in 2013 per common share / unit)

-89,634

'

-89,634

'

'

'

'

-89,634

'

'

-896

-88,470

-268

Ending balance at Dec. 31, 2011

828,815

1,055,256

-214,059

-262

111

-12,231

'

829,205

-12,231

'

8,418

833,018

'

Ending balance (in shares) at Dec. 31, 2011

'

'

'

'

110,786

'

'

'

'

'

1,107

109,679

150

Net income

10,606

'

'

'

'

'

'

10,606

'

'

'

'

'

Ending balance at Mar. 31, 2012

'

'

'

'

'

'

'

'

'

'

'

'

'

Beginning balance at Dec. 31, 2011

828,815

1,055,256

-214,059

-262

111

-12,231

'

829,205

-12,231

'

8,418

833,018

'

Beginning balance (in shares) at Dec. 31, 2011

'

'

'

'

110,786

'

'

'

'

'

1,107

109,679

150

Net income

90,077

'

89,900

'

'

'

177

90,077

'

177

899

88,733

268

Unrealized gain ( loss) on interest rate swaps

-251

'

'

'

'

-251

'

-251

-251

'

'

'

'

Stock (Unit) vesting and amortization of stock (unit)-based compensation

7,637

7,636

'

'

1

'

'

7,637

'

'

76

7,561

'

Stock (Unit) vesting and amortization of stock (unit)-based compensation (shares)

'

'

'

'

854

'

'

'

'

'

4

850

71

Distributions to non-controlling interests

-177

'

'

'

'

'

-177

-177

'

-177

'

'

'

Proceeds from offering (net of offering costs)

233,048

233,024

'

'

24

'

'

233,048

'

'

2,331

24,449

'

Proceeds from offering (net of offering costs) (shares)

'

'

'

'

24,695

'

'

'

'

'

246

24,449

'

Dividends (Distributions) declared ($0.80 in 2011, $0.80 in 2012 and $0.81 in 2013 per common share / unit)

-109,335

'

-109,335

'

'

'

'

-109,335

'

'

-1,094

-107,973

-268

Ending balance at Dec. 31, 2012

1,049,814

1,295,916

-233,494

-262

136

-12,482

'

1,050,204

-12,482

'

10,630

1,052,056

'

Ending balance (in shares) at Dec. 31, 2012

'

'

'

'

136,335

'

'

'

'

'

1,357

134,978

221

Beginning balance at Sep. 30, 2012

'

'

'

'

'

'

'

'

'

'

'

'

'

Net income

28,603

'

'

'

'

'

'

28,603

'

'

'

'

'

Ending balance at Dec. 31, 2012

1,049,814

'

'

-262

'

'

'

1,050,204

'

'

'

'

'

Net income

26,210

'

'

'

'

'

'

26,210

'

'

'

'

'

Ending balance at Mar. 31, 2013

'

'

'

'

'

'

'

'

'

'

'

'

'

Beginning balance at Dec. 31, 2012

1,049,814

1,295,916

-233,494

-262

136

-12,482

'

1,050,204

-12,482

'

10,630

1,052,056

'

Beginning balance (in shares) at Dec. 31, 2012

'

'

'

'

136,335

'

'

'

'

'

1,357

134,978

221

Net income

97,215

'

96,991

'

'

'

224

97,215

'

224

972

95,748

271

Unrealized gain ( loss) on interest rate swaps

3,474

'

'

'

'

3,474

'

3,474

3,474

'

'

'

'

Foreign currency translation gain

67

'

'

'

'

67

'

67

67

'

'

'

'

Stock (Unit) vesting and amortization of stock (unit)-based compensation

8,833

8,832

'

'

1

'

'

8,833

'

'

88

8,745

71

Stock (Unit) vesting and amortization of stock (unit)-based compensation (shares)

'

'

'

'

811

'

'

'

'

'

9

802

'

Distributions to non-controlling interests

-224

'

'

'

'

'

-224

-224

'

-224

'

'

'

Proceeds from offering (net of offering costs)

313,330

313,306

'

'

24

'

'

313,330

'

'

3,133

310,197

'

Proceeds from offering (net of offering costs) (shares)

'

'

'

'

24,164

'

'

'

'

'

242

23,922

'

Dividends (Distributions) declared ($0.80 in 2011, $0.80 in 2012 and $0.81 in 2013 per common share / unit)

-128,301

'

-128,301

'

'

'

'

-128,301

'

'

-1,282

-126,748

-271

Ending balance at Dec. 31, 2013

1,344,208

1,618,054

-264,804

-262

161

-8,941

'

1,344,598

-8,941

'

13,541

1,339,998

'

Ending balance (in shares) at Dec. 31, 2013

'

'

'

'

161,310

'

'

'

'

'

1,608

159,702

292

Beginning balance at Sep. 30, 2013

'

'

'

'

'

'

'

'

'

'

'

'

'

Net income

17,897

'

'

'

'

'

'

17,897

'

'

'

'

'

Ending balance at Dec. 31, 2013

$1,344,208

'

'

($262)

'

'

'

$1,344,598

'

'

'

'

'

Consolidated_Statements_of_Equ1

Consolidated Statements of Equity / Capital (Parenthetical) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Dividends (Distributions) declared per common share / unit	$0.81	$0.80	$0.80
MPT Operating Partnership, L.P. [Member]	'	'	'
Dividends (Distributions) declared per common share / unit	$0.81	$0.80	$0.80

Consolidated_Statements_of_Cas

Consolidated Statements of Cash Flow (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Operating activities	'	'	'
Net income	$97,215	$90,077	$26,714
Adjustments to reconcile net income to net cash provided by operating activities:	'	'	'
Depreciation and amortization	38,818	35,593	35,477
Amortization and write-off of deferred financing costs and debt discount	3,559	3,457	9,289
Premium on extinguishment of debt	'	'	13,091
Direct financing lease (interest) accretion	-5,774	-3,104	'
Straight-line rent revenue	-11,265	7,911	5,277
Share (Unit)-based compensation expense	8,832	7,637	6,983
Impairment charge	'	'	564
(Gain) loss from sale of real estate	-7,659	-16,369	-5,431
Provision for uncollectible receivables and loans	'	'	1,499
Straight-line rent write-off	1,457	6,456	2,470
Payment of discount on extinguishment of debt	'	'	-4,850
Other adjustments	-70	538	1,058
Decrease (increase) in:	'	'	'
Interest and rent receivable	-13,211	-17,261	-6,118
Other assets	1,855	91	142
Accounts payable and accrued expenses	23,867	9,201	5,354
Deferred revenue	3,177	-2,698	170
Net cash provided by operating activities	140,801	105,309	79,270
Investing Activities	'	'	'
Cash paid for acquisitions and other related investments	-654,922	-621,490	-278,963
Net proceeds from sale of real estate	32,409	71,202	41,130
Principal received on loans receivable	7,249	10,931	4,289
Investment in loans receivable	-3,746	-1,293	-861
Construction in progress	-41,452	-44,570	-22,999
Other investments, net	-52,115	-31,908	-8,217
Net cash (used for) provided by investing activities	-712,577	-617,128	-265,621
Financing Activities	'	'	'
Proceeds from term debt, net of discount	424,580	300,000	450,000
Payments of term debt	-11,249	-232	-246,262
Payment of deferred financing costs	-9,760	-6,247	-15,454
Revolving credit facilities, net	-20,000	35,400	89,600
Distributions paid	-120,309	-103,952	-89,601
Lease deposits and other obligations to tenants	3,231	-11,436	8,621
Proceeds from sale of common shares/units, net of offering costs	313,331	233,048	'
Other	'	-177	-6,235
Net cash provided by (used in) financing activities	579,824	446,404	190,669
Increase (decrease) in cash and cash equivalents for the year	8,048	-65,415	4,318
Effect of exchange rate changes	620	'	'
Cash and cash equivalents at beginning of period	37,311	102,726	98,408
Cash and cash equivalents at end of period	45,979	37,311	102,726
Interest paid, including capitalized interest of $1,729 in 2013, $1,596 in 2012, and $896 in 2011	58,110	51,440	38,463
Supplemental schedule of non-cash investing activities:	'	'	'
Real estate acquired via assumption of mortgage loan	'	'	-14,592
Loan conversion to equity interest	'	1,648	'
Mortgage loan issued from sale of real estate	'	3,650	'
Supplemental schedule of non-cash financing activities:	'	'	'
Assumption of mortgage loan (as part of real estate acquired)	'	'	14,592
Dividends declared, not paid	35,778	27,786	22,407
MPT Operating Partnership, L.P. [Member]	'	'	'
Operating activities	'	'	'
Net income	97,215	90,077	26,731
Adjustments to reconcile net income to net cash provided by operating activities:	'	'	'
Depreciation and amortization	38,818	35,593	35,477
Amortization and write-off of deferred financing costs and debt discount	3,559	3,457	9,289
Premium on extinguishment of debt	'	'	13,091
Direct financing lease (interest) accretion	-11,265	-3,104	'
Straight-line rent revenue	-5,774	-8,309	-7,142
Share (Unit)-based compensation expense	8,832	7,637	6,983
Impairment charge	'	'	564
(Gain) loss from sale of real estate	-7,659	-16,369	-5,431
Provision for uncollectible receivables and loans	'	'	1,499
Straight-line rent write-off	1,457	6,456	2,470
Payment of discount on extinguishment of debt	'	'	-4,850
Other adjustments	-70	538	1,058
Decrease (increase) in:	'	'	'
Interest and rent receivable	-13,211	-17,261	-6,118
Other assets	1,855	91	142
Accounts payable and accrued expenses	23,867	9,201	5,337
Deferred revenue	3,177	-2,698	170
Net cash provided by operating activities	140,801	105,309	79,270
Investing Activities	'	'	'
Cash paid for acquisitions and other related investments	-654,922	-621,490	-278,963
Net proceeds from sale of real estate	32,409	71,202	41,130
Principal received on loans receivable	7,249	10,931	4,289
Investment in loans receivable	-3,746	-1,293	-861
Construction in progress	-41,452	-44,570	-22,999
Other investments, net	-52,115	-31,908	-8,217
Net cash (used for) provided by investing activities	-712,577	-617,128	-265,621
Financing Activities	'	'	'
Proceeds from term debt, net of discount	424,580	300,000	450,000
Payments of term debt	-11,249	-232	-246,262
Payment of deferred financing costs	-9,760	-6,247	-15,454
Revolving credit facilities, net	-20,000	35,400	89,600
Distributions paid	-120,309	-103,952	-89,601
Lease deposits and other obligations to tenants	3,231	-11,436	8,621
Proceeds from sale of common shares/units, net of offering costs	313,331	233,048	'
Other	'	-177	-6,235
Net cash provided by (used in) financing activities	579,824	446,404	190,669
Increase (decrease) in cash and cash equivalents for the year	8,048	-65,415	4,318
Effect of exchange rate changes	620	'	'
Cash and cash equivalents at beginning of period	37,311	102,726	98,408
Cash and cash equivalents at end of period	45,979	37,311	102,726
Interest paid, including capitalized interest of $1,729 in 2013, $1,596 in 2012, and $896 in 2011	58,110	51,440	38,463
Supplemental schedule of non-cash investing activities:	'	'	'
Real estate acquired via assumption of mortgage loan	'	'	-14,592
Loan conversion to equity interest	'	1,648	'
Mortgage loan issued from sale of real estate	'	3,650	'
Supplemental schedule of non-cash financing activities:	'	'	'
Assumption of mortgage loan (as part of real estate acquired)	'	'	14,592
Dividends declared, not paid	$35,778	$27,786	$22,407

Consolidated_Statements_of_Cas1

Consolidated Statements of Cash Flow (Parenthetical) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Interest paid, capitalized	$1,729	$1,596	$896
MPT Operating Partnership, L.P. [Member]	'	'	'
Interest paid, capitalized	$1,729	$1,596	$896

Organization

Organization	12 Months Ended
	Dec. 31, 2013
Accounting Policies [Abstract]	'
Organization	'
	1	Organization
	Medical Properties Trust, Inc., a Maryland corporation, was formed on August 27, 2003, under the General Corporation Law of Maryland for the purpose of engaging in the business of investing in, owning, and leasing commercial real estate. Our operating partnership subsidiary, MPT Operating Partnership, L.P., (the “Operating Partnership”) through which we conduct all of our operations, was formed in September 2003. Through another wholly-owned subsidiary, Medical Properties Trust, LLC, we are the sole general partner of the Operating Partnership. At present, we directly own substantially all of the limited partnership interests in the Operating Partnership and have elected to report our required disclosures and that of the Operating Partnership on a combined basis except where material differences exist.
	We have operated as a real estate investment trust (“REIT”) since April 6, 2004, and accordingly, elected REIT status upon the filing in September 2005 of the calendar year 2004 federal income tax return. Accordingly, we will not be subject to U.S. federal income tax, provided that we continue to qualify as a REIT and our distributions to our stockholders equal or exceed our taxable income. Certain activities we undertake must be conducted by entities which we elected to be treated as taxable REIT subsidiaries (“TRSs”). Our TRSs are subject to both U.S. federal and state income taxes.
	Our primary business strategy is to acquire and develop real estate and improvements, primarily for long-term lease to providers of healthcare services such as operators of general acute care hospitals, inpatient physical rehabilitation hospitals, long-term acute care hospitals, surgery centers, centers for treatment of specific conditions such as cardiac, pulmonary, cancer, and neurological hospitals, and other healthcare-oriented facilities. We also make mortgage and other loans to operators of similar facilities. In addition, we may obtain profits or equity interests in our tenants, from time to time, in order to enhance our overall return. We manage our business as a single business segment. All of our properties are located in the United States and Europe—we made our first acquisition outside the United States in the fourth quarter of 2013 (as more fully described in Note 3).

Summary_of_Significant_Account

Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2013
Accounting Policies [Abstract]	'
Summary of Significant Accounting Policies	'
	2	Summary of Significant Accounting Policies
	Use of Estimates: The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
	Principles of Consolidation: Property holding entities and other subsidiaries of which we own 100% of the equity or have a controlling financial interest evidenced by ownership of a majority voting interest are consolidated. All inter-company balances and transactions are eliminated. For entities in which we own less than 100% of the equity interest, we consolidate the property if we have the direct or indirect ability to control the entities’ activities based upon the terms of the respective entities’ ownership agreements. For these entities, we record a non-controlling interest representing equity held by non-controlling interests.
	We continually evaluate all of our transactions and investments to determine if they represent variable interests in a variable interest entity (“VIE”). If we determine that we have a variable interest in a VIE, we then evaluate if we are the primary beneficiary of the VIE. The evaluation is a qualitative assessment as to whether we have the ability to direct the activities of a VIE that most significantly impact the entity’s economic performance. We consolidate each VIE in which we, by virtue of or transactions with our investments in the entity, are considered to be the primary beneficiary.
	At December 31, 2013, we had loans and/or equity investments in certain VIEs, which are also tenants of our facilities (including but not limited to Ernest, Monroe and Vibra). We have determined that we are not the primary beneficiary of these VIEs. The carrying value and classification of the related assets and maximum exposure to loss as a result of our involvement with these VIEs are presented below at December 31, 2013 (in thousands):
	VIE		Maximum Loss		Asset Type	Carrying
	Type		Exposure(1)		Classification	Amount(2)
	Loans, net			$283,273	Mortgage and other loans	$	228,996
	Equity investments			$  19,308	Other assets	$	5,198
	-1	Our maximum loss exposure related to loans with VIEs represents our current aggregate gross carrying value of the loan plus accrued interest and any other related assets (such as rents receivable), less any liabilities. Our maximum loss exposure related to our equity investment in VIEs represent the current carrying values of such investment plus any other related assets (such as rent receivables) less any liabilities.
	-2	Carrying amount reflects the net book value of our loan or equity interest only in the VIE.
	For the VIE types above, we do not consolidate the VIE because we do not have the ability to control the activities (such as the day-to-day healthcare operations of our borrowers or investees) that most significantly impact the VIE’s economic performance. As of December 31, 2013, we were not required to provide financial support through a liquidity arrangement or otherwise to our unconsolidated VIEs, including circumstances in which it could be exposed to further losses (e.g., cash short falls).
	Typically, our loans are collateralized by assets of the borrower (some assets of which are on the premises of facilities owned by us) and further supported by limited guarantees made by certain principals of the borrower.
	See Note 3 for additional description of the nature, purpose and activities of our more significant VIEs and interests therein.
	Investments in Unconsolidated Entities: Investments in entities in which we have the ability to influence (but not control) are typically accounted for by the equity method. Under the equity method of accounting, our share of the investee’s earnings or losses are included in our consolidated results of operations, and we have elected to record our share of such investee’s earnings or losses on a 90-day lag basis. The initial carrying value of investments in unconsolidated entities is based on the amount paid to purchase the interest in the investee entity. Subsequently, our investments are increased by the equity in our investee earnings and decreased by cash distributions from our investees. To the extent that our cost basis is different from the basis reflected at the investee entity level, the basis difference is generally amortized over the lives of the related assets and liabilities, and such amortization is included in our share of equity in earnings of the investee. We evaluate our equity method investments for impairment based upon a comparison of the fair value of the equity method investment to its carrying value. If we determine a decline in the fair value of an investment in an unconsolidated investee entity below its carrying value is other - than - temporary, an impairment is recorded.
	Cash and Cash Equivalents: Certificates of deposit, short-term investments with original maturities of three months or less and money-market mutual funds are considered cash equivalents. The majority of our cash and cash equivalents are held at major commercial banks which at times may exceed the Federal Deposit Insurance Corporation limit. We have not experienced any losses to date on our invested cash. Cash and cash equivalents which have been restricted as to its use are recorded in other assets.
	Revenue Recognition: We receive income from operating leases based on the fixed, minimum required rents (base rents) per the lease agreements. Rent revenue from base rents is recorded on the straight-line method over the terms of the related lease agreements for new leases and the remaining terms of existing leases for acquired properties. The straight-line method records the periodic average amount of base rent earned over the term of a lease, taking into account contractual rent increases over the lease term. The straight-line method typically has the effect of recording more rent revenue from a lease than a tenant is required to pay early in the term of the lease. During the later parts of a lease term, this effect reverses with less rent revenue recorded than a tenant is required to pay. Rent revenue as recorded on the straight-line method in the consolidated statements of income is presented as two amounts: billed rent revenue and straight-line revenue. Billed rent revenue is the amount of base rent actually billed to the customer each period as required by the lease. Straight-line rent revenue is the difference between rent revenue earned based on the straight-line method and the amount recorded as billed rent revenue. We record the difference between base rent revenues earned and amounts due per the respective lease agreements, as applicable, as an increase or decrease to straight-line rent receivable.
	Certain leases provide for additional rents contingent upon a percentage of the tenant’s revenue in excess of specified base amounts/thresholds (percentage rents). Percentage rents are recognized in the period in which revenue thresholds are met. Rental payments received prior to their recognition as income are classified as deferred revenue. We also receive additional rent (contingent rent) under some leases based on increases in the consumer price index or when the consumer price index exceeds the annual minimum percentage increase in the lease. Contingent rents are recorded as billed rent revenue in the period earned.
	We use direct finance lease accounting (“DFL”) to record rent on certain leases deemed to be financing leases rather than operating leases. For leases accounted for as DFLs, the future minimum lease payments are recorded as a receivable. Unearned income represents the net investment in the DFL, less the sum of minimum lease payments receivable and the estimated residual values of the leased properties. Unearned income is deferred and amortized to income over the lease terms to provide a constant yield when collectability of the lease payments is reasonably assured. Investments in DFLs are presented net of unamortized and unearned income.
	In instances where we have a profits or equity interest in our tenant’s operations, we record revenue equal to our percentage interest of the tenant’s profits, as defined in the lease or tenant’s operating agreements, once annual thresholds, if any, are met.
	We begin recording base rent income from our development projects when the lessee takes physical possession of the facility, which may be different from the stated start date of the lease. Also, during construction of our development projects, we are generally entitled to accrue rent based on the cost paid during the construction period (construction period rent). We accrue construction period rent as a receivable and deferred revenue during the construction period. When the lessee takes physical possession of the facility, we begin recognizing the accrued construction period rent on the straight-line method over the remaining term of the lease.
	We receive interest income from our tenants/borrowers on mortgage loans, working capital loans, and other long-term loans. Interest income from these loans is recognized as earned based upon the principal outstanding and terms of the loans.
	Commitment fees received from development and leasing services for lessees are initially recorded as deferred revenue and recognized as income over the initial term of a lease to produce a constant effective yield on the lease (interest method). Commitment and origination fees from lending services are also recorded as deferred revenue and recognized as income over the life of the loan using the interest method.
	Tenant payments for certain taxes, insurance, and other operating expenses related to our facilities (most of which are paid directly by our tenants to the government or related vendor) are recorded net of the respective expense as generally our leases are “triple-net” leases, with terms requiring such expenses to be paid by our tenants. Failure on the part of our tenants to pay such expense or to pay late would result in a violation of the lease agreement, which could lead to an event of default, if not cured.
	Acquired Real Estate Purchase Price Allocation: We allocate the purchase price of acquired properties to net tangible and identified intangible assets acquired based on their fair values. In making estimates of fair values for purposes of allocating purchase prices of acquired real estate, we utilize a number of sources, from time to time, including independent appraisals that may be obtained in connection with the acquisition or financing of the respective property and other market data. We also consider information obtained about each property as a result of our pre-acquisition due diligence, marketing and leasing activities in estimating the fair value of the tangible and intangible assets acquired.
	We record above-market and below-market in-place lease values, if any, for our facilities, which are based on the present value of the difference between (i) the contractual amounts to be paid pursuant to the in-place leases and (ii) management’s estimate of fair market lease rates for the corresponding in-place leases, measured over a period equal to the remaining non-cancelable term of the lease. We amortize any resulting capitalized above-market lease values as a reduction of rental income over the lease term. We amortize any resulting capitalized below-market lease values as an increase to rental income over the lease term.
	We measure the aggregate value of other lease intangible assets acquired based on the difference between (i) the property valued with new or in-place leases adjusted to market rental rates and (ii) the property valued as if vacant. Management’s estimates of value are made using methods similar to those used by independent appraisers (e.g., discounted cash flow analysis). Factors considered by management in our analysis include an estimate of carrying costs during hypothetical expected lease-up periods, considering current market conditions, and costs to execute similar leases. We also consider information obtained about each targeted facility as a result of our pre-acquisition due diligence, marketing, and leasing activities in estimating the fair value of the intangible assets acquired. In estimating carrying costs, management includes real estate taxes, insurance and other operating expenses and estimates of lost rentals at market rates during the expected lease-up periods, which we expect to be about six months. depending on specific local market conditions. Management also estimates costs to execute similar leases including leasing commissions, legal costs, and other related expenses to the extent that such costs are not already incurred in connection with a new lease origination as part of the transaction.
	Other intangible assets acquired, may include customer relationship intangible values which are based on management’s evaluation of the specific characteristics of each prospective tenant’s lease and our overall relationship with that tenant. Characteristics to be considered by management in allocating these values include the nature and extent of our existing business relationships with the tenant, growth prospects for developing new business with the tenant, the tenant’s credit quality and expectations of lease renewals, including those existing under the terms of the lease agreement, among other factors.
	We amortize the value of in-place leases, if any, to expense over the initial term of the respective leases. The value of customer relationship intangibles is amortized to expense over the initial term and any renewal periods in the respective leases, but in no event will the amortization period for intangible assets exceed the remaining depreciable life of the building. If a lease is terminated, the unamortized portion of the in-place lease value and customer relationship intangibles are charged to expense.
	Real Estate and Depreciation: Real estate, consisting of land, buildings and improvements, are recorded at cost. Although typically paid by our tenants, any expenditure for ordinary maintenance and repairs that we pay are expensed to operations as incurred. Significant renovations and improvements which improve and/or extend the useful life of the asset are capitalized and depreciated over their estimated useful lives. We record impairment losses on long-lived assets used in operations when events and circumstances indicate that the assets might be impaired and the undiscounted cash flows estimated to be generated by those assets, including an estimated liquidation amount, during the expected holding periods are less than the carrying amounts of those assets. Impairment losses are measured as the difference between carrying value and fair value of assets. For assets held for sale, we cease recording depreciation expense and adjust the assets’ value to the lower of its carrying value or fair value, less cost of disposal. Fair value is based on estimated cash flows discounted at a risk-adjusted rate of interest. We classify real estate assets as held for sale when we have commenced an active program to sell the assets, and in the opinion of management, it is probable the asset will be sold within the next 12 months. We record the results of operations from material property sales or planned sales (which include real property, loans and any receivables) as discontinued operations in the consolidated statements of income for all periods presented if we do not have any continuing involvement with the property subsequent to its sale. Results of discontinued operations include interest expense from debt which specifically collateralizes the property sold or held for sale.
	Construction in progress includes the cost of land, the cost of construction of buildings, improvements and fixed equipment, and costs for design and engineering. Other costs, such as interest, legal, property taxes and corporate project supervision, which can be directly associated with the project during construction, are also included in construction in progress. We commence capitalization of costs associated with a development project when the development of the future asset is probable and activities necessary to get the underlying property ready for its intended use have been initiated. We stop the capitalization of costs when the property is substantially complete and ready for its intended use.
	Depreciation is calculated on the straight-line method over the weighted average useful lives of the related real estate and other assets, as follows:
	Buildings and improvements			38.2 years
	Tenant lease intangibles			18.6 years
	Leasehold improvements			22.2 years
	Furniture, equipment and other			9.4 years
	Losses from Rent Receivables: For all leases, we continuously monitor the performance of our existing tenants including, but not limited to: admission levels and surgery/procedure volumes by type; current operating margins; ratio of our tenant’s operating margins both to facility rent and to facility rent plus other fixed costs; trends in revenue and patient mix; and the effect of evolving healthcare regulations on tenant’s profitability and liquidity.
	Losses from Operating Lease Receivables:  We utilize the information above along with the tenant’s payment and default history in evaluating (on a property-by-property basis) whether or not a provision for losses on outstanding rent receivables is needed. A provision for losses on rent receivables (including straight-line rent receivables) is ultimately recorded when it becomes probable that the receivable will not be collected in full. The provision is an amount which reduces the receivable to its estimated net realizable value based on a determination of the eventual amounts to be collected either from the debtor or from existing collateral, if any.
	Losses on DFL Receivables:  Allowances are established for DFLs based upon an estimate of probable losses for the individual DFLs deemed to be impaired. DFLs are impaired when it is deemed probable that we will be unable to collect all amounts due in accordance with the contractual terms of the lease. Like operating lease receivables, the need for an allowance is based upon our assessment of the lessee’s overall financial condition; economic resources and payment record; the prospects for support from any financially responsible guarantors; and, if appropriate, the realizable value of any collateral. These estimates consider all available evidence including the expected future cash flows discounted at the DFL’s effective interest rate, fair value of collateral, and other relevant factors, as appropriate. DFLs are placed on non-accrual status when we determine that the collectability of contractual amounts is not reasonably assured. While on non-accrual status, we generally account for the DFLs on a cash basis, in which income is recognized only upon receipt of cash.
	Loans: Loans consist of mortgage loans, working capital loans and other long-term loans. Mortgage loans are collateralized by interests in real property. Working capital and other long-term loans are generally collateralized by interests in receivables and corporate and individual guarantees. We record loans at cost. We evaluate the collectability of both interest and principal on a loan-by-loan basis (using the same process as we do for assessing the collectability of rents) to determine whether they are impaired. A loan is considered impaired when, based on current information and events, it is probable that we will be unable to collect all amounts due according to the existing contractual terms. When a loan is considered to be impaired, the amount of the allowance is calculated by comparing the recorded investment to either the value determined by discounting the expected future cash flows using the loan’s effective interest rate or to the fair value of the collateral if the loan is collateral dependent. When a loan is deemed to be impaired, we generally place the loan on non-accrual status and record interest income only upon receipt of cash.
	Earnings Per Share/Units: Basic earnings per common share/unit is computed by dividing net income applicable to common shares/units by the weighted number of shares/units of common stock/units outstanding during the period. Diluted earnings per common share/units is calculated by including the effect of dilutive securities.
	Certain of our unvested restricted and performance stock/unit awards contain non-forfeitable rights to dividends, and accordingly, these awards are deemed to be participating securities. These participating securities are included in the earnings allocation in computing both basic and diluted earnings per common share/unit.
	Income Taxes: We conduct our business as a real estate investment trust (“REIT”) under Sections 856 through 860 of the Internal Revenue Code. To qualify as a REIT, we must meet certain organizational and operational requirements, including a requirement to distribute to stockholders at least 90% of our REIT’s ordinary taxable income. As a REIT, we generally are not subject to federal income tax on taxable income that we distribute to our stockholders. If we fail to qualify as a REIT in any taxable year, we will then be subject to federal income taxes on our taxable income at regular corporate rates and will not be permitted to qualify for treatment as a REIT for federal income tax purposes for four years following the year during which qualification is lost, unless the Internal Revenue Service grants us relief under certain statutory provisions. Such an event could materially adversely affect our net income and net cash available for distribution to stockholders. However, we intend to operate in such a manner so that we will remain qualified as a REIT for federal income tax purposes.
	Our financial statements include the operations of taxable REIT subsidiaries (“TRS”), including MPT Development Services, Inc. (“MDS”) and MPT Covington TRS, Inc. (“CVT”), along with 29 others, which are single member LLCs that are disregarded for tax purposes and are reflected in the tax returns of MDS. Our TRS entities are not entitled to a dividends paid deduction and are subject to federal, state, and local income taxes. Our TRS entities are authorized to provide property development, leasing, and management services for third-party owned properties, and they make loans to and/or investments in our lessees.
	With the property acquisitions in Germany, we will be subject to income taxes internationally. However, we do not expect to incur any additional income tazes in the United States as such income from our German properties will flow through our REIT income tax returns. For our TRS and international subsidiaries, we determine deferred tax assets and liabilities based on the differences between the financial reporting and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Any increase or decrease in the deferred tax liability that results from a change in circumstances, and that causes us to change our judgment about expected future tax consequences of events, is reflected in our tax provision when such changes occur. Deferred income taxes also reflect the impact of operating loss carryforwards. A valuation allowance is provided if we believe it is more likely than not that all or some portion of the deferred tax asset will not be realized. Any increase or decrease in the valuation allowance that results from a change in circumstances, and that causes us to change our judgment about the realizability of the related deferred tax asset, is reflected in our tax provision when such changes occur.
	Stock-Based Compensation: We adopted the 2013 Equity Incentive Plan (the “Equity Incentive Plan”) during the second quarter of 2013, which replaced the 2004 Equity Incentive Plan. Awards of restricted stock, stock options and other equity-based awards with service conditions are amortized to compensation expense over the vesting periods (typically three years), using the straight-line method. Awards of deferred stock units vest when granted and are charged to expense at the date of grant. Awards that contain market conditions are amortized to compensation expense over the derived vesting periods, which correspond to the periods over which we estimate the awards will be earned, which generally range from three to five years, using the straight-line method. Awards with performance conditions are amortized using the straight-line method over the service period in which the performance conditions are measured, adjusted for the probability of achieving the performance conditions.
	Deferred Costs: Costs incurred prior to the completion of offerings of stock or other capital instruments that directly relate to the offering are deferred and netted against proceeds received from the offering. External costs incurred in connection with anticipated financings and refinancings of debt are generally capitalized as deferred financing costs in other assets and amortized over the lives of the related loans as an addition to interest expense. For debt with defined principal re-payment terms, the deferred costs are amortized to produce a constant effective yield on the loan (interest method). For debt without defined principal repayment terms, such as revolving credit agreements, the deferred costs are amortized on the straight-line method over the term of the debt. Leasing commissions and other leasing costs directly attributable to tenant leases are capitalized as deferred leasing costs and amortized on the straight-line method over the terms of the related lease agreements. Costs identifiable with loans made to borrowers are recognized as a reduction in interest income over the life of the loan.
	Foreign Currency Translation and Transactions: Certain of our subsidiaries’ functional currencies are the local currencies of their respective countries. We translate the results of operations of our foreign subsidiaries into U.S. dollars using average rates of exchange in effect during the period, and we translate balance sheet accounts using exchange rates in effect at the end of the period. We record resulting currency translation adjustments in accumulated other comprehensive income, a component of stockholders’ equity on our consolidated balance sheets.
	Certain of our U.S. subsidiaries will enter into transactions denominated in foreign currency from time to time. Gains or losses resulting from these foreign currency transactions are translated into U.S. dollars at the rates of exchange prevailing at the dates of the transactions. The effects of transaction gains or losses are included in other income in the consolidated statements of income.
	Derivative Financial Investments and Hedging Activities: During our normal course of business, we may use certain types of derivative instruments for the purpose of managing interest rate and/or foreign currency risk. We record our derivative and hedging instruments at fair value on the balance sheet. Changes in the estimated fair value of derivative instruments that are not designated as hedges or that do not meet the criteria for hedge accounting are recognized in earnings. For derivatives designated as cash flow hedges, the change in the estimated fair value of the effective portion of the derivative is recognized in accumulated other comprehensive income (loss), whereas the change in the estimated fair value of the ineffective portion is recognized in earnings. For derivatives designated as fair value hedges, the change in the estimated fair value of the effective portion of the derivatives offsets the change in the estimated fair value of the hedged item, whereas the change in the estimated fair value of the ineffective portion is recognized in earnings.
	To qualify for hedge accounting, we formally document all relationships between hedging instruments and hedged items, as well as our risk management objective and strategy for undertaking the hedge prior to entering into a derivative transaction. This process includes specific identification of the hedging instrument and the hedge transaction, the nature of the risk being hedged and how the hedging instrument’s effectiveness in hedging the exposure to the hedged transaction’s variability in cash flows attributable to the hedged risk will be assessed. Both at the inception of the hedge and on an ongoing basis, we assess whether the derivatives that are used in hedging transactions are highly effective in offsetting changes in cash flows or fair values of hedged items. In addition, for cash flow hedges, we assess whether the underlying forecasted transaction will occur. We discontinue hedge accounting if a derivative is not determined to be highly effective as a hedge or that it is probable that the underlying forecasted transaction will not occur.
	Fair Value Measurement: We measure and disclose the estimated fair value of financial assets and liabilities utilizing a hierarchy of valuation techniques based on whether the inputs to a fair value measurement are considered to be observable or unobservable in a marketplace. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect our market assumptions. This hierarchy requires the use of observable market data when available. These inputs have created the following fair value hierarchy:
		•		Level 1 — quoted prices for identical instruments in active markets;
		•		Level 2 — quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which significant inputs and significant value drivers are observable in active markets; and
		•		Level 3 — fair value measurements derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
	We measure fair value using a set of standardized procedures that are outlined herein for all assets and liabilities which are required to be measured at their estimated fair value on either a recurring or non-recurring basis. When available, we utilize quoted market prices from an independent third party source to determine fair value and classify such items in Level 1. In some instances where a market price is available, but the instrument is in an inactive or over-the-counter market, we consistently apply the dealer (market maker) pricing estimate and classify the asset or liability in Level 2.
	If quoted market prices or inputs are not available, fair value measurements are based upon valuation models that utilize current market or independently sourced market inputs, such as interest rates, option volatilities, credit spreads, market capitalization rates, etc. Items valued using such internally-generated valuation techniques are classified according to the lowest level input that is significant to the fair value measurement. As a result, the asset or liability could be classified in either Level 2 or 3 even though there may be some significant inputs that are readily observable. Internal fair value models and techniques used by us include discounted cash flow and Monte Carlo valuation models. We also consider our counterparty’s and own credit risk on derivatives and other liabilities measured at their estimated fair value.
	Fair Value Option Election: For our equity interest in Ernest and related loans (as more fully described in Note 3), we have elected to account for these investments at fair value due to the size of the investments and because we believe this method is more reflective of current values. We have not made a similar election for other equity interest or loans made in or prior to 2012.
	Recent Accounting Developments: In July 2013, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update No. 2013-10, Inclusion of the Fed Funds Effective Swap Rate (or Overnight Index Swap Rate) as a Benchmark Interest Rate for Hedge Accounting Purposes (a consensus of the FASB Emerging Issues Task Force) (“ASU 2013-10”). This update permits the Fed Funds Effective Swap Rate to be used as a U.S. benchmark interest rate for hedge accounting purposes under Topic 815, in addition to the interest rates on direct Treasury obligations of the U.S. government and the London Interbank Offered Rate (“LIBOR”). The amendments are effective prospectively for qualifying new or redesignated hedging relationships entered into on or after July 17, 2013. The adoption of ASU 2013-10 on July 17, 2013, did not have a material impact on our 2013 consolidated financial position or results of operations.
	In January 2013, the FASB issued Accounting Standards Update (“ASU”) No. 2013-02, Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income (“ASU 2013-02”). The amendments in this update require an entity to provide information about the amounts reclassified from accumulated other comprehensive income by component. In addition, an entity is required to present, either on the face of the income statement or in the notes, significant amounts reclassified from accumulated other comprehensive income by the net income line item. The adoption of ASU 2013-02 did not have an impact on our 2013 consolidated financial position or results of operations.
	Reclassifications: Certain reclassifications have been made to the consolidated financial statements to conform to the 2013 consolidated financial statement presentation. Assets sold or held for sale have been reclassified to Real Estate Held for Sale on the consolidated balance sheets and related operating results have been reclassified from continuing operations to discontinued operations for all periods presented (see Note 11).

Real_Estate_and_Loans_Receivab

Real Estate and Loans Receivable	12 Months Ended
	Dec. 31, 2013
Text Block [Abstract]	'
Real Estate and Loans Receivable	'
	3	Real Estate and Loans Receivable
	Acquisitions
	We acquired the following assets:
			2013			2012				2011
	Assets Acquired			(in thousands)
	Land		$	41,473		$	518			$	19,705
	Building			439,030			8,942				220,769
	Intangible lease assets — subject to amortization (weighted average useful life 21.0 years in 2013, 15.0 years in 2012 and 13.9 years in 2011)			38,589			1,040				20,630
	Net investments in direct financing leases			110,580			310,000				—
	Mortgage loans			20,000			200,000				—
	Other loans			5,250			95,690				27,283
	Equity investments			—			5,300				5,168
	Total assets acquired		$	654,922		$	621,490			$	293,555
	Total liabilities assumed			—			—				(14,592	)
	Net assets acquired		$	654,922		$	621,490			$	278,963
	2013 Activity
	RHM Portfolio Acquisition
	On November 29, 2013, we acquired 11 rehabilitation facilities in the Federal Republic of Germany from RHM Klinik-und Altenheimbetriebe GmbH & Co. KG (“RHM”) for an aggregate purchase price, excluding €9 million applicable transfer taxes, of €175 million or $237.8 million. Each of the facilities are leased to RHM under a master lease providing for a term of 27 years and for annual rent increases of 2.0% from 2015 through 2017, and of 0.5% thereafter. On December 31, 2020 and every three years thereafter, rent will be increased to reflect 70% of cumulative increases in the German consumer price index.
	The RHM Acquisition represents our first acquisition outside of the United States. This acquisition adds a portfolio of assets with a financially stable long-term operating history and helps improve both our tenant and geographic diversification. As of December 31, 2013, we had $240.5 million of gross real estate assets located outside of the United States that generated $1.8 million of revenue in 2013.
	On December 12, 2013, we acquired the real estate of Dallas Medical Center in Dallas, Texas from affiliates of Prime for a purchase price of $25 million and leased the facility to Prime with an initial 10-year lease term under the master lease agreement, plus two renewal options of five years each. This lease is accounted for as a direct financing lease.
	On September 26, 2013, we acquired three general acute care hospitals from affiliates of IASIS for a combined purchase price of $281.3 million. Each of the facilities were leased back to IASIS under leases with initial 15-year terms plus two renewal options of five years each, and consumer price-indexed rent increases limited to a 2.5% ceiling annually. The lessees have a right of first refusal option with respect to subsequent proposed sales of the facilities. All of our leases with affiliates of IASIS will be cross-defaulted with each other. In addition to the IASIS acquisitions transactions, we have amended our lease with IASIS for the Pioneer Valley Hospital in West Valley City, Utah, which extended the lease to 2028 from 2019 and adjusted the rent.
	On July 18, 2013, we acquired the real estate of Esplanade Rehab Hospital in Corpus Christi, Texas (now operating as Corpus Christi Rehabilitation Hospital). The total purchase price was $10.5 million including $0.5 million for adjacent land. The facility is leased to an affiliate of Ernest under the master lease agreement entered into with Ernest in 2012 that initially provided for a 20-year term with three five-year extension options, plus consumer price-indexed rent increases, limited to a 2% floor and 5% ceiling annually. This lease is accounted for as a DFL. In addition, we made a $5.3 million loan on this property with terms similar to the lease terms.
	On June 11, 2013, we acquired the real estate of two acute care hospitals in Kansas from affiliates of Prime for a combined purchase price of $75 million and leased the facilities to the operator under a master lease agreement. The master lease is for 10 years and contains two renewal options of five years each, and the rent increases annually based on the greater of the consumer price-index or 2%. This lease is accounted for as a DFL.
	On December 31, 2013, we provided a $20 million mortgage financing to Alecto Healthcare Services for the 204-bed Olympia Medical Center.
	The purchase price allocations attributable to the RHM and IASIS acquisitions are preliminary. When all relevant information is obtained, resulting changes, if any, to our provisional purchase price allocation will be retrospectively adjusted to reflect new information obtained about the facts and circumstances that existed as of the respective acquisition dates that, if known, would have affected the measurement of the amounts recognized as of those dates.
	From the respective acquisition dates, these 2013 acquisitions contributed $13.6 million and $10.6 million of revenue and income (excluding related acquisition expenses) for the period ended December 31, 2013. In addition, we incurred $19.5 million of acquisition related expenses in 2013, of which $18.0 million (including $12 million in transfer taxes as a part of the RHM acquisition) related to acquisitions consummated as of December 31, 2013.
	2012 Activity
	On February 29, 2012, we made loans to and acquired assets from Ernest for a combined purchase price and investment of $396.5 million (“Ernest Transaction”).
	Real Estate Acquisition and Mortgage Loan Financing
	Pursuant to a definitive real property asset purchase agreement, we acquired from Ernest and certain of its subsidiaries (i) a portfolio of five rehabilitation facilities (including a ground lease interest relating to a community-based acute rehabilitation facility in Wyoming), (ii) seven long-term acute care facilities located in seven states and (iii) undeveloped land in Provo, Utah (collectively, the “Acquired Facilities”) for an aggregate purchase price of $200 million, subject to certain adjustments. The Acquired Facilities are leased to subsidiaries of Ernest pursuant to a master lease agreement. The master lease agreement has a 20-year term with three five-year extension options and provided for an initial rental rate of 9%, with consumer price-indexed increases, limited to a 2% floor and 5% ceiling annually thereafter. In addition, we made Ernest a $100 million loan secured by a first mortgage interest in four subsidiaries of Ernest, which has terms similar to the leasing terms described above.
	Acquisition Loan and Equity Contribution
	Through an affiliate of one of our TRSs, we made investments of approximately $96.5 million in Ernest Health Holdings, LLC, which is the owner of Ernest. These investments are structured as a $93.2 million acquisition loan and a $3.3 million equity contribution.
	The interest rate on the acquisition loan is 15%. Ernest is required to pay us a minimum of 6% and 7% of the loan amount in years one and two, respectively, and 10% thereafter, although there are provisions in the loan agreement that are expected to result in full payment of the 15% preference when funds are sufficient. Any of the 15% in excess of the minimum that is not paid may be accrued and paid upon the occurrence of a capital or liquidity event and is payable at maturity. The loan may be prepaid without penalty at any time.
	On July 3, 2012, we funded a $100 million mortgage loan secured by the real property of Centinela Hospital Medical Center. Centinela is a 369 bed acute care facility that is operated by Prime. This mortgage loan is cross-defaulted with other mortgage loans to Prime and certain master lease agreements. The initial term of this mortgage loan runs through 2022.
	On September 19, 2012, we acquired the real estate of the 380 bed St. Mary’s Regional Medical Center, an acute care hospital in Reno, Nevada for $80 million and the real estate of the 140 bed Roxborough Memorial Hospital in Pennsylvania for $30 million. The acquired facilities are leased to Prime pursuant to a master lease agreement, which is more fully described below in the Leasing Operations section.
	On December 14, 2012, we acquired the real estate of a 40 bed long-term acute care hospital in Hammond, Louisiana for $10.5 million and leased the facility to the operator under a 15-year lease, with three five-year extension options. The rent escalates annually based on consumer price indexed increases. As part of this transaction, we made a secured working capital loan of $2.5 million as well as a revolving loan of up to $2.0 million. In addition, we made a $2.0 million equity investment for a 25% equity ownership in the operator of this facility.
	From the respective acquisition dates in 2012 through that year end, these 2012 acquisitions contributed $46.3 million and $46.1 million of revenue and income (excluding related acquisition expenses) for the period ended December 31, 2012. In addition, we incurred $5.4 million of acquisition related expenses in 2012, of which $5.1 million related to acquisitions consummated as of December 31, 2012.
	2011 Activity
	On January 4, 2011, we acquired the real estate of the 19-bed, 4-year old Gilbert Hospital in a suburb of Phoenix, Arizona area for $17.1 million. Gilbert Hospital is operated by affiliates of Visionary Health, LLC, the same group that operates our Florence, Arizona facility. We acquired this asset subject to an existing lease that expires in May 2022. The lease contains three five-year extension options, and the rent escalates annually at 2.5%.
	On January 31, 2011, we acquired for $23.5 million the real estate of the 60-bed Atrium Medical Center at Corinth in the Dallas area, a long-term acute care hospital that was completed in 2009 and is subject to a lease that expires in June 2024. The lease contains two ten-year extension options, and the rent escalates annually based on consumer price indexed increases and to be not less than 1% or greater than 5%. In addition, through one of our affiliates, we invested $1.3 million to acquire approximately 19% of a joint venture arrangement with an affiliate of Vibra Healthcare, LLC (“Vibra”) that will manage and has acquired a 51% interest in the operations of the facility. We also made a $5.2 million working capital loan to the joint venture. The former operators of the hospital, comprised primarily of local physicians, retained ownership of 49% of the operating entity.
	On February 4, 2011, we purchased for $58 million the real estate of Bayonne Medical Center, a 6-story, 278-bed acute care hospital in the New Jersey area of metropolitan New York, and leased the facility to the operator under a 15-year lease, with six five-year extension options. The rent escalates annually based on consumer price indexed increases. The operator is an affiliate of a private hospital operating company that acquired the hospital in 2008.
	On February 9, 2011, we acquired the real estate of the 306-bed Alvarado Hospital in San Diego, California for $70 million from Prime. Prime is the operator of the facility.
	On February 14, 2011, we completed the acquisition of the Northland LTACH Hospital located in Kansas City, a 35-bed hospital that opened in April 2008 and has a lease that expires in 2028. The lease contains three five-year extension options, and the rent increases annually at 2.75%. This hospital is currently being operated by Kindred Healthcare Inc. The purchase price of this hospital was $19.5 million, which included the assumption of a $15 million existing mortgage loan that matures in January 2018.
	On July 18, 2011, we acquired the real estate of the 40-bed Vibra Specialty Hospital of DeSoto in Desoto, Texas for $13.0 million. This long-term acute care facility is leased to a subsidiary of Vibra for a fixed term of 15 years with three five-year extension options. Rent escalates annually based on consumer priced indexed increases. In addition, we made a $2.5 million equity investment in the operator of this facility for a 25% equity ownership.
	On September 30, 2011, we purchased the real estate of a 40-bed long-term acute care facility in New Braunfels, Texas for $10.0 million. This facility is leased to an affiliate of Post Acute Medical, LLC for a fixed term of 15 years with three five-year extension options. Rent escalates annually based on consumer priced indexed increases. In addition, we made a $1.4 million equity investment for a 25% equity ownership in the operator of this facility and funded a $2.0 million working capital loan.
	On November 4, 2011, we made investments in Hoboken University Medical Center in Hoboken, New Jersey, a 350-bed acute care facility. The total investment for this transaction was $75.0 million, comprising $50.0 million for the acquisition of an 100% ownership of the real estate, a secured working capital loan of up to $20.0 million (of which $15.1 million has been funded to-date), and the funding of a $5.0 million convertible note, which provides us with the option to acquire up to 25% of the hospital operator—See Loans section of this Note 3 for an update. The lease with the tenant has an initial term of 15 years, contains six five-year extension options, and the rent escalates annually based on consumer price indexed increases.
	From the respective acquisition dates in 2011 through that year-end, these 2011 acquisitions contributed $21.2 million of revenue and $14.1 million of income (excluding related acquisition expenses). In addition, we incurred $4.2 million in acquisition related expenses in 2011, of which $1.9 million related to acquisitions consummated as of December 31, 2011.
	The results of operations for each of the properties acquired in 2013 and 2012 are included in our consolidated results from the effective date of each acquisition. The following table sets forth certain unaudited pro forma consolidated financial data for 2013 and 2012, as if each acquisition was consummated on the same terms at the beginning of 2012 and 2011, respectively. Supplemental pro forma earnings were adjusted to exclude $18.0 million and $5.1 million of acquisition-related costs on these consummated deals incurred during 2013 and 2012, respectively (dollar amounts in thousands except per share/unit data).
			2013			2012
			(Amounts in thousands
			except per share/unit
			amounts)
	Total revenues		$	288,159		$	280,539
	Net income			133,258			135,402
	Net income per share/unit		$	0.82		$	0.85
	Development Activities
	On June 11, 2013, we entered into a master funding and development agreement with First Choice Emergency Room, LLC (“First Choice”) to develop up to 25 freestanding emergency room facilities for a maximum aggregate funding of $100 million. During 2013, we began construction on eight of these emergency room facilities for a total development price of $37.8 million. One of the facilities was completed in the fourth quarter of 2013, while the others are expected to be completed in 2014. We have funded $9.1 million through the end of 2013 for these facilities still under construction.
	On May 20, 2013, we entered into an agreement to finance the development of and lease an inpatient rehabilitation facility in South Ogden, Utah for $19.2 million, which will be leased to Ernest under the 2012 master lease. The facility is expected to be completed in the 2014 second quarter. We have funded $16.4 million through the end of 2013.
	On March 4, 2013, we entered into an agreement to finance the development of and lease an inpatient rehabilitation facility in Post Falls, Idaho for $14.4 million, which will be leased to Ernest under the 2012 master lease.
	On December 20, 2012, we entered into an agreement to finance the development of and lease an acute care facility in Altoona, Wisconsin for $33.5 million, which will be leased to an affiliate of National Surgical Hospitals.
	On October 1, 2012, we agreed to fund the construction of an inpatient rehabilitation hospital in Spartanburg, South Carolina that will be operated by Ernest. The facility was completed in 2013 for a total development cost of $16.9 million, and we began recognizing rent in August 2013.
	On June 13, 2012, we entered into an agreement with Ernest to fund the development of and lease a 40-bed rehabilitation hospital in Lafayette, Indiana. The facility was completed in 2013 for a total development costs of $15.7 million, and we began recognizing rent in February 2013.
	On May 4, 2012, we amended the current lease on our Victoria, Texas facility with Post Acute Medical to extend the current lease term to 2028, and we agreed to develop and lease a 26-bed facility next to the existing facility. The facilities will be operated as separate LTACH and rehabilitation hospitals. We completed development of the rehabilitation facility in 2013 for a total development costs of $9.4 million, and began recognizing rent in December 2013.
On March 1, 2012, we received a certificate of occupancy for our constructed Florence acute care facility near Phoenix, Arizona. With this, we started recognizing rent on this facility in March 2012. Land and building costs associated with this property approximates $30 million, and the lease term is 25 years.
On October 14, 2011, we entered into agreements with a joint venture of Emerus Holding, Inc. and Baptist Health System, to acquire, provide for development funding and lease three acute care hospitals for $30.0 million in the suburban markets of San Antonio, Texas. The three facilities are subject to a master lease structure with an initial term of 15 years and three five-year extension options. Rent escalates annually based on consumer priced indexed increases and to be not less than one percent or greater than three percent. We completed development and started recognizing rent on one of the facilities in October 2012 and in 2013 for the remaining two facilities.
In regards to our Twelve Oaks facility, approximately 55% of this facility became occupied as of January 23, 2013, pursuant to a 15 year lease.
See table below for a status update on our current development projects (in thousands):
Property		Location		Property Type	Operator		Commitment				Costs Incurred				Estimated
											as of				Completion
											12/31/13				Date
First Choice ER- Nacogdoches		San Antonio, TX		Acute Care Hospital	First Choice ER, LLC		$	5,100			$	2,681				1Q 2014
First Choice ER- Brodie		Austin, TX		Acute Care Hospital	First Choice ER, LLC			5,470				1,950				2Q 2014
First Choice ER- Alvin		Houston, TX		Acute Care Hospital	First Choice ER, LLC			5,240				1,328				2Q 2014
Northern Utah Rehabilitation Hospital		South Ogden, UT		Inpatient Rehabilitation Hospital	Ernest Health, Inc.			19,153				16,391				2Q 2014
First Choice ER- Briar Forest		Houston, TX		Acute Care Hospital	First Choice ER, LLC			5,833				1,386				3Q 2014
First Choice ER- Cedar Hill		Cedar Hill, TX		Acute Care Hospital	First Choice ER, LLC			5,768				1,167				3Q 2014
First Choice ER- Firestone		Firestone, CO		Acute Care Hospital	First Choice ER, LLC			5,172				544				3Q 2014
Oakleaf Surgical Hospital		Altoona, WI		Acute Care Hospital	National Surgical			33,500				16,324				3Q 2014
					Hospitals
First Choice Emergency Rooms		Various		Acute Care Hospital	First Choice			62,217				—				Various
							$	147,453			$	41,771
Disposals
On November 27, 2013, we sold the real estate of an inpatient rehabilitation facility, Warm Springs Rehabilitation Hospital of San Antonio, for $14 million, resulting in a gain on sale of $5.6 million.
On April 17, 2013, we sold two long-term acute care hospitals, Summit Hospital of Southeast Arizona and Summit Hospital of Southeast Texas, for total proceeds of $18.5 million, resulting in a gain of $2.1 million.
On December 27, 2012, we sold our Huntington Beach facility for $12.5 million, resulting in a gain of $1.9 million. Due to this sale, we wrote-off $0.7 million of straight-line rent receivable.
During the third quarter of 2012, we entered into a definitive agreement to sell the real estate of two LTACH facilities, Thornton and New Bedford, to Vibra for total cash proceeds of $42 million. The sale of Thornton was completed on September 28, 2012, resulting in a gain of $8.4 million. Due to this sale, we wrote-off $1.6 million in straight-line rent receivables. The sale of New Bedford was completed on October 22, 2012, resulting in a gain of $7.2 million. Associated with this sale, we wrote-off $4.1 million in straight-line rent receivables in the fourth quarter 2012.
On August 21, 2012, we sold our Denham Springs facility for $5.2 million, resulting in a gain of $0.3 million.
On June 15, 2012, we sold the HealthSouth Rehabilitation Hospital of Fayetteville in Fayetteville, Arkansas for $16 million, resulting in a loss of $1.4 million. In connection with this sale, HealthSouth Corporation agreed to extend the lease on our Wichita, Kansas property, which is now set to end in March 2022.
On December 30, 2011, we sold Sherman Oaks Hospital in Sherman Oaks, California to Prime for $20.0 million, resulting in a gain of $3.1 million. Due to this sale, we wrote-off $1.2 million in straight-line rent receivables.
On December 30, 2011, we sold MountainView Regional Rehabilitation Hospital in Morgantown, West Virginia to HealthSouth Corporation for $21.1 million, resulting in a gain of $2.3 million.
For each of these disposals, the operating results of these facilities for the current and all prior periods have been included in discontinued operations, and we have reclassified the related real estate to Real Estate Held for Sale.
Intangible Assets
At December 31, 2013 and 2012, our intangible lease assets were $90.5 million ($75.0 million, net of accumulated amortization) and $52.0 million ($40.1 million, net of accumulated amortization), respectively.
We recorded amortization expense related to intangible lease assets of $4.0 million, $3.9 million, and $5.2 million in 2013, 2012, and 2011, respectively, and expect to recognize amortization expense from existing lease intangible assets as follows: (amounts in thousands)
For the Year Ended December 31:
2014		$	5,086
2015			4,896
2016			4,855
2017			4,845
2018			4,784
As of December 31, 2013, capitalized lease intangibles have a weighted average remaining life of 18.6 years.
Leasing Operations
All of our leases are accounted for as operating leases except we are accounting for 13 Ernest facilities and five Prime facilities as DFLs. The components of our net investment in DFLs consisted of the following (dollars in thousands):
		As of December 31,
		2013
Minimum lease payments receivable		$	1,647,567
Estimated residual values			211,863
Less unearned income			(1,428,406	)
Net investment in direct financing leases		$	431,024
Minimum rental payments due to us in future periods under operating leases and DFL, which have non-cancelable terms extending beyond one year at December 31, 2013, are as follows: (amounts in thousands)
		Total Under			Total Under				Total
		Operating Leases			DFLs
2014		$	166,602		$	42,535			$	209,137
2015			164,754			43,386				208,140
2016			165,517			44,254				209,771
2017			165,418			45,139				210,557
2018			165,679			46,041				211,720
Thereafter			1,536,759			601,981				2,138,740
		$	2,364,729		$	823,336			$	3,188,065
On July 3, 2012, we entered into master lease agreements with certain subsidiaries of Prime, which replaced the then current leases with the same tenants covering the same properties. The master leases are for 10 years and contain two renewal options of five years each. The initial lease rate is generally consistent with the blended average rate of the prior lease agreements. However, the annual escalators, which in the prior leases were limited, have been increased to 100% of consumer price index increases, along with a minimum floor. The master leases include repurchase options substantially similar to those in the prior leases, including provisions establishing minimum repurchase prices equal to our total investment.
In the 2011 fourth quarter, we consented to the sale by Vibra of its Dallas LTACH, for which we own the real estate to an affiliate of LifeCare Reit 2, Inc. (“LifeCare”) and LifeCare executed a restated lease agreement. As a result of this transaction, we wrote off the related straight line rent receivables of $1.3 million and accelerated the amortization of the related lease intangibles resulting in $0.6 million of expense in the 2011 fourth quarter.
Monroe Facility
As of December 31, 2013, we have advanced $31.1 million to the operator/lessee of Monroe Hospital in Bloomington, Indiana pursuant to a working capital loan agreement, including $1.2 million in advances during 2013. In addition, as of December 31, 2013, we have $21.0 million of rent, interest and other charges owed to us by the operator, of which $6.0 million of interest receivables are significantly more than 90 days past due. Because the operator has not made all payments required by the working capital loan agreement and the related real estate lease agreement, we consider the loan to be impaired. During 2010, we recorded a $12 million impairment charge on the working capital loan and recorded a valuation allowance for unbilled straight-line rent in the amount of $2.5 million. We have not recognized any interest income on the Monroe loan since it was considered impaired and have not recorded any unbilled rent since 2010. In addition, we stopped recording rental revenue on April 1, 2013, until we begin receiving cash payments.
At December 31, 2013, our net investment (exclusive of the related real estate) of approximately $40.3 million is our maximum exposure to Monroe and the amount is deemed collectible/recoverable. In making this determination, we considered our first priority secured interest in approximately (i) $4 million in hospital patient receivables, (ii) cash balances of approximately $0.1 million, (iii) our assessment of the realizable value of our other collateral and (iv) projected EBITDA of the hospital operations that we have modeled under various scenarios for sensitivity purposes. In order to recover our aggregate net investment in Monroe, we believe a restructuring of our lease and loan with a new operator may be needed. Among other provisions, we expect this would include our participation in future operating income and sale proceeds, if any, over a multi-year period. We are presently negotiating the potential terms of such a restructuring with several separate parties, although there is no assurance that we will complete a transaction with any of these parties. Moreover, we may conclude that the potential lease income and our share of operating income and sale proceeds would be insufficient for us to recover all of our net investment , in which case further impairment charges would be necessary. The amount, if any, of such further impairment is uncertain, and no assurances can be made that we will not have additional impairment charges on our working capital loan or other receivables in the future. Additional uncertainty may result if our current lessee/borrower enters bankruptcy proceedings, which is possible.
Florence facility
On March 6, 2013, the tenant of our $29.4 million facility in Phoenix, Arizona filed for Chapter 11 bankruptcy. Florence is current on its rent, and at December 31, 2013, we had less than $0.8 million of receivables outstanding. In addition, we have a letter of credit for approximately $1.2 million to cover any rent and other monetary payments not paid in the future. Although no assurances can be made that we will not have any impairment charges in the future, we believe our investment in Florence at December 31, 2013, is fully recoverable.
Gilbert facility
In 2014, the tenant of our $17.1 million facility in Gilbert, Arizona filed for Chapter 11 bankruptcy, and we sent notice of termination of the lease prior to the bankruptcy filing. Gilbert was current on its rent through December 31, 2013. However, we did have approximately $0.9 million of straight-line rent receivables associated with this lease at December 31, 2013. Although no assurances can be made that we will not have any impairment charges or write-offs of receivables in the future, we believe our investment in Gilbert at December 31, 2013, is fully recoverable.
Loans
The following is a summary of our loans ($ amounts in thousands):
		As of December 31, 2013							As of December 31, 2012
		Balance			Weighted Average				Balance				Weighted Average
					Interest Rate								Interest Rate
Mortgage loans		$	388,650			10.2	%		$	368,650				10	%
Acquisition loans			103,266			14.5	%			98,433				14.7	%
Working capital and other loans			57,724			10.9	%			60,810				10.8	%
		$	549,640						$	527,893
Our mortgage loans cover 9 of our properties with four operators. The increase from 2012 is primarily related to the $20 million loan for the Olympia property as previously discussed under the heading of Acquisitions in this Note 3.
Other loans typically consist of loans to our tenants for acquisitions and working capital purposes. Our $98.0 million acquisition loans with Ernest, our Hoboken convertible loan and our $19.1 million working capital loan to Monroe (net of $12 million loan loss reserve) are included in other loans.
On March 1, 2012, pursuant to our convertible note agreement, we converted $1.6 million of our $5.0 million convertible note into a 9.9% equity interest in the operator of our Hoboken University Medical Center facility. At December 31, 2013, $3.4 million remains outstanding on the convertible note, and we retain the option, to convert this remainder into an additional 15.1% equity interest in the operator.
Concentration of Credit Risks
For the year ended December 31, 2013 and 2012, revenue from affiliates of Ernest (including rent and interest from mortgage and acquisition loans) accounted for 20.2% and 18.6% of total revenue, respectively. From an investment concentration perspective, Ernest represented 15.9% and 18.2% of our total assets at December 31, 2013 and December 31, 2012, respectively.
For the years ended December 31, 2013 and 2012, revenue from affiliates of Prime (including rent and interest from mortgage loans) accounted for 32.0% and 27.3%, respectively, of total revenue. From an investment concentration perspective, Prime represented 24.5% and 27.9% of our total assets at December 31, 2013 and December 31, 2012, respectively.
On an individual property basis, we had no investment of any single property greater than 4% of our total assets as of December 31, 2013.
From a geographic perspective, Investments located in California represented 18.7% of our total assets at December 31, 2013, down from 24.0% in the prior year. Investments located in Texas represented 22.7% of our total assets at December 31, 2013, down from 23.6% in the prior year. In addition, we further expanded our portfolio into Europe with the RHM portfolio acquisition, which represents less than 9% of total assets at December 31, 2013.
Related Party Transactions
Lease and interest revenue earned from tenants in which we have an equity interest in were $70.0 million, $54.3 million and $5.5 million in 2013, 2012 and 2011, respectively.

Debt

Debt	12 Months Ended
	Dec. 31, 2013
Debt Disclosure [Abstract]	'
Debt	'
	4	Debt
	The following is a summary of debt ($ amounts in thousands):
			As of December 31, 2013					As of December 31, 2012
			Balance		Interest Rate			Balance			Interest Rate
	Revolving credit facility		$	105,000		Variable		$	125,000			Variable
	2006 Senior Unsecured Notes			125,000		Various			125,000			Various
	2011 Senior Unsecured Notes			450,000		6.875	%		450,000			6.875	%
	2012 Senior Unsecured Notes:
	Principal amount			350,000		6.375	%		200,000			6.375	%
	Unamortized premium			2,873					—
				352,873					200,000
	Exchangeable senior notes:
	Principal amount			—					11,000			9.25	%
	Unamortized discount			—					(37	)
				—					10,963
	2013 Senior Unsecured Notes			274,860		5.75	%		—
	Term loans			113,948		Various			114,197			Various
			$	1,421,681				$	1,025,160
	As of December 31, 2013, principal payments due on our debt (which exclude the effects of any discounts or premiums recorded) are as follows: (A)
	2014		$	265
	2015			105,283
	2016			225,299
	2017			320
	2018			12,781
	Thereafter			1,074,860
	Total		$	1,418,808
	(A)	Our 2013 Senior Unsecured Notes are Euro-denominated. We have used the exchange rate at December 31, 2013 in this debt maturity schedule.
	In order to fund our 2013 acquisitions disclosed in Note 3, we completed a public offering of €200 million aggregate principal amount of our 5.750% Senior Notes due 2020 (the “2013 Senior Unsecured Notes”) and did a $150 million tack on to our 2012 Senior Unsecured Notes.
	To help fund the 2012 acquisitions disclosed in Note 3, on February 17, 2012, we completed the “2012 Senior Unsecured Notes” for $200 million, resulting in net proceeds, after underwriting discount, of $196.5 million. These 2012 Senior Unsecured Notes accrue interest at a fixed rate of 6.375% per year and mature on February 15, 2022. The 2012 Senior Unsecured Notes include covenants substantially consistent with our 2011 Senior Unsecured Notes. In addition, on March 9, 2012, we closed on a $100 million senior unsecured term loan facility (“2012 Term Loan”).
	Revolving Credit Facility
	In March 2012, we exercised the $70 million accordion feature on our unsecured revolving credit facility, increasing the capacity from $330 million to $400 million. The unsecured revolving credit facility matures in October 2015. The interest rate is (1) the higher of the “prime rate” or federal funds rate plus 0.5%, plus a spread initially set at 1.60%, but that is adjustable from 1.60% to 2.40% based on current total leverage, or (2) LIBOR plus a spread initially set at 2.60%, but that is adjustable from 2.60% to 3.40% based on current total leverage. Interest rate spread was 2.85% at December 31, 2013 and 2012. In addition to interest expense, we are required to pay a quarterly commitment fee on the undrawn portion of the revolving credit facility, ranging from 0.375% to 0.500% per year. At December 31, 2013 and 2012, our outstanding balance on the revolving credit facility was $105 million and $125 million, respectively. At December 31, 2013, our availability under our revolving credit facility was $295 million. The weighted average interest rate on this facility was 3.2% and 3.2% for 2013 and 2012, respectively.
	2013 Senior Unsecured Notes
	On October 10, 2013, we completed the 2013 Senior Unsecured Notes offering for €200 million (or $274.9 million.) Interest on the Notes will be payable semi-annually on April 1 and October 1 of each year, commencing on April 1, 2014. The 2013 Senior Unsecured Notes will pay interest in cash at a rate of 5.750% per year. The Notes mature on October 1, 2020. We may redeem some or all of the 2013 Senior Unsecured Notes at any time prior to October 1, 2016 at a “make-whole” redemption price. On or after October 1, 2016, we may redeem some or all of the Notes at a premium that will decrease over time. In addition, at any time and from time to time prior to October 1, 2016, we may redeem up to 35% of the aggregate principal amount of the 2013 Senior Unsecured Notes using the proceeds of one or more equity offerings. The 2013 Senior Unsecured Notes are fully and unconditionally guaranteed, jointly and severally, on an unsecured basis, by certain subsidiary guarantors. In the event of a change of control, each holder of the 2013 Senior Unsecured Notes may require us to repurchase some or all of our 2013 Senior Unsecured Notes at a repurchase price equal to 101% of the aggregate principal amount of the 2013 Senior Unsecured Notes plus accrued and unpaid interest to the date of purchase.
	2012 Senior Unsecured Notes
	On February 17, 2012, we completed a $200 million offering of senior unsecured notes (“2012 Senior Unsecured Notes”) (resulting in net proceeds of $196.5 million, after underwriting discount). On August 20, 2013, we completed a $150 million tack on to the notes (resulting in net proceeds of $150.4 million, after underwriting discount). These 2012 Senior Unsecured Notes accrue interest at a fixed rate of 6.375% per year and mature on February 15, 2022. The 2013 tack on offering, was issued at a premium (price of 102%), resulting in an effective rate of 5.998%. Interest on these notes is payable semi-annually on February 15 and August 15 of each year. We may redeem some or all of the 2012 Senior Unsecured Notes at any time prior to February 15, 2017 at a “make-whole” redemption price. On or after February 15, 2017, we may redeem some or all of the 2012 Senior Unsecured Notes at a premium that will decrease over time, plus accrued and unpaid interest to, but not including, the redemption date. The 2012 Senior Unsecured Notes are guaranteed, jointly and severally, on an unsecured basis, by certain subsidiary guarantors. In the event of a change of control, each holder of the 2012 Senior Unsecured Notes may require us to repurchase some or all of its 2012 Senior Unsecured Notes at a repurchase price equal to 101% of the aggregate principal amount plus accrued and unpaid interest to the date of purchase.
	2011 Senior Unsecured Notes
	On April 26, 2011, we closed on a private placement of $450 million aggregate principal amount of 6.875% Senior Notes due 2021 (the “2011 Senior Unsecured Notes”) to qualified institutional buyers in reliance on Rule 144A under the Securities Act. The 2011 Senior Unsecured Notes were subsequently registered under the Securities Act pursuant to an exchange offer. Interest on the 2011 Senior Unsecured Notes is payable semi-annually on May 1 and November 1 of each year. The 2011 Senior Unsecured Notes pay interest in cash at a rate of 6.875% per year and mature on May 1, 2021. We may redeem some or all of the 2011 Senior Unsecured Notes at any time prior to May 1, 2016 at a “make-whole” redemption price. On or after May 1, 2016, we may redeem some or all of the 2011 Senior Unsecured Notes at a premium that will decrease over time, plus accrued and unpaid interest to, but not including, the redemption date. The 2011 Senior Unsecured Notes are guaranteed, jointly and severally, on an unsecured basis, by the certain subsidiary guarantors. In the event of a change of control, each holder of the 2011 Senior Unsecured Notes may require us to repurchase some or all of its 2011 Senior Unsecured Notes at a repurchase price equal to 101% of the aggregate principal amount plus accrued and unpaid interest to the date of purchase.
	2006 Senior Unsecured Notes
	During 2006, we issued $125.0 million of Senior Unsecured Notes (the “2006 Senior Unsecured Notes”). The 2006 Senior Unsecured Notes were placed in private transactions exempt from registration under the Securities Act of 1933, as amended, (the “Securities Act”). One of the issuances of the 2006 Senior Unsecured Notes totaling $65.0 million paid interest quarterly at a fixed annual rate of 7.871% through July 30, 2011, thereafter, at a floating annual rate of three-month LIBOR plus 2.30% and can be called at par value by us at any time. This portion of the 2006 Senior Unsecured Notes matures in July 2016. The remaining issuances of 2006 Senior Unsecured Notes paid interest quarterly at fixed annual rates ranging from 7.333% to 7.715% through October 30, 2011, thereafter, at a floating annual rate of three-month LIBOR plus 2.30% and can also called at par value by us at any time. These remaining notes mature in October 2016.
	During the second quarter 2010, we entered into an interest rate swap to manage our exposure to variable interest rates by fixing $65 million of our $125 million 2006 Senior Unsecured Notes, which started July 31, 2011 (date on which the interest rate turned variable) through maturity date (or July 2016), at a rate of 5.507%. We also entered into an interest rate swap to fix $60 million of 2006 Senior Unsecured Notes which started October 31, 2011 (date on which the related interest rate turned variable) through the maturity date (or October 2016) at a rate of 5.675%. At December 31, 2013 and 2012, the fair value of the interest rate swaps was $9.0 million and $12.5 million, respectively, which is reflected in accounts payable and accrued expenses on the consolidated balance sheets.
	We account for our interest rate swaps as cash flow hedges. Accordingly, the effective portion of changes in the fair value of our swaps is recorded as a component of accumulated other comprehensive income/loss on the balance sheet and reclassified into earnings in the same period, or periods, during which the hedged transactions effects earnings, while any ineffective portion is recorded through earnings immediately. We did not have any hedge ineffectiveness from inception of our interest rate swaps through December 31, 2013 and therefore, there was no income statement effect recorded during the years ended December 31, 2013, 2012, and 2011. We do not expect any of the current losses included in accumulated other comprehensive loss to be reclassified into earnings in the next 12 months. At December 31, 2013 and 2012, we have posted $5.0 million and $6.6 million of collateral related to our interest rate swaps, respectively, which is reflected in other assets on our consolidated balance sheets.
	Term Loans
	As noted previously, we closed on the 2012 Term Loan for $100 million on March 9, 2012. The 2012 Term Loan facility has an interest rate option of (1) LIBOR plus an initial spread of 2.25% or (2) the higher of the “prime rate”, federal funds rate plus 0.5%, or Eurodollar rate plus 1.0%, plus an initial spread of 1.25%. The interest rate in effect at December 31, 2013 and December 31, 2012 were 2.43% and 2.47%, respectively. The 2012 Term Loan facility is scheduled to mature on March 9, 2016, but we have the option to extend the facility one year to March 9, 2017.
	In connection with our acquisition of the Northland LTACH Hospital on February 14, 2011, we assumed a $14.6 million mortgage. The Northland mortgage loan requires monthly principal and interest payments based on a 30-year amortization period. The Northland mortgage loan has a fixed interest rate of 6.2%, matures on January 1, 2018 and can be prepaid after January 1, 2013, subject to a certain prepayment premium. At December 31, 2013, the remaining balance on this term loan was $13.9 million. The loan was collateralized the real estate of the Northland LTACH Hospital, which had a net book value of $18.0 million and $18.5 million at December 31, 2013 and 2012, respectively.
	Exchangeable Senior Notes
	In March 2008, our Operating Partnership issued and sold, in a private offering, $75.0 million of Exchangeable Senior Notes (the “2008 Exchangeable Notes”) and received proceeds of $72.8 million. In April 2008, the Operating Partnership sold an additional $7.0 million of the 2008 Exchangeable Notes (under the initial purchasers’ overallotment option) and received proceeds of $6.8 million. The interest rate on our 2008 Exchangeable Notes was 9.25% per annum. In July 2011, we used a portion of the proceeds from the 2011 Senior Unsecured Notes to repurchase 85% of the outstanding 2008 Exchangeable Notes at a price of 118.5% of the principal amount plus accrued and unpaid interest (or $84.2 million) pursuant to a cash tender offer. Additionally, in August 2011, we repurchased $1.5 million of the outstanding 2008 Exchangeable Notes in the open market. The remainder of our 2008 Exchangeable Notes were paid in full in April 2013.
	Covenants
	Our debt facilities impose certain restrictions on us, including restrictions on our ability to: incur debts; create or incur liens; provide guarantees in respect of obligations of any other entity; make redemptions and repurchases of our capital stock; prepay, redeem or repurchase debt; engage in mergers or consolidations; enter into affiliated transactions; dispose of real estate or other assets; and change our business. In addition, the credit agreements governing our revolving credit facility and 2012 Term Loan limit the amount of dividends we can pay as a percentage of normalized adjusted funds from operations, as defined in the agreements, on a rolling four quarter basis. At December 31, 2013, the dividend restriction was 95% of normalized adjusted FFO. The indentures governing our 2011 and 2012 Senior Unsecured Notes also limit the amount of dividends we can pay based on the sum of 95% of funds from operations, proceeds of equity issuances and certain other net cash proceeds. Finally, our 2011 and 2012 Senior Unsecured Notes require us to maintain total unencumbered assets (as defined in the related indenture) of not less than 150% of our unsecured indebtedness.
	In addition to these restrictions, the revolving credit facility and 2012 Term Loan contain customary financial and operating covenants, including covenants relating to our total leverage ratio, fixed charge coverage ratio, mortgage secured leverage ratio, recourse mortgage secured leverage ratio, consolidated adjusted net worth, facility leverage ratio, and unsecured interest coverage ratio. This facility also contains customary events of default, including among others, nonpayment of principal or interest, material inaccuracy of representations and failure to comply with our covenants. If an event of default occurs and is continuing under the facility, the entire outstanding balance may become immediately due and payable. At December 31, 2013, we were in compliance with all such financial and operating covenants.

Income_Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2013
Income Tax Disclosure [Abstract]	'
Income Taxes	'
	5	Income Taxes
	Medical Properties Trust, Inc.
	We have maintained and intend to maintain our election as a REIT under the Internal Revenue Code of 1986, as amended. To qualify as a REIT, we must meet a number of organizational and operational requirements, including a requirement to distribute at least 90% of our taxable income to our stockholders. As a REIT, we generally will not be subject to federal income tax if we distribute 100% of our taxable income to our stockholders and satisfy certain other requirements. Income tax is paid directly by our stockholders on the dividends distributed to them. If our taxable income exceeds our dividends in a tax year, REIT tax rules allow us to designate dividends from the subsequent tax year in order to avoid current taxation on undistributed income. If we fail to qualify as a REIT in any taxable year, we will be subject to federal income taxes at regular corporate rates, including any applicable alternative minimum tax. Taxable income from non-REIT activities managed through our taxable REIT subsidiaries is subject to applicable United States federal, state and local income taxes. Our international subsidiaries are also subject to income taxes in the jurisdictions in which they operate.
	From our taxable REIT subsidiaries and our foreign operations (which realized a $12.9 million loss before income taxes in 2013 primarily due to the real estate transfer taxes), we incurred income tax expenses as follows (in thousands):
			For the Years Ended December 31,
			2013			2012			2011
	Domestic		$	568		$	19		$	128
	Foreign			158			—			—
			$	726		$	19		$	128
	At December 31, 2013 and 2012, components of our deferred tax assets and liabilities were as follows (in thousands):
			2013			2012
	Deferred tax liabilities:
	Property and equipment		$	(2,870	)	$	(2,370	)
	Other			(2,923	)		(1,673	)
	Total deferred tax liabilities			(5,793	)		(4,043	)
	Deferred tax assets:
	Loan loss and other reserves			7,751			7,218
	Operating loss and interest deduction carry forwards			2,283			3,938
	Other			3,371			1,261
	Total deferred tax assets			13,405			12,417
	Valuation allowance			(7,843	)		(8,540	)
	Net deferred tax (liability)		$	(231	)	$	(166	)
	At December 31, 2013, we had U.S. federal and state NOLs of $0.2 million and $7.6 million, respectively, that expire in 2026 through 2032.
	In 2013, our valuation allowance increased by $1.9 million as a result of book losses sustained by our German subsidiaries as the result of significant acquisition expenses incurred. This was offset by a $2.6 million decrease in the valuation allowance at one of the U.S. TRS entities (MDS), which generated income in 2013 (after having historical losses). We believe (based on cumulative losses) that we should reserve for our net deferred tax assets. We will continue to monitor this valuation allowance and, if circumstances change (such as entering into new transactions including working capital loans, equity investments, etc), we will adjust this valuation allowance accordingly.
	We have met the annual REIT distribution requirements by payment of at least 90% of our estimated taxable income in 2013, 2012, and 2011. Earnings and profits, which determine the taxability of such distributions, will differ from net income reported for financial reporting purposes due primarily to differences in cost basis, differences in the estimated useful lives used to compute depreciation, and differences between the allocation of our net income and loss for financial reporting purposes and for tax reporting purposes.
	A schedule of per share distributions we paid and reported to our stockholders is set forth in the following:
			For the Years Ended December 31,
			2013			2012			2011
	Common share distribution		$	0.8		$	0.8		$	0.8
	Ordinary income			0.599384			0.601216			0.300844
	Capital gains(1)			0.04638			0.117584			0.031396
	Unrecaptured Sec. 1250 gain			0.026512			0.086976			0.031396
	Return of capital			0.154236			0.0812			0.46776
	Allocable to next year			—			—			—
	-1	Capital gains include unrecaptured Sec. 1250 gains.
	MPT Operating Partnership, L.P.
	As a partnership, the allocated share of income of the Operating Partnership is included in the income tax returns of the general and limited partners. Accordingly, no accounting for income taxes is generally required for such income of the Operating Partnership. However, the Operating Partnership has formed taxable REIT subsidiaries on behalf of Medical Properties Trust, Inc., which are subject to federal, state and local income taxes at regular corporate rates, and its international subsidiaries are subject to income taxes in the jurisdictions in which they operate. See discussion above under Medical Properties Trust, Inc. for more details of income taxes associated with our taxable REIT subsidiaries.

Earnings_Per_ShareUnit

Earnings Per Share/Unit	12 Months Ended
	Dec. 31, 2013
Earnings Per Share [Abstract]	'
Earnings Per Share/Unit	'
	6	Earnings Per Share/Unit
	Medical Properties Trust, Inc.
	Our earnings per share were calculated based on the following (amounts in thousands):
			For the Years Ended December 31,
			2013			2012			2011
	Numerator:
	Income from continuing operations		$	89,301		$	72,870		$	12,120
	Non-controlling interests’ share in continuing operations			(224	)		(177	)		(178	)
	Participating securities’ share in earnings			(729	)		(887	)		(1,090	)
	Income from continuing operations, less participating securities’ share in earnings			88,348			71,806			10,852
	Income from discontinued operations attributable to MPT common stockholders			7,914			17,207			14,594
	Net income, less participating securities’ share in earnings		$	96,262		$	89,013		$	25,446
	Denominator:
	Basic weighted-average common shares			151,439			132,331			110,623
	Dilutive potential common shares			1,159			2			6
	Diluted weighted-average common shares			152,598			132,333			110,629
	MPT Operating Partnership, L.P.
	Our earnings per unit were calculated based on the following (amounts in thousands):
			For the Years Ended December 31,
			2013			2012			2011
	Numerator:
	Income from continuing operations		$	89,301		$	72,870		$	12,137
	Non-controlling interests’ share in continuing operations			(244	)		(177	)		(178	)
	Participating securities’ share in earnings			(729	)		(887	)		(1,090	)
	Income from continuing operations, less participating securities’ share in earnings			88,328			71,806			10,869
	Income from discontinued operations attributable to MPT Operating Partnership partners			7,914			17,207			14,594
	Net income, less participating securities’ share in earnings		$	96,242		$	89,013		$	25,463
	Denominator:
	Basic weighted-average units			151,439			132,331			110,623
	Dilutive potential units			1,159			2			6
	Diluted weighted-average units			152,598			132,333			110,629
	For each of the years ended December 31, 2012 and 2011, approximately 0.1 million of options were excluded from the diluted earnings per share/unit calculation as they were not determined to be dilutive.

Stock_Awards

Stock Awards	12 Months Ended
	Dec. 31, 2013
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]	'
Stock Awards	'
	7	Stock Awards
	Stock Awards
	Our Equity Incentive Plan authorizes the issuance of common stock options, restricted stock, restricted stock units, deferred stock units, stock appreciation rights, performance units and awards of interests in our Operating Partnership. Our Equity Incentive Plan is administered by the Compensation Committee of the Board of Directors. We have reserved 7,643,651 shares of common stock for awards under the Equity Incentive Plan and 7,643,651 shares remain available for future stock awards as of December 31, 2013. The Equity Incentive Plan contains a limit of 5,000,000 shares as the maximum number of shares of common stock that may be awarded to an individual in any fiscal year. Awards under the Equity Incentive Plan are subject to forfeiture due to termination of employment prior to vesting. In the event of a change in control, outstanding and unvested options will immediately vest, unless otherwise provided in the participant’s award or employment agreement, and restricted stock, restricted stock units, deferred stock units and other stock-based awards will vest if so provided in the participant’s award agreement. The term of the awards is set by the Compensation Committee, though Incentive Stock Options may not have terms of more than ten years. Forfeited awards are returned to the Equity Incentive Plan and are then available to be re-issued as future awards. For each share of common stock issued by Medical Properties Trust, Inc. pursuant to its Equity Incentive Plan, the Operating Partnership issues a corresponding number of operating partnership units.
	The following awards have been granted pursuant to our Equity Incentive Plan (and its predecesor plan):
	Stock Options
	At December 31, 2013, we had 20,000 options outstanding and exercisable, with a weighted-average exercise price of $10.00 per option. The intrinsic value of options exercisable and outstanding at December 31, 2013, is $-0-. In 2013, 40,000 options were exercised, while 20,000 options were settled for cash in 2011. No options were granted in 2013, 2012, or 2011. The weighted average remaining contractual term of options exercisable and outstanding is 0.3 years.
	Restricted Equity Awards
	Other stock-based awards are in the form of service-based awards and performance-based awards. The service-based awards vest as the employee provides the required service (typically three to five years). Service based awards are valued at the average price per share of common stock on the date of grant. In 2013, 2012, and 2011, the Compensation Committee granted awards to employees which vest based on us achieving certain total shareholder returns or comparisons of our total shareholder returns to peer total return indices. Generally, dividends are not paid on these performance awards until the award is earned. See below for details of such grants:
		-	2013 performance awards - The 2013 performance awards were granted in three parts:
		1)	Approximately 27% of the 2013 performance awards were based on us achieving a simple 8.5% annual total shareholder return over a three year period; however, the award contained both carry forward and carry back provisions through December 31, 2017. None of these shares may be sold for two years after they have vested. The fair value of this award was estimated on the date of grant using a Monte Carlo valuation model that assumed the following: risk free interest rate of 0.72%; expected volatility of 27%; expected dividend yield of 8.0%; and expected service period of 3 years.
		2)	Approximately 36% of the 2013 performance awards were based on us achieving a cumulative total shareholder return from January 1, 2013 to December 31, 2015. The minimum total shareholder return needed to earn a portion of this award is 25.5% with 100% of the award earned if our total shareholder return reaches 33.5%. If any shares are earned from this award, the shares will vest in equal annual amounts on December 31, 2015, 2016 and 2017. The fair value of this award was estimated on the date of grant using a Monte Carlo valuation model that assumed the following: risk free interest rate of 0.38%; expected volatility of 28%; expected dividend yield of 8.0%; and expected service period of 5 years.
		3)	The remainder of the 2013 performance awards will be earned if our total shareholder return outpaces that of the MSCI U.S. REIT Index (“Index”) over the cumulative period from January 1, 2013 to December 31, 2015. Our total shareholder return must exceed that of the Index to earn the minimum number of shares under this award, while it must exceed the Index by 6% to earn 100% of the award. If any shares are earned from this award, the shares will vest in equal annual amounts on December 31, 2015, 2016 and 2017. The fair value of this award was estimated on the date of grant using a Monte Carlo valuation model that assumed the following: risk free interest rate of 0.38%; expected volatility of 28%; expected dividend yield of 8.0%; and expected service period of 5 years.
			There were 68,086 of the 2013 performance awards earned and vested in 2013. At December 31, 2013, we have 686,169 of 2013 performance awards remaining to be earned.
		-	2012 performance awards - The 2012 performance awards were granted in three parts:
		1)	Approximately 30% of the 2012 performance awards were based on us achieving a simple 9.0% annual total shareholder return over a three year period; however, the award contains both carry forward and carry back provisions through December 31, 2016. The fair value of this award was estimated on the date of grant using a Monte Carlo valuation model that assumed the following: risk free interest rate of 0.93%; expected volatility of 34%; expected dividend yield of 8.6%; and expected service period of 4 years.
		2)	Approximately 35% of the 2012 performance awards were based on us achieving a cumulative total shareholder return from January 1, 2012 to December 31, 2014. The minimum total shareholder return needed to earn a portion of this award is 27% with 100% of the award earned if our total shareholder return reaches 35%. If any shares are earned from this award, the shares will vest in equal annual amounts on January 1, 2015, 2016 and 2017. The fair value of this award was estimated on the date of grant using a Monte Carlo valuation model that assumed the following: risk free interest rate of 0.43%; expected volatility of 35%; expected dividend yield of 8.6%; and expected service period of 5 years.
		3)	The remainder of the 2012 performance awards will be earned if our total shareholder return outpaces that of the Index over the cumulative period from January 1, 2012 to December 31, 2014. Our total shareholder return must exceed that of the Index to earn the minimum number of shares under this award, while it must exceed the Index by 6% to earn 100% of the award. If any shares are earned from this award, the shares will vest in equal annual amounts on January 1, 2015, 2016 and 2017. The fair value of this award was estimated on the date of grant using a Monte Carlo valuation model that assumed the following: risk free interest rate of 0.43%; expected volatility of 35%; expected dividend yield of 8.6%; and expected service period of 5 years.
	There were 84,188 of the 2012 performance awards earned and vested in 2013 and 2,599 forfeited in 2013. There were 84,188 of the 2012 performance awards earned and vested in 2012 and 5,718 forfeited in 2012. At December 31, 2013, we have 725,666 of 2012 performance awards remaining to be earned.
		-	2011 performance awards - The 2011 performance awards were granted in three parts:
		1)	Approximately 30% of the 2011 performance awards were based on us achieving a simple 9.0% annual total shareholder return over a three year period; however, the award contained both carry forward and carry back provisions through December 31, 2015. The fair value of this award was estimated on the date of grant using a Monte Carlo valuation model that assumed the following: risk free interest rate of 2.07%; expected volatility of 33%; expected dividend yield of 8.5%; and expected service period of 4 years.
		2)	Approximately 18% of the 2011 performance awards were based on us achieving a cumulative total shareholder return from January 1, 2011 to December 31, 2013. The minimum total shareholder return needed to earn a portion of this award is 27% with 100% of the award earned if our total shareholder return reaches 39%. If any shares are earned from this award, the shares will vest in equal annual amounts on January 1, 2014, 2015 and 2016. The fair value of this award was estimated on the date of grant using a Monte Carlo valuation model that assumed the following: risk free interest rate of 1.07%; expected volatility of 34%; expected dividend yield of 8.5%; and expected service period of 5 years.
		3)	The remainder of the 2011 performance awards will be earned if our total shareholder return outpaces that of the Index over the cumulative period from January 1, 2011 to December 31, 2013. Our total shareholder return must exceed that of the Index to earn the minimum number of shares under this award, while it must exceed the Index by 12% to earn 100% of the award. If any shares are earned from this award, the shares will vest in equal annual amounts on January 1, 2014, 2015 and 2016. The fair value of this award was estimated on the date of grant using a Monte Carlo valuation model that assumed the following: risk free interest rate of 1.07%; expected volatility of 34%; expected dividend yield of 8.5%; and expected service period of 5 years.
	There were 81,359 and 155,162 of the 2011 performance awards earned and vested in 2013 and 2012, respectively, but none in 2011. In 2013, 8,062 shares were forfeited, while 14,456 shares were forfeited in 2012. At December 31, 2013, we have 587,344 of 2011 performance awards that have been earned but not vested.
	The following summarizes restricted equity award activity in 2013 and 2012 (which includes awards granted in 2013, 2012, 2011, and any applicable prior years), respectively:
	For the Year Ended December 31, 2013:
			Vesting Based					Vesting Based on
			on Service					Market/Performance
								Conditions
			Shares			Weighted Average		Shares			Weighted Average
						Value at Award Date					Value at Award Date
	Nonvested awards at beginning of the year			466,883		$	10.72		1,879,889		$	6.48
	Awarded			240,425		$	12.26		754,255		$	6.13
	Vested			(381,309	)	$	11.15		(386,446	)	$	8.27
	Forfeited			—		$	—		(248,519	)	$	11.03
	Nonvested awards at end of year			325,999		$	11.36		1,999,179		$	5.44
	For the Year Ended December 31, 2012:
			Vesting Based					Vesting Based on
			on Service					Market/Performance
								Conditions
			Shares			Weighted Average		Shares			Weighted Average
						Value at Award Date					Value at Award Date
	Nonvested awards at beginning of the year			603,980		$	11.02		1,511,397		$	7.6
	Awarded			275,464		$	10.14		902,359		$	5.81
	Vested			(410,261	)	$	10.78		(513,693	)	$	8.63
	Forfeited			(2,300	)	$	10.24		(20,174	)	$	5.45
	Nonvested awards at end of year			466,883		$	10.72		1,879,889		$	6.48
	The value of stock-based awards is charged to compensation expense over the vesting periods. In the years ended December 31, 2013, 2012 and 2011, we recorded $8.8 million, $7.6 million, and $7.0 million respectively, of non-cash compensation expense. The remaining unrecognized cost from restricted equity awards at December 31, 2013, is $10.1 million and will be recognized over a weighted average period of 2.5 years. Restricted equity awards which vested in 2013, 2012, and 2011 had a value of $9.2 million, $9.2 million, and $6.1 million, respectively.

Commitments_and_Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2013
Commitments And Contingencies Disclosure [Abstract]	'
Commitments and Contingencies	'
	8	Commitments and Contingencies
	Commitments
	Our operating leases primarily consist of ground leases on which certain of our facilities or other related property reside along with corporate office and equipment leases. These ground leases are long-term leases (almost all having terms for approximately 50 years or more), some contain escalation provisions and one contains a purchase option. Properties subject to these ground leases are subleased to our tenants. Lease and rental expense (which is recorded on the straight-line method) for 2013, 2012 and 2011, respectively, were $2,304,461, $2,195,835, and $1,994,565, which was offset by sublease rental income of $512,503, $492,095, and $443,829 for 2013, 2012, and 2011, respectively.
	Fixed minimum payments due under operating leases with non-cancelable terms of more than one year at December 31, 2013 are as follows: (amounts in thousands)
	2014		$	2,471
	2015			2,644
	2016			2,659
	2017			2,620
	2018			2,614
	Thereafter			37,213
			$	50,221
	The total amount to be received in the future from non-cancellable subleases at December 31, 2013, is $30.1 million.
	Contingencies
	We are a party to various legal proceedings incidental to our business. In the opinion of management, after consultation with legal counsel, the ultimate liability, if any, with respect to those proceedings is not presently expected to materially affect our financial position, results of operations or cash flows.

Common_StockPartners_Capital

Common Stock/Partner's Capital	12 Months Ended
	Dec. 31, 2013
Text Block [Abstract]	'
Common Stock/Partner's Capital	'
	9	Common Stock/Partner’s Capital
	Medical Properties Trust, Inc.
	On August 20, 2013, we completed an offering of 11,500,000 shares of common stock (including 1,500,000 shares sold pursuant to the exercise in full of the underwriters’ option to purchase additional shares) at a price of $12.75 per share, resulting in net proceeds (after underwriting discount and expenses) of $140.4 million. These proceeds were used to fund the acquisition of the three IASIS properties more fully described in Note 3.
	On February 28, 2013, we completed an offering of 12,650,000 shares of our common stock (including 1,650,000 shares sold pursuant to the exercise in full of the underwriters’ option to purchase additional shares) at a price of $14.25 per share, resulting in net proceeds (after underwriting discount and expenses) of $172.9 million. A portion of the net proceeds from this offering were used to pay down our revolving credit facility.
	To help fund the 2012 acquisitions disclosed in Note 3, on February 7, 2012, we completed an offering of 23,575,000 shares of our common stock (including 3,075,000 shares sold pursuant to the exercise in full of the underwriters’ overallotment option) at a price of $9.75 per share, resulting in net proceeds (after underwriting discount) of $220.1 million.
	In November 2009, we put an at-the-market equity offering program in place, giving us the ability to sell up to $50 million of stock. During the fourth quarter 2012, we sold 1.1 million shares of our common stock under our at-the-market equity offering program, at an average price of $11.84 per share resulting in total proceeds, net of a 2% commission, of $13.2 million. In January 2014, we replaced this at-the-market offering program with a similar program but increased the size to up to $250 million of stock with a commission of 1.25% (of which $12.5 million has been sold as of February 28, 2014).
	In February 2012, we filed Articles of Amendment to our charter with the Maryland State Department of Assessments and Taxation increasing the number of authorized shares of common stock, par value $0.001 per share available for issuance from 150,000,000 to 250,000,000.
	MPT Operating Partnership, L.P.
	The Operating Partnership is made up of a general partner, Medical Properties Trust, LLC (“General Partner”) and limited partners, including the Company (which owns 100% of the General Partner) and three other partners. By virtue of its ownership of the General Partner, the Company has a 99.8% ownership interest in Operating Partnership via its ownership of all the common units. The remaining ownership interest is held by the two employees and one director via their ownership of LTIP units. These LTIP units were issued to the employees pursuant to the 2007 Multi-Year Incentive Plan, which is part of the Equity Incentive Plan discussed in Note 7 and once vested in accordance with their award agreement, may be converted to common units per the Second Amended and Restated Agreement of Limited Partnership of MPT Operating Partnership, L.P. (“Operating Partnership Agreement”).
	In regards to distributions, the Operating Partnership shall distribute cash at such times and in such amounts as are determined by the General Partner in its sole and absolute discretion, to common unit holders who are common unit holders on the record date. However, per the Operating Partnership Agreement, the General Partner shall use its reasonable efforts to cause the Operating Partnership to distribute amounts sufficient to enable the Company to pay stockholder dividends that will allow the Company to (i) meet its distribution requirement for qualification as a REIT and (ii) avoid any federal income or excise tax liability imposed by the Internal Revenue Code, other than to the extent the Company elects to retain and pay income tax on its net capital gain. In accordance with the Operating Partnership Agreement, LTIP units are treated as common units for distribution purposes.
	The Operating Partnership’s net income will generally be allocated first to the General Partner to the extent of any cumulative losses and then to the limited partners in accordance with their respective percentage interests in the common units issued by the Operating Partnership. Any losses of the Operating Partnership will generally be allocated first to the limited partners until their capital account is zero and then to the General Partner. In accordance with the Operating Partnership Agreement, LTIP units are treated as common units for purposes of income and loss allocations. Limited partners have the right to require the Operating Partnership to redeem part or all of their common units. It is at the Operating Partnership’s discretion to redeem such common units for cash based on the fair market value of an equivalent number of shares of the Company’s common stock at the time of redemption or, alternatively, redeem the common units for shares of the Company’s common stock on a one-for-one basis, subject to adjustment in the event of stock splits, stock dividends, or similar events. In order for LTIP units to be redeemed, they must first be converted to common units and then must wait two years from the issuance of the LTIP units to be redeemed.
	For each share of common stock issued by Medical Properties Trust, Inc., the Operating Partnership issues a corresponding number of operating partnership units.

Fair_Value_of_Financial_Instru

Fair Value of Financial Instruments	12 Months Ended
	Dec. 31, 2013
Fair Value Disclosures [Abstract]	'
Fair Value of Financial Instruments	'
	10	Fair Value of Financial Instruments
	We have various assets and liabilities that are considered financial instruments. We estimate that the carrying value of cash and cash equivalents, and accounts payable and accrued expenses approximate their fair values. Included in our accounts payable and accrued expenses are our interest rate swaps, which are recorded at fair value based on Level 2 observable market assumptions using standardized derivative pricing models. We estimate the fair value of our interest and rent receivables using Level 2 inputs such as discounting the estimated future cash flows using the current rates at which similar receivables would be made to others with similar credit ratings and for the same remaining maturities. The fair value of our mortgage loans and working capital loans are estimated by using Level 2 inputs (except for the Monroe loan for which we use Level 3 inputs) such as discounting the estimated future cash flows using the current rates which similar loans would be made to borrowers with similar credit ratings and for the same remaining maturities. We determine the fair value of our exchangeable notes (for 2012 only) and 2011, 2012 and 2013 Senior Unsecured Notes, using Level 2 inputs such as quotes from securities dealers and market makers. We estimate the fair value of our 2006 Senior Unsecured Notes, revolving credit facilities, and term loans using Level 2 inputs based on the present value of future payments, discounted at a rate which we consider appropriate for such debt.
	Fair value estimates are made at a specific point in time, are subjective in nature, and involve uncertainties and matters of significant judgment. Settlement of such fair value amounts may not be possible and may not be a prudent management decision. The following table summarizes fair value estimates for our financial instruments (in thousands):
			December 31,						December 31,
			2013						2012
	Asset (Liability)		Book			Fair			Book			Fair
			Value			Value			Value			Value
	Interest and rent receivables		$	58,499		$	44,349		$	45,289		$	36,700
	Loans(1)			351,607			358,277			334,693			335,595
	Debt, net			(1,421,681	)		(1,486,090	)		(1,025,160	)		(1,082,333	)
	-1	Excludes loans related to Ernest Transaction since they are recorded at fair value and discussed below.
	Items Measured at Fair Value on a Recurring Basis
	Our equity interest in Ernest and related loans, as discussed in Note 2, are being measured at fair value on a recurring basis as we elected to account for these investments using the fair value option method. We have elected to account for these investments at fair value due to the size of the investments and because we believe this method is more reflective of current values. We have not made a similar election for other equity interests or loans in or prior to 2013.
	At December 31, 2013. these amounts were as follows (in thousands):
	Asset (Liability)		Fair			Cost			Asset Type
			Value						Classification
	Mortgage loans		$	100,000		$	100,000		Mortgage loans
	Acquisition loan			98,033			98,033		Other loans
	Equity investments			3,300			3,300		Other assets
			$	201,333		$	201,333
	Our mortgage loans with Ernest are recorded at fair value based on Level 3 inputs by discounting the estimated cash flows using the market rates which similar loans would be made to borrowers with similar credit ratings and the same remaining maturities. Our acquisition loan and equity investments in Ernest are recorded at fair value based on Level 3 inputs, by using a discounted cash flow model, which requires significant estimates of our investee such as projected revenue and expenses and appropriate consideration of the underlying risk profile of the forecast assumptions associated with the investee. We classify these loans and equity investments as Level 3, as we use certain unobservable inputs to the valuation methodology that are significant to the fair value measurement, and the valuation requires management judgment due to the absence of quoted market prices. For these cash flow models, our observable inputs include use of a capitalization rate, discount rate (which is based on a weighted-average cost of capital), and market interest rates, and our unobservable input includes an adjustment for a lack of marketability discount (“DLOM”) on our equity investment of 40% at December 31, 2013.
	In regards to the underlying projection of revenues and expenses used in the discounted cash flow model, such projections are provided by Ernest. However, we will modify such projections (including underlying assumptions used) as needed based on our review and analysis of Ernest’s historical results, meetings with key members of management, and our understanding of trends and developments within the healthcare industry.
	In arriving at the DLOM, we started with a DLOM range based on the results of studies supporting valuation discounts for other transactions or structures without a public market. To select the appropriate DLOM within the range, we then considered many qualitative factors including the percent of control, the nature of the underlying investee’s business along with our rights as an investor pursuant to the operating agreement, the size of investment, expected holding period, number of shareholders, access to capital marketplace, etc. To illustrate the effect of movements in the DLOM, we performed a sensitivity analysis below by using basis point variations (dollars in thousands):
	Basis Point		Estimated Increase (Decrease)
	Change in		In Fair Value
	Marketability Discount
	+100 basis points		($320)
	- 100 basis points		320
	Because the fair value of Ernest investments noted above approximate their original cost, we did not recognize any unrealized gains/losses during 2013 or 2012. To date, we have not received any distribution payments from our equity investment in Ernest.

Discontinued_Operations

Discontinued Operations	12 Months Ended
	Dec. 31, 2013
Discontinued Operations And Disposal Groups [Abstract]	'
Discontinued Operations	'
	11	Discontinued Operations
	As more fully discussed in Note 3 under the heading “Disposals”, we sold three properties in 2013, five properties in 2012, and two properties in 2011. We have classified current and prior year activity related to these transactions, along with the related operating results of the facilities prior to these transactions taking place, as discontinued operations. In addition, we have reclassified the related real estate assets to Real Estate Held for Sale in all prior periods. Real estate held for sale of $25.5 million in 2012 includes $1.9 million of land, $26.7 million of building, $0.8 million of intangible lease assets, $3.5 million of accumulated depreciation, $0.4 million of accumulated amortization.
	The following table presents the results of discontinued operations for the years ended December 31, 2013, 2012 and 2011 (in thousands except per share/unit amounts):
			For the Years Ended
			December 31,
			2013		2012		2011
	Revenues		$	988	$	3,470	$	14,531
	Gain on sale			7,659		16,369		5,431
	Income from discontinued operations			7,914		17,207		14,594
	Income from discontinued operations — diluted per share/unit		$	0.05	$	0.13	$	0.12

Quarterly_Financial_Data_unaud

Quarterly Financial Data (unaudited)	12 Months Ended
	Dec. 31, 2013
Quarterly Financial Information Disclosure [Abstract]	'
Quarterly Financial Data (unaudited)	'
	12. Quarterly Financial Data (unaudited)
	As disclosed in Note 11, we sold properties during 2013 resulting in the reclassification of those properties current and prior year results to discontinued operations. The quarterly data presented below reflects these reclassifications.
	Medical Properties Trust, Inc.
	The following is a summary of the unaudited quarterly financial information for the years ended December 31, 2013 and 2012: (amounts in thousands, except for per share data)
		For the Three Month Periods in 2013 Ended
		March 31		June 30		September 30		December 31
	Revenues	$	57,614	$	57,124	$	60,106	$	67,679
	Income from continuing operations		25,570		25,031		25,391		13,309
	Income from discontinued operations		640		2,374		312		4,588
	Net income		26,210		27,405		25,703		17,897
	Net income attributable to MPT common stockholders		26,156		27,348		25,648		17,839
	Net income attributable to MPT common stockholders per share — basic	$	0.19	$	0.18	$	0.16	$	0.11
	Weighted average shares outstanding — basic		140,347		149,509		154,758		161,143
	Net income attributable to MPT common stockholders per share — diluted	$	0.18	$	0.18	$	0.16	$	0.11
	Weighted average shares outstanding — diluted		141,526		151,056		155,969		161,840
		For the Three Month Periods in 2012 Ended
		March 31		June 30		September 30		December 31
	Revenues	$	40,455	$	48,569	$	52,504	$	56,597
	Income (loss) from continuing operations		8,294		18,718		22,594		23,264
	Income from discontinued operations		2,312		642		8,914		5,339
	Net income		10,606		19,360		31,508		28,603
	Net income attributable to MPT common stockholders		10,564		19,316		31,464		28,556
	Net income attributable to MPT common stockholders per share — basic	$	0.08	$	0.14	$	0.23	$	0.21
	Weighted average shares outstanding — basic		124,906		134,715		134,781		134,923
	Net income attributable to MPT common stockholders per share — diluted	$	0.08	$	0.14	$	0.23	$	0.21
	Weighted average shares outstanding — diluted		124,906		134,715		134,782		134,930
	MPT Operating Partnership, L.P.
	The following is a summary of the unaudited quarterly financial information for the years ended December 31, 2013 and 2012: (amounts in thousands, except for per unit data)
		For the Three Month Periods in 2013 Ended
		March 31		June 30		September 30		December 31
	Revenues	$	57,614	$	57,124	$	60,106	$	67,679
	Income from continuing operations		25,570		25,031		25,391		13,309
	Income from discontinued operations		640		2,374		312		4,588
	Net income		26,210		27,405		25,703		17,897
	Net income attributable to MPT Operating Partnership partners		26,156		27,348		25,648		17,839
	Net income attributable to MPT Operating Partnership partners per unit — basic	$	0.19	$	0.18	$	0.16	$	0.11
	Weighted average units outstanding — basic		140,347		149,509		154,758		161,143
	Net income attributable to MPT Operating Partnership partners per unit — diluted	$	0.18	$	0.18	$	0.16	$	0.11
	Weighted average units outstanding — diluted		141,526		151,056		155,969		161,840
		For the Three Month Periods in 2012 Ended
		March 31		June 30		September 30		December 31
	Revenues	$	40,455	$	48,569	$	52,504	$	56,597
	Income from continuing operations		8,294		18,718		22,594		23,264
	Income from discontinued operations		2,312		642		8,914		5,339
	Net income		10,606		19,360		31,508		28,603
	Net income attributable to MPT Operating Partnership partners		10,564		19,316		31,464		28,556
	Net income attributable to MPT Operating Partnership partners per unit — basic	$	0.08	$	0.14	$	0.23	$	0.21
	Weighted average units outstanding — basic		124,906		134,715		134,781		134,923
	Net income attributable to MPT Operating Partnership partners per unit — diluted	$	0.08	$	0.14	$	0.23	$	0.21
	Weighted average units outstanding — diluted		124,906		134,715		134,782		134,930

Condensed_Consolidating_Financ

Condensed Consolidating Financial Information	12 Months Ended
	Dec. 31, 2013
Condensed Financial Information Of Parent Company Only Disclosure [Abstract]	'
Condensed Consolidating Financial Information	'
	13	Condensed Consolidating Financial Information
	The following tables present the condensed consolidating financial information for (a) Medical Properties Trust, Inc. (“Parent” and a guarantor to our 2011, 2012, and 2013 Senior Unsecured Notes), (b) MPT Operating Partnership, L.P. and MPT Finance Corporation (“Subsidiary Issuer”), (c) on a combined basis, the guarantors of our 2011, 2012 and 2013 Senior Unsecured Notes (“Subsidiary Guarantors”), and (d) on a combined basis, the non-guarantor subsidiaries (“Non-Guarantor Subsidiaries”). Separate financial statements of the Subsidiary Guarantors are not presented because the guarantee by each 100% owned Subsidiary Guarantor is joint and several and we believe separate financial statements and other disclosures regarding the Subsidiary Guarantors are not material to investors. Furthermore, there are no significant legal restrictions on the Parent’s ability to obtain funds from its subsidiaries by dividend or loan.
	The guarantees by the Subsidiary Guarantors may be released and discharged upon: (1) any sale, exchange or transfer of all of the capital stock of a Subsidiary Guarantor; (2) the merger or consolidation of a Subsidiary Guarantor with a Subsidiary Issuer or any other Subsidiary Guarantor; (3) the proper designation of any Subsidiary Guarantor by the Subsidiary Issuers as “unrestricted” for covenant purposes under the indenture governing the 2011, 2012, and 2013 Senior Unsecured Notes; (4) the legal defeasance or covenant defeasance or satisfaction and discharge of the indenture; (5) a liquidation or dissolution of a Subsidiary Guarantor permitted under the indenture governing the 2011, 2012 and 2013 Senior Unsecured Notes; or (6) the release or discharge of the Subsidiary Guarantor from its guarantee obligations under our revolving credit facility.
	Subsequent to December 31, 2012, certain of our subsidiaries were re-designated as non-guarantors of our 2011, 2012 and 2013 Senior Unsecured Notes, as the underlying properties were sold in 2013 (such subsidiaries were guarantors prior to 2013). With these re-designations, we have restated the 2012 and 2011 consolidating financial information below to reflect these changes.
	In the second quarter of 2013, we revised our condensed consolidating balance sheets as of December 31, 2012 and 2011 to adjust negative net intercompany receivables (payable) balances from Total Assets to Total Liabilities. The impact of this revision was to increase total assets (and, correspondingly increase total liabilities) as of December 31, 2012 for Subsidiary Guarantors by $997.2 million and also to increase total assets (and, correspondingly increase total liabilities) for Non-Guarantor Subsidiaries by $404.1 million with an offset to Eliminations. In addition, we revised our condensed consolidating statements of cash flows for the years ended December 31, 2012 and 2011 to adjust the classification of cash flows related to intercompany transactions. For the year ended December 31, 2012, these adjustments had the effect of a) increasing net cash provided by investing activities and decreasing net cash provided by financing activities for the Parent and Subsidiary Issuers by $129.4 million and $501.8 million, respectively, and b) decreasing net cash provided by investing activities and increasing net cash provided by financing activities for the Subsidiary Guarantors and the Non-Guarantor Subsidiaries by $365.8 million and $136.1 million, respectively, with an offset to Eliminations. For the year ended December 31, 2011, these adjustments had the effect of a) increasing net cash provided by investing activities and decreasing net cash provided by financing activities for the Subsidiary Issuers and Non-Guarantor Subsidiaries by $92.1 million and $22.4 million, respectively, and b) decreasing net cash provided by investing activities and increasing net cash provided by financing activities for the Parent and Subsidiary Guarantors by $89.6 million and $114.2 million, respectively, with an offset to Eliminations. These revisions are not material to the related financial statements for any prior periods and had no impact on our consolidated balance sheet or consolidated statement of cash flows. As prior period financial information is presented in future filings, we will similarly revise the condensed consolidating statements of cash flows for comparative periods presented in future filings.
	Condensed Consolidated Balance Sheets
	December 31, 2013
	(in thousands)
			Parent			Subsidiary			Subsidiary			Non-Guarantor			Eliminations			Total
						Issuers			Guarantors			Subsidiaries						Consolidated
	Assets
	Real estate assets
	Land, buildings and improvements and intangible lease assets		$	—		$	—		$	1,795,084		$	70,371		$	—		$	1,865,455
	Net investment in direct financing leases			—			—			212,543			218,481			—			431,024
	Mortgage loans			—			—			268,650			120,000			—			388,650
	Gross investment in real estate assets			—			—			2,276,277			408,852			—			2,685,129
	Accumulated depreciation and amortization			—			—			(151,624	)		(8,152	)		—			(159,776	)
	Net investment in real estate assets			—			—			2,124,653			400,700			—			2,525,353
	Cash and cash equivalents			—			18,815			27,094			70			—			45,979
	Interest and rent receivables			—			336			31,324			26,839			—			58,499
	Straight-line rent receivables			—			—			37,015			8,814			—			45,829
	Other loans			—			178			1,100			159,712			—			160,990
	Net intercompany receivable			35,363			1,907,474			—			—			(1,942,837	)		—
	Investment in subsidiaries			1,344,598			825,153			42,407			—			(2,212,158	)		—
	Other assets			—			37,311			1,168			29,441			—			67,920
	Total Assets		$	1,379,961		$	2,789,267		$	2,264,761		$	625,576		$	(4,154,995	)	$	2,904,570
	Liabilities and Equity
	Liabilities
	Debt, net		$	—		$	1,407,733		$	—		$	13,948		$	—		$	1,421,681
	Accounts payable and accrued expenses			35,753			36,887			20,367			1,304			—			94,311
	Net intercompany payable			—			—			1,538,934			403,903			(1,942,837	)		—
	Deferred revenue			—			49			17,772			5,966			—			23,787
	Lease deposits and other obligations to tenants			—			—			17,964			2,619			—			20,583
	Total liabilities			35,753			1,444,669			1,595,037			427,740			(1,942,837	)		1,560,362
	Total Equity			1,344,208			1,344,598			669,724			197,836			(2,212,158	)		1,344,208
	Total Liabilities and Equity		$	1,379,961		$	2,789,267		$	2,264,761		$	625,576		$	(4,154,995	)	$	2,904,570
	Condensed Consolidated Statements of Income
	For the Year Ended December 31, 2013
	(in thousands)
			Parent			Subsidiary			Subsidiary			Non-Guarantor			Eliminations			Total
						Issuers			Guarantors			Subsidiaries						Consolidated
	Revenues
	Rent billed		$	—		$	—		$	124,651		$	20,028		$	(12,101	)	$	132,578
	Straight-line rent			—			—			8,438			2,268			—			10,706
	Income from direct financing leases			—			—			38,522			22,577			(20,269	)		40,830
	Interest and fee income			—			21,797			38,696			29,834			(31,918	)		58,409
	Total revenues			—			21,797			210,307			74,707			(64,288	)		242,523
	Expenses
	Real estate depreciation and amortization			—			—			35,277			1,701			—			36,978
	Property-related			—			601			1,356			32,863			(32,370	)		2,450
	Acquisition expenses			—			7,356			12,138			—			—			19,494
	General and administrative			—			29,033			375			655			—			30,063
	Total operating expenses			—			36,990			49,146			35,219			(32,370	)		88,985
	Operating income			—			(15,193	)		161,161			39,488			(31,918	)		153,538
	Other income (expense)
	Interest and other (expense) income			—			(110	)		—			(209	)		—			(319	)
	Earnings from equity and other interests			—			—			948			2,606			—			3,554
	Interest expense			—			(67,484	)		(1,912	)		(29,268	)		31,918			(66,746	)
	Income tax expense			—			—			(158	)		(568	)		—			(726	)
	Net other expense			—			(67,594	)		(1,122	)		(27,439	)		31,918			(64,237	)
	Income (loss) from continuing operations			—			(82,787	)		160,039			12,049			—			89,301
	Income (loss) from discontinued operations			—			—			(4	)		7,918			—			7,914
	Equity in earnings of consolidated subsidiaries net of income taxes			97,215			180,002			4,477			—			(281,694	)		—
Net income (loss)			97,215			97,215			164,512			19,967			(281,694	)		97,215
Net income (loss) attributable to non-controlling interests			(224	)		(224	)		—			—			224			(224	)
Net income attributable to MPT common stockholders		$	96,991		$	96,991		$	164,512		$	19,967		$	(281,470	)	$	96,991
Condensed Consolidated Statements of Comprehensive Income (Loss)
For the Year Ended December 31, 2013
(in thousands)
		Parent			Subsidiary			Subsidiary			Non-Guarantor			Eliminations			Total
					Issuers			Guarantors			Subsidiaries						Consolidated
Net income		$	97,215		$	97,215		$	164,512		$	19,967		$	(281,694	)	$	97,215
Other comprehensive income (loss):
Unrealized gain (loss) on interest rate swap			3,474			3,474			—			—			(3,474	)		3,474
Foreign currency translation gain (loss)			67			67			—			—			(67	)		67
Total comprehensive income			100,756			100,756			164,512			19,967			(285,235	)		100,756
Comprehensive income attributable to non-controlling interests			(224	)		(224	)		—			—			224			(224	)
Comprehensive income attributable to MPT common stockholders		$	100,532		$	100,532		$	164,512		$	19,967		($	285,011	)	$	100,532
Condensed Consolidated Statements of Cash Flows
For the Year Ended December 31, 2013
(in thousands)
		Parent			Subsidiary			Subsidiary			Non-Guarantor			Eliminations			Total
					Issuers			Guarantors			Subsidiaries						Consolidated
Operating Activities
Net cash provided by (used in) operating activities		$	4		$	(53,846	)	$	196,883		$	(2,240	)	$	—		$	140,801
Investing Activities
Cash paid for acquisitions and other related investments			—			—			(619,092	)		(35,830	)		—			(654,922	)
Net proceeds from sales of real estate			—			—			—			32,409			—			32,409
Principal received on loans receivable			—			—			—			7,249			—			7,249
Investments in loans receivable			—			—			(1,100	)		(2,646	)		—			(3,746	)
Construction in progress and other			—			136			(94,737	)		1,034			—			(93,567	)
Net cash provided by (used in) investing activities			—			136			(714,929	)		2,216			—			(712,577	)
Financing Activities
Additions to term debt			—			424,580			—			—			—			424,580
Payments of term debt			—			(11,000	)		—			(249	)		—			(11,249	)
Revolving credit facilities, net			—			(20,000	)		—			—			—			(20,000	)
Distributions paid			(120,038	)		(120,309	)		—			—			120,038			(120,309	)
Lease deposits and other obligations to tenants			—			—			1,606			1,625			—			3,231
Net payments relating to intercompany financing			(193,297	)		(539,776	)		541,325			(1,545	)		193,293			—
Proceeds from sale of common shares, net of offering costs			313,331			313,331			—			—			(313,331	)		313,331
Debt issuance costs paid and other financing activities			—			(9,760	)		—			—			—			(9,760	)
Net cash provided by (used in) financing activities			(4	)		37,066			542,931			(169	)		—			579,824
Increase (decrease) in cash and cash equivalents for period			—			(16,644	)		24,885			(193	)		—			8,048
Effect of exchange rate changes			—			(24	)		644			—			—			620
Cash and cash equivalents at beginning of period			—			35,483			1,565			263			—			37,311
Cash and cash equivalents at end of period		$	—		$	18,815		$	27,094		$	70		$	—		$	45,979
Condensed Consolidated Balance Sheets
December 31, 2012
(in thousands)
		Parent			Subsidiary			Subsidiary			Non-Guarantor			Eliminations			Total
					Issuers			Guarantors			Subsidiaries						Consolidated
Assets
Real estate assets
Land, buildings and improvements and intangible lease assets		$	—		$	28		$	1,185,265		$	65,947		$	—		$	1,251,240
Real estate held for sale			—			—			—			25,537			—			25,537
Net investment in direct financing leases			—			—			110,155			204,257			—			314,412
Mortgage loans			—			—			268,650			100,000			—			368,650
Gross investment in real estate assets			—			28			1,564,070			395,741			—			1,959,839
Accumulated depreciation and amortization			—			—			(116,344	)		(6,452	)		—			(122,796	)
Net investment in real estate assets			—			28			1,447,726			389,289			—			1,837,043
Cash and cash equivalents			—			35,483			1,565			263			—			37,311
Interest and rent receivables			—			212			29,150			15,927			—			45,289
Straight-line rent receivables			—			—			28,416			7,444			—			35,860
Other loans			—			177			—			159,066			—			159,243
Net intercompany receivable			27,393			1,373,941			—			—			(1,401,334	)		—
Investment in subsidiaries			1,050,204			647,029			42,666			—			(1,739,899	)		—
Other assets			—			31,097			1,522			31,521			—			64,140
Total Assets		$	1,077,597		$	2,087,967		$	1,551,045		$	603,510		$	(3,141,233	)	$	2,178,886
Liabilities and Equity
Liabilities
Debt, net		$	—		$	1,010,962		$	—		$	14,198		$	—		$	1,025,160
Accounts payable and accrued expenses			27,783			26,658			10,492			1,028			—			65,961
Net intercompany payable			—			—			997,231			404,103			(1,401,334	)		—
Deferred revenue			—			143			19,431			1,035			—			20,609
Lease deposits and other obligations to tenants			—			—			16,357			985			—			17,342
Total liabilities			27,783			1,037,763			1,043,511			421,349			(1,401,334	)		1,129,072
Total Equity			1,049,814			1,050,204			507,534			182,161			(1,739,899	)		1,049,814
Total Liabilities and Equity		$	1,077,597		$	2,087,967		$	1,551,045		$	603,510		$	(3,141,233	)	$	2,178,886
Condensed Consolidated Statements of Income
For the Year Ended December 31, 2012
(in thousands)
		Parent			Subsidiary			Subsidiary			Non-Guarantor			Eliminations			Total
					Issuers			Guarantors			Subsidiaries						Consolidated
Revenues
Rent billed		$	—		$	—		$	112,573		$	16,619		$	(9,309	)	$	119,883
Straight-line rent			—			—			6,429			1,482			—			7,911
Income from direct financing leases			—			—			19,870			18,090			(16,232	)		21,728
Interest and fee income			—			18,341			29,606			25,387			(24,731	)		48,603
Total revenues			—			18,341			168,478			61,578			(50,272	)		198,125
Expenses
Real estate depreciation and amortization			—			—			31,115			1,700			—			32,815
Property-related			—			495			816			25,707			(25,541	)		1,477
Acquisition expenses			—			5,420			—			—			—			5,420
General and administrative			—			26,018			—			2,544			—			28,562
Total operating expenses			—			31,933			31,931			29,951			(25,541	)		68,274
Operating income			—			(13,592	)		136,547			31,627			(24,731	)		129,851
Other income (expense)
Interest and other (expense) income			—			(69	)		—			(1,593	)		—			(1,662	)
Earnings from equity and other interests			—			—			1,061			1,882			—			2,943
Interest expense			—			(58,729	)		1,408			(25,653	)		24,731			(58,243	)
Income tax expense			—			—			—			(19	)		—			(19	)
Net other expense			—			(58,798	)		2,469			(25,383	)		24,731			(56,981	)
Income (loss) from continuing operations			—			(72,390	)		139,016			6,244			—			72,870
Income (loss) from discontinued operations			—			—			103			17,104			—			17,207
Equity in earnings of consolidated subsidiaries net of income taxes			90,077			162,467			4,481			—			(257,025	)		—
Net income (loss)			90,077			90,077			143,600			23,348			(257,025	)		90,077
Net income (loss) attributable to non-controlling interests			(177	)		(177	)		—			—			177			(177	)
Net income attributable to MPT common stockholders		$	89,900		$	89,900		$	143,600		$	23,348		$	(256,848	)	$	89,900
Condensed Consolidated Statements of Comprehensive Income (Loss)
For the Year Ended December 31, 2012
(in thousands)
		Parent			Subsidiary			Subsidiary			Non-Guarantor			Eliminations			Total
					Issuers			Guarantors			Subsidiaries						Consolidated
Net income		$	90,077		$	90,077		$	143,600		$	23,348		$	(257,025	)	$	90,077
Other comprehensive income:
Unrealized loss on interest rate swap			(251	)		(251	)		—			—			251			(251	)
Total comprehensive income			89,826			89,826			143,600			23,348			(256,774	)		89,826
Comprehensive income attributable to non-controlling interests			(177	)		(177	)		—			—			177			(177	)
Comprehensive income attributable to MPT common stockholders		$	89,649		$	89,649		$	143,600		$	23,348		($	256,597	)	$	89,649
Condensed Consolidated Statements of Cash Flows
For the Year Ended December 31, 2012
(in thousands)
		Parent			Subsidiary			Subsidiary			Non-Guarantor			Eliminations			Total
					Issuers			Guarantors			Subsidiaries						Consolidated
Operating Activities
Net cash provided by (used in) operating activities		$	57		$	(61,002	)	$	165,454		$	800		$	—		$	105,309
Investing Activities
Cash paid for acquisitions and other related investments			—			—			(420,500	)		(200,990	)		—			(621,490	)
Net proceeds from sales of real estate			—			—			—			71,202			—			71,202
Principal received on loans receivable			—			—			5,491			5,440			—			10,931
Investments in loans receivable			—			—			—			(1,293	)		—			(1,293	)
Construction in progress and other			—			(578	)		(66,467	)		(9,433	)		—			(76,478	)
Net cash provided by (used in) investing activities			—			(578	)		(481,476	)		(135,074	)		—			(617,128	)
Financing Activities
Additions to term debt			—			300,000			—			—			—			300,000
Payments of term debt			—			—			—			(232	)		—			(232	)
Revolving credit facilities, net			—			75,000			(39,600	)		—			—			35,400
Distributions paid			(103,684	)		(103,952	)		—			—			103,684			(103,952	)
Lease deposits and other obligations to tenants			—			—			(10,031	)		(1,405	)		—			(11,436	)
Net payments relating to intercompany financing			(129,421	)		(501,839	)		365,809			136,087			129,364			—
Proceeds from sale of common shares, net of offering costs			233,048			233,048			—			—			(233,048	)		233,048
Debt issuance costs paid and other financing activities			—			(6,424	)		—			—			—			(6,424	)
Net cash provided by (used in) financing activities			(57	)		(4,167	)		316,178			134,450			—			446,404
Increase (decrease) in cash and cash equivalents for period			—			(65,747	)		156			176			—			(65,415	)
Cash and cash equivalents at beginning of period			—			101,230			1,409			87			—			102,726
Cash and cash equivalents at end of period		$	—		$	35,483		$	1,565		$	263		$	—		$	37,311
Condensed Consolidated Statements of Income
For the Year Ended December 31, 2011
(in thousands)
		Parent			Subsidiary			Subsidiary			Non-Guarantor			Eliminations			Total
					Issuers			Guarantors			Subsidiaries						Consolidated
Revenues
Rent billed		$	—		$	—		$	99,494		$	9,286		$	(3,092	)	$	105,688
Straight-line rent			—			—			3,515			1,762			—			5,277
Interest and fee income			—			6,124			17,543			3,926			(6,236	)		21,357
Total revenues			—			6,124			120,552			14,974			(9,328	)		132,322
Expenses
Real estate depreciation and amortization			—			—			28,489			1,658			—			30,147
Property-related			—			217			458			3,141			(3,092	)		724
Acquisition expenses			—			3,713			—			471			—			4,184
General and administrative			17			23,914			—			3,160			—			27,091
Total operating expenses			17			27,844			28,947			8,430			(3,092	)		62,146
Operating income			(17	)		(21,720	)		91,605			6,544			(6,236	)		70,176
Other income (expense)
Interest and other (expense) income			—			26			2			(10	)		—			18
Earnings from equity and other interests			—			—			345			(267	)		—			78
Debt refinancing costs			—			(14,109	)		(105	)		—			—			(14,214	)
Interest expense			—			(43,063	)		139			(7,122	)		6,236			(43,810	)
Income tax expense			—			—			—			(128	)		—			(128	)
Net other expense			—			(57,146	)		381			(7,527	)		6,236			(58,056	)
Income (loss) from continuing operations			(17	)		(78,866	)		91,986			(983	)		—			12,120
Income (loss) from discontinued operations			—			—			(1,969	)		16,563			—			14,594
Equity in earnings of consolidated subsidiaries net of income taxes			26,731			105,597			4,578			—			(136,906	)		—
Net income			26,714			26,731			94,595			15,580			(136,906	)		26,714
Net income attributable to non-controlling interests			(178	)		(178	)		—			—			178			(178	)
Net income attributable to MPT common stockholders		$	26,536		$	26,553		$	94,595		$	15,580		$	(136,728	)	$	26,536
Condensed Consolidated Statements of Comprehensive Income (Loss)
For the Year Ended December 31, 2011
(in thousands)
		Parent			Subsidiary			Subsidiary			Non-Guarantor			Eliminations			Total
					Issuers			Guarantors			Subsidiaries						Consolidated
Net income		$	26,714		$	26,731		$	94,595		$	15,580		$	(136,906	)	$	26,714
Other comprehensive income:
Unrealized loss on interest rate swap			(8,590	)		(8,590	)		—			—			8,590			(8,590	)
Total comprehensive income			18,124			18,141			94,595			15,580			(128,316	)		18,124
Comprehensive income attributable to non-controlling interests			(178	)		(178	)		—			—			178			(178	)
Comprehensive income attributable to MPT common stockholders		$	17,946		$	17,963		$	94,595		$	15,580		$	(128,138	)	$	17,946
Condensed Consolidated Statements of Cash Flows
For the Year Ended December 31, 2011
(in thousands)
		Parent			Subsidiary			Subsidiary			Non-Guarantor			Eliminations			Total
					Issuers			Guarantors			Subsidiaries						Consolidated
Operating Activities
Net cash provided by (used in) operating activities		$	(209	)	$	(48,779	)	$	109,329		$	18,929		$	—		$	79,270
Investing Activities
Cash paid for acquisitions and other related investments			—			—			(241,626	)		(37,337	)		—			(278,963	)
Net proceeds from sales of real estate			—			—			—			41,130			—			41,130
Principal received on loans receivable			—			—			230			4,059			—			4,289
Investments in loans receivable			—			—			(230	)		(631	)		—			(861	)
Construction in progress and other			—			(6,466	)		(24,081	)		(669	)		—			(31,216	)
Net cash provided by (used in) investing activities			—			(6,466	)		(265,707	)		6,552			—			(265,621	)
Financing Activities
Additions to term debt			—			450,000			—			—			—			450,000
Payments of term debt			—			(237,666	)		(8,433	)		(163	)		—			(246,262	)
Revolving credit facilities, net			—			50,000			39,600			—			—			89,600
Distributions paid			(89,342	)		(89,601	)		—			—			89,342			(89,601	)
Lease deposits and other obligations to tenants			—			—			10,986			(2,365	)		—			8,621
Net payments relating to intercompany financing			89,551			(92,052	)		114,247			(22,404	)		(89,342	)		—
Debt issuance costs paid and other financing activities			—			(21,028	)		—			(661	)		—			(21,689	)
Net cash provided by (used in) financing activities			209			59,653			156,400			(25,593	)		—			190,669
Increase (decrease) in cash and cash equivalents for period			—			4,408			22			(112	)		—			4,318
Cash and cash equivalents at beginning of period			—			96,822			1,387			199			—			98,408
Cash and cash equivalents at end of period		$	—		$	101,230		$	1,409		$	87		$	—		$	102,726

Valuation_and_Qualifying_Accou

Valuation and Qualifying Accounts	12 Months Ended
	Dec. 31, 2013
Valuation And Qualifying Accounts [Abstract]	'
Valuation and Qualifying Accounts	'
	Medical Properties Trust, Inc. and MPT Operating Partnership, L.P.
	Schedule II: Valuation and Qualifying Accounts
	December 31, 2013
					Additions			Deduction,
	Year Ended December 31,		Balance at		Charged			Net			Balance at
			Beginning  of		Against			Recoveries/			End of  Year(1)
			Year(1)		Operations(1)			Writeoffs(1)
			(In thousands)
	2013		$	34,769	$	9,397	-2	$	(2,593	)	$	41,573
	2012		$	32,618	$	4,540	-4	$	(2,389	)	$	34,769
	2011		$	23,926	$	8,692	-3	$	(—	)	$	32,618
	-1	Includes allowance for doubtful accounts, straight-line rent reserves, allowance for loan losses, tax valuation allowances and other reserves.
	-2	Includes $4.8 million and $2.7 million in rent and interest reserves, respectively, related to our Monroe properties along with $1.9 million to fully reserve for the net deferred tax asset of certain German subsidiaries.
	-3	Includes $3.7 million and $2.9 million in rent and interest reserves, respectively, related to our Denham Springs and Monroe properties and $2.1 million to fully reserve for the net deferred tax asset of one of our taxable REIT subsidiaries.
	-4	Includes $1.6 million and $2.9 million in rent and interest reserves, respectively, related to our Monroe properties.

SCHEDULE_III_REAL_ESTATE_INVES

SCHEDULE III - REAL ESTATE INVESTMENTS AND ACCUMULATED DEPRECIATION	12 Months Ended
	Dec. 31, 2013
Real Estate And Accumulated Depreciation Disclosure [Abstract]	'
SCHEDULE III - REAL ESTATE INVESTMENTS AND ACCUMULATED DEPRECIATION	'
	SCHEDULE III — REAL ESTATE INVESTMENTS AND ACCUMULATED DEPRECIATION
	December 31, 2013
	Location		Type of		Initial Costs								Additions					Cost at December 31,						Accumu-		Encum-		Date of		Date		Life on
			Property										Subsequent to					2013						lated		brances		Constr-		Acquired		which
													Acquisition											Depreci-				uction				depreci-
																								ation								ation in
																																latest
																																income
																																state-
																																ments is
																																computed
					Land				Buildings				Improve-		Carrying			Land		Buildings		Total										(Years)
													ments		Costs
			(Amounts in thousands)
	Baden-Wurttemburg, Germany		Rehabilitation hospital		$	—			$	11,968			$	—	$	—		$	—	$	11,968	$	11,968	$	29				1994		November 29,		40
																															2013
	Saxony, Germany		Rehabilitation hospital			471				25,956				—		—			471		25,956		26,427		73				1996		November 29,		40
																															2013
	Rhineland-Pflaz, Germany		Rehabilitation hospital			4,017				18,989				—		—			4,017		18,989		23,006		48				1960		November 29,		40
																															2013
	Brandenburg, Germany		Rehabilitation hospital			438				22,615				—		—			438		22,615		23,053		68				1994		November 29,		40
																															2013
	Hesse, Germany		Rehabilitation hospital			116				6,625				—		—			116		6,625		6,741		19				1981		November 29,		40
																															2013
	Hesse, Germany		Rehabilitation hospital			3,894				18,730				—		—			3,894		18,730		22,624		53				1977		November 29,		40
																															2013
	Rhineland-Pflaz, Germany		Rehabilitation hospital			—				37,579				—		—			—		37,579		37,579		103				1992		November 29,		40
																															2013
	Saxony, Germany		Rehabilitation hospital			682				18,907				—		—			682		18,907		19,589		48				1904, 1995		November 29,		40
																															2013
	Rhineland-Pflaz, Germany		Rehabilitation hospital			921				8,281				—		—			921		8,281		9,202		21				1980		November 29,		40
																															2013
	Rhineland-Pflaz, Germany		Rehabilitation hospital			7,382				20,382				—		—			7,382		20,382		27,764		67				1930		November 29,		40
																															2013
	Baden-Wurttemburg, Germany		Rehabilitation hospital			4,327				7,372				—		—			4,327		7,372		11,699		25				1986		November 29,		40
																															2013
	Little Elm, TX		Acute care general hospital			1,241				2,963				—		—			1,241		2,963		4,204		6				2013		December 1,		40
																															2013
	Port Arthur, TX		Acute care general hospital			2,178				74,225				—		—			2,178		74,225		76,403		464				2005		September 26,		40
																															2013
	West Monroe, LA		Acute care general hospital			10,555				71,429				—		—			10,555		71,429		81,984		449				1962		September 26,		40
																															2013
	Hausman, TX		Acute care general hospital			1,500				8,958				—		—			1,500		8,958		10,458		169				2013		March 1,		40
																															2013
	Lafayette, IN		Rehabilitation hospital			800				14,968				—		—			800		14,968		15,768		328				2013		February 1,		40
																															2013
	Mesa, AZ		Acute care general hospital			3,875				101,248				—		—			3,875		101,248		105,123		633				2007		September 26,		40
																															2013
	Overlook, TX		Acute care general hospital			2,452				9,666				—		—			2,452		9,666		12,118		203				2012		February 1,		40
																															2013
	Post Falls, ID		Rehabilitation hospital			417				12,175				—		—			417		12,175		12,592		25				2013		December 31,		40
																															2013
	Spartanburg, SC		Rehabilitation hospital			1,135				15,717				—		—			1,135		15,717		16,852		145				2013		August 1,		40
																															2013
	Victoria, TX		Rehabilitation hospital			—				9,355				—		—			—		9,355		9,355		—				2013		December 31,		40
																															2013
	Covington, LA		Long term acute care hospital			821				10,238				—		14			821		10,252		11,073		2,200		—		1984		June 9,		40
																															2005
	Redding, CA		Long term acute care hospital			—				19,952				—		4,361			1,629		22,684		24,313		4,621		—		1991		June 30,		40
																															2005
	Bloomington, IN		Acute care general hospital			2,457				31,209				—		408			2,576		31,498		34,074		5,800		—		2006		August 8,		40
																															2006
	Dallas, TX		Long term acute care hospital			1,000				13,589				—		368			1,421		13,536		14,957		2,481		—		2006		September 5,		40
2006
La Palma, CA		Acute care general hospital			937				10,907				—		3			937		10,910		11,847		1,954		—		1971		November 8,		40
																														2006
Anaheim, CA		Acute care general hospital			1,875				21,814				—		10			1,875		21,824		23,699		3,910		—		1964		November 8,		40
																														2006
Luling, TX		Long term acute care hospital			811				9,345				—		—			811		9,345		10,156		1,655		—		2002		December 1,		40
																														2006
Victoria, TX		Long term acute care hospital			625				7,197				—		—			625		7,197		7,822		1,275		—		1998		December 1,		40
																														2006
Houston, TX		Acute care general hospital			4,757				56,238				—		1,259			5,464		56,790		62,254		10,006		41,200		2006		December 1,		40
																														2006
Bensalem, PA		Acute care general hospital			6,911				38,185				—		(353	)		6,911		37,832		44,743		6,602		—		2006		March 19,		40
																														2007
Portland, OR		Long term acute care hospital			3,085				17,859				—		2,559			3,071		20,432		23,503		3,356		—		1964		April 18,		40
																														2007
San Diego, CA		Acute care general hospital			6,550				15,653				—		77			6,550		15,730		22,280		2,619		—		1964		May 9,		40
																														2007
Redding, CA		Acute care general hospital			1,555				53,863				—		13			1,555		53,876		55,431		8,653		—		1974		August 10,		40
																														2007
Houston, TX		Acute care general hospital			3,501				34,530				7,433		12,468			3,274		54,658		57,932		4,948		—		1960		August 10,		40
																														2007
Bennettsville, SC		Acute care general hospital			794				15,772				—		—			794		15,772		16,566		2,268		—		1984		April 1,		40
																														2008
Bossier City, LA		Long term acute care hospital			900				17,818				—		—			900		17,818		18,718		2,559		—		1982		April 1,		40
																														2008
Bristol, CT		Wellness			485				2,267				—		—			485		2,267		2,752		1,047		—		1975		April 22,		10
		Center																												2008
Cheraw, SC		Acute care general hospital			657				19,576				—		—			657		19,576		20,233		2,814		—		1982		April 1,		40
																														2008
Detroit, MI		Long term acute care hospital			1,220				8,687				—		(365	)		1,220		8,322		9,542		1,243		—		1956		May 22,		40
																														2008
Enfield, CT		Wellness			384				2,257				—		—			384		2,257		2,641		1,043		—		1974		April 22,		10
		Center																												2008
Fort Lauderdale, FL		Rehabilitation hospital			3,499				21,939				—		1			3,499		21,940		25,439		3,114		—		1985		April 22,		40
																														2008
Garden Grove, CA		Acute care general hospital			5,502				10,748				—		51			5,502		10,799		16,301		1,385		—		1982		November 25,		40
																														2008
Garden Grove, CA		Medical Office Building			862				7,888				—		28			862		7,916		8,778		1,007		—		1982		November 25,		40
																														2008
Idaho Falls, ID		Acute care general hospital			1,822				37,467				—		4,665			1,822		42,132		43,954		5,913		—		2002		April 1,		40
																														2008
Newington, CT		Wellness			270				1,615				—		—			270		1,615		1,885		748		—		1979		April 22,		10
		Center																												2008
Petersburg, VA		Rehabilitation hospital			1,302				9,121				—		—			1,302		9,121		10,423		1,254		—		2006		July 1,		40
																														2008
West Valley City, UT		Acute care general hospital			5,516				58,314				—		—			5,516		58,314		63,830		8,278		—		1980		April 22,		40
																														2008
Poplar Bluff, MO		Acute care general hospital			2,659				38,694				—		1			2,660		38,694		41,354		5,493		—		1980		April 22,		40
																														2008
East Providence, RI		Wellness			209				1,265				—		—			209		1,265		1,474		586		—		1979		April 22,		10
		Center																												2008
San Dimas, CA		Acute care general hospital			6,160				6,839				—		34			6,160		6,873		13,033		874		—		1972		November 25,		40
																														2008
San Dimas, CA		Medical Office Building			1,915				5,085				—		18			1,915		5,103		7,018		650		—		1979		November 25,		40
																														2008
West Springfield, MA		Wellness			583				3,185				—		—			583		3,185		3,768		1,475		—		1976		April 22,		10
		Center																												2008
Warwick, RI		Wellness			1,265				759				—		—			1,265		759		2,024		351		—		1979		April 22,		10
		Center																												2008
Wichita, KS		Rehabilitation hospital			1,019				18,373				—		1			1,019		18,374		19,393		2,641		8,678		1992		April 4,		40
																														2008
Addison, TX		Rehabilitation hospital			2,013				22,531				—		—			2,013		22,531		24,544		1,971				2008		June 17,		40
																														2010
Shenandoah, TX		Rehabilitation hospital			2,033				21,943				—		—			2,033		21,943		23,976		1,920				2008		June 17,		40
																														2010
Richardson, TX		Rehabilitation hospital			2,219				17,419				—		—			2,219		17,419		19,638		1,524				2008		June 17,		40
																														2010
Hill County, TX		Acute care general hospital			1,120				17,882				—		—			1,120		17,882		19,002		3,897				1980		September 17,		40
																														2010
Webster, TX		Long term acute care hospital			663				33,751				—		—			663		33,751		34,414		2,531				2004		December 21,		40
																														2010
Tomball, TX		Long term acute care hospital			1,298				23,982				—		—			1,298		23,982		25,280		1,799				2005		December 21,		40
																														2010
Gilbert, AZ		Acute care general hospital			150				15,553				—		—			150		15,553		15,703		1,166				2005		January 4,		40
																														2011
Corinth, TX		Long term acute care hospital			1,288				21,175				313		—			1,601		21,175		22,776		1,570				2008		January 31,		40
																														2011
Bayonne, NJ		Acute care general hospital			2,003				51,495				—		—			2,003		51,495		53,498		7,510				1918		February 4,		20
																														2011
San Diego, CA		Acute care general hospital			12,663				52,432				—		—			12,663		52,432		65,095		3,823				1973		February 9,		40
																														2011
Northland, MO		Long term acute care hospital			834				17,182				—		—			834		17,182		18,016		1,253				2007		February 14,		40
																														2011
DeSoto, TX		Long term acute care hospital			1,067				10,701				86		8			1,161		10,701		11,862		655				2008		July 18,		40
																														2011
New Braunfels, TX		Long term acute care hospital			1,100				7,883				—		—			1,100		7,883		8,983		443				2007		September 30,		40
																														2011
Hoboken, NJ		Acute care general hospital			1,387				44,351				—		—			1,387		44,351		45,738		4,730				1863		November 4,		20
																														2011
Florence, AZ		Acute care general hospital			900				28,462				—		—			900		28,462		29,362		1,236				2012		November 4,		40
																														2010
Hammond, LA		Long term acute care hospital			519				8,941				—		—			519		8,941		9,460		242				2003		December 14,		40
																														2012
San Antonio, TX		Acute care general hospital			2,248				5,880				—		—			2,249		5,879		8,128		166				2012		October 14,		40
																														2011
				$	151,814			$	1,547,919			$	7,832	$	25,629		$	154,858	$	1,578,336	$	1,733,194	$	144,235	$	49,878
The changes in total real estate assets including real estate held for sale but excluding construction in progress, intangible lease asset, investment in direct financing leases, and mortgage loans for the years ended (in thousands):
		December 31,				December 31,				December 31,
		2013				2012				2011
COST
Balance at beginning of period		$	1,189,552			$	1,191,096			$	990,635
Acquisitions			483,162				9,460				240,474
Transfers from construction in progress			81,347				37,174				—
Additions			7,749				19,971				1,011
Dispositions			(28,616	)			(68,149	)			(40,460	)
Other			—				—				(564	)
Balance at end of period		$	1,733,194			$	1,189,552	(3)		$	1,191,096	(1)
The changes in accumulated depreciation including real estate assets held for sale for the years ended (in thousands):
		December 31,				December 31,				December 31,
		2013				2012				2011
ACCUMULATED DEPRECIATION
Balance at beginning of period		$	114,399			$	93,430			$	68,662
Depreciation			33,349				31,026				29,523
Depreciation on disposed property			(3,513	)			(10,057	)			(4,755	)
Balance at end of period		$	144,235			$	114,399	(4)		$	93,430	(2)
-1	Includes real estate cost included in real estate held for sale of $96,766 at December 31, 2011. Excludes intangible lease assets that are included in real estate held for sale of $3,012 for 2011.
-2	Includes accumulated depreciation in real estate held for sale of $11,807 for 2011. Excludes accumulated amortization related to intangible lease assets that are included in real estate held for sale of $1,949 for 2011.
-3	Includes real estate cost included in real estate held for sale of $28,617 at December 31, 2012. Excludes intangible lease assets that are included in real estate held for sale of $858 for 2012.
-4	Includes in accumulated depreciation in real estate held for sale of $3,511 for 2012. Excludes accumulated amortization related to intangible lease assets that are included in real estate held for sale of $426 for 2012.
-5	The aggregate cost for federal income tax purposes is $2,155,240.

SCHEDULE_IV_MORTGAGE_LOANS_ON_

SCHEDULE IV - MORTGAGE LOANS ON REAL ESTATE	12 Months Ended
	Dec. 31, 2013
Mortgage Loans On Real Estate [Abstract]	'
SCHEDULE IV - MORTGAGE LOANS ON REAL ESTATE	'
	SCHEDULE IV — MORTGAGE LOANS ON REAL ESTATE
	MEDICAL PROPERTIES TRUST, INC. AND MPT OPERATING PARTNERSHIP, L.P.
	Column A		Column B			Column C		Column D		Column E			Column F		Column G(3)		Column H
	Description		Interest			Final		Periodic Payment		Prior			Face		Carrying		Principal
			Rate			Maturity		Terms		Liens			Amount of		Amount of		Amount of
						Date							Mortgages		Mortgages		Loans
																	Subject to
																	Delinquent
																	Principal or
																	Interest
			(Dollar amounts in thousands)
	Long-term first mortgage loan:							Payable in monthly
								installments of
								interest plus
								principal payable
								in full at maturity
	Desert Valley Hospital			10.7	%		2022				(1	)	$	70,000	$	70,000		(2	)
	Desert Valley Hospital			11.3	%		2022				(1	)		20,000		20,000		(2	)
	Chino Valley Medical Center			10.7	%		2022				(1	)		50,000		50,000		(2	)
	Paradise Valley Hospital			10.3	%		2022				(1	)		25,000		25,000		(2	)
	Ernest Mortgage Loan(4)			9.2	%		2032				(1	)		100,000		100,000		(2	)
	Centinela Hospital Medical Center			10.5	%		2022				(1	)		100,000		100,000		(2	)
	Olympia Medical Center			11	%		2024				(1	)		20,000		20,000		(2	)
	Denham Springs LTACH			6	%		2014				(1	)		3,650		3,650		(2	)
													$	388,650	$	388,650
	-1	There were no prior liens on loans as of December 31, 2013.
	-2	The mortgage loan was not delinquent with respect to principal or interest.
	-3	The aggregate cost for Federal income tax purposes is $388,650.
	-4	Mortgage loans on four properties.
	Changes in mortgage loans for the years ended December 31, 2013, 2012, and 2011 are summarized as follows:
			Year Ended December 31,
			2013			2012		2011
			(Dollar amounts in thousands)
	Balance at beginning of year		$	368,650		$	165,000	$	165,000
	Additions during year:
	New mortgage loans and additional advances on existing loans			20,000			203,650		—
				388,650			368,650		165,000
	Deductions during year:
	Collection of principal			—			—		—
				—			—		—
	Balance at end of year		$	388,650		$	368,650	$	165,000

Summary_of_Significant_Account1

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2013
Accounting Policies [Abstract]	'
Use of Estimates	'
	Use of Estimates: The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Principles of Consolidation	'
	Principles of Consolidation: Property holding entities and other subsidiaries of which we own 100% of the equity or have a controlling financial interest evidenced by ownership of a majority voting interest are consolidated. All inter-company balances and transactions are eliminated. For entities in which we own less than 100% of the equity interest, we consolidate the property if we have the direct or indirect ability to control the entities’ activities based upon the terms of the respective entities’ ownership agreements. For these entities, we record a non-controlling interest representing equity held by non-controlling interests.
	We continually evaluate all of our transactions and investments to determine if they represent variable interests in a variable interest entity (“VIE”). If we determine that we have a variable interest in a VIE, we then evaluate if we are the primary beneficiary of the VIE. The evaluation is a qualitative assessment as to whether we have the ability to direct the activities of a VIE that most significantly impact the entity’s economic performance. We consolidate each VIE in which we, by virtue of or transactions with our investments in the entity, are considered to be the primary beneficiary.
	At December 31, 2013, we had loans and/or equity investments in certain VIEs, which are also tenants of our facilities (including but not limited to Ernest, Monroe and Vibra). We have determined that we are not the primary beneficiary of these VIEs. The carrying value and classification of the related assets and maximum exposure to loss as a result of our involvement with these VIEs are presented below at December 31, 2013 (in thousands):
	VIE		Maximum Loss		Asset Type	Carrying
	Type		Exposure(1)		Classification	Amount(2)
	Loans, net			$283,273	Mortgage and other loans	$	228,996
	Equity investments			$  19,308	Other assets	$	5,198
	-1	Our maximum loss exposure related to loans with VIEs represents our current aggregate gross carrying value of the loan plus accrued interest and any other related assets (such as rents receivable), less any liabilities. Our maximum loss exposure related to our equity investment in VIEs represent the current carrying values of such investment plus any other related assets (such as rent receivables) less any liabilities.
	-2	Carrying amount reflects the net book value of our loan or equity interest only in the VIE.
	For the VIE types above, we do not consolidate the VIE because we do not have the ability to control the activities (such as the day-to-day healthcare operations of our borrowers or investees) that most significantly impact the VIE’s economic performance. As of December 31, 2013, we were not required to provide financial support through a liquidity arrangement or otherwise to our unconsolidated VIEs, including circumstances in which it could be exposed to further losses (e.g., cash short falls).
	Typically, our loans are collateralized by assets of the borrower (some assets of which are on the premises of facilities owned by us) and further supported by limited guarantees made by certain principals of the borrower.
	See Note 3 for additional description of the nature, purpose and activities of our more significant VIEs and interests therein.
Investments in Unconsolidated Entities	'
	Investments in Unconsolidated Entities: Investments in entities in which we have the ability to influence (but not control) are typically accounted for by the equity method. Under the equity method of accounting, our share of the investee’s earnings or losses are included in our consolidated results of operations, and we have elected to record our share of such investee’s earnings or losses on a 90-day lag basis. The initial carrying value of investments in unconsolidated entities is based on the amount paid to purchase the interest in the investee entity. Subsequently, our investments are increased by the equity in our investee earnings and decreased by cash distributions from our investees. To the extent that our cost basis is different from the basis reflected at the investee entity level, the basis difference is generally amortized over the lives of the related assets and liabilities, and such amortization is included in our share of equity in earnings of the investee. We evaluate our equity method investments for impairment based upon a comparison of the fair value of the equity method investment to its carrying value. If we determine a decline in the fair value of an investment in an unconsolidated investee entity below its carrying value is other - than - temporary, an impairment is recorded.
Cash and Cash Equivalents	'
	Cash and Cash Equivalents: Certificates of deposit, short-term investments with original maturities of three months or less and money-market mutual funds are considered cash equivalents. The majority of our cash and cash equivalents are held at major commercial banks which at times may exceed the Federal Deposit Insurance Corporation limit. We have not experienced any losses to date on our invested cash. Cash and cash equivalents which have been restricted as to its use are recorded in other assets.
Revenue Recognition	'
	Revenue Recognition: We receive income from operating leases based on the fixed, minimum required rents (base rents) per the lease agreements. Rent revenue from base rents is recorded on the straight-line method over the terms of the related lease agreements for new leases and the remaining terms of existing leases for acquired properties. The straight-line method records the periodic average amount of base rent earned over the term of a lease, taking into account contractual rent increases over the lease term. The straight-line method typically has the effect of recording more rent revenue from a lease than a tenant is required to pay early in the term of the lease. During the later parts of a lease term, this effect reverses with less rent revenue recorded than a tenant is required to pay. Rent revenue as recorded on the straight-line method in the consolidated statements of income is presented as two amounts: billed rent revenue and straight-line revenue. Billed rent revenue is the amount of base rent actually billed to the customer each period as required by the lease. Straight-line rent revenue is the difference between rent revenue earned based on the straight-line method and the amount recorded as billed rent revenue. We record the difference between base rent revenues earned and amounts due per the respective lease agreements, as applicable, as an increase or decrease to straight-line rent receivable.
	Certain leases provide for additional rents contingent upon a percentage of the tenant’s revenue in excess of specified base amounts/thresholds (percentage rents). Percentage rents are recognized in the period in which revenue thresholds are met. Rental payments received prior to their recognition as income are classified as deferred revenue. We also receive additional rent (contingent rent) under some leases based on increases in the consumer price index or when the consumer price index exceeds the annual minimum percentage increase in the lease. Contingent rents are recorded as billed rent revenue in the period earned.
	We use direct finance lease accounting (“DFL”) to record rent on certain leases deemed to be financing leases rather than operating leases. For leases accounted for as DFLs, the future minimum lease payments are recorded as a receivable. Unearned income represents the net investment in the DFL, less the sum of minimum lease payments receivable and the estimated residual values of the leased properties. Unearned income is deferred and amortized to income over the lease terms to provide a constant yield when collectability of the lease payments is reasonably assured. Investments in DFLs are presented net of unamortized and unearned income.
	In instances where we have a profits or equity interest in our tenant’s operations, we record revenue equal to our percentage interest of the tenant’s profits, as defined in the lease or tenant’s operating agreements, once annual thresholds, if any, are met.
	We begin recording base rent income from our development projects when the lessee takes physical possession of the facility, which may be different from the stated start date of the lease. Also, during construction of our development projects, we are generally entitled to accrue rent based on the cost paid during the construction period (construction period rent). We accrue construction period rent as a receivable and deferred revenue during the construction period. When the lessee takes physical possession of the facility, we begin recognizing the accrued construction period rent on the straight-line method over the remaining term of the lease.
	We receive interest income from our tenants/borrowers on mortgage loans, working capital loans, and other long-term loans. Interest income from these loans is recognized as earned based upon the principal outstanding and terms of the loans.
	Commitment fees received from development and leasing services for lessees are initially recorded as deferred revenue and recognized as income over the initial term of a lease to produce a constant effective yield on the lease (interest method). Commitment and origination fees from lending services are also recorded as deferred revenue and recognized as income over the life of the loan using the interest method.
	Tenant payments for certain taxes, insurance, and other operating expenses related to our facilities (most of which are paid directly by our tenants to the government or related vendor) are recorded net of the respective expense as generally our leases are “triple-net” leases, with terms requiring such expenses to be paid by our tenants. Failure on the part of our tenants to pay such expense or to pay late would result in a violation of the lease agreement, which could lead to an event of default, if not cured.
Acquired Real Estate Purchase Price Allocation	'
	Acquired Real Estate Purchase Price Allocation: We allocate the purchase price of acquired properties to net tangible and identified intangible assets acquired based on their fair values. In making estimates of fair values for purposes of allocating purchase prices of acquired real estate, we utilize a number of sources, from time to time, including independent appraisals that may be obtained in connection with the acquisition or financing of the respective property and other market data. We also consider information obtained about each property as a result of our pre-acquisition due diligence, marketing and leasing activities in estimating the fair value of the tangible and intangible assets acquired.
	We record above-market and below-market in-place lease values, if any, for our facilities, which are based on the present value of the difference between (i) the contractual amounts to be paid pursuant to the in-place leases and (ii) management’s estimate of fair market lease rates for the corresponding in-place leases, measured over a period equal to the remaining non-cancelable term of the lease. We amortize any resulting capitalized above-market lease values as a reduction of rental income over the lease term. We amortize any resulting capitalized below-market lease values as an increase to rental income over the lease term.
	We measure the aggregate value of other lease intangible assets acquired based on the difference between (i) the property valued with new or in-place leases adjusted to market rental rates and (ii) the property valued as if vacant. Management’s estimates of value are made using methods similar to those used by independent appraisers (e.g., discounted cash flow analysis). Factors considered by management in our analysis include an estimate of carrying costs during hypothetical expected lease-up periods, considering current market conditions, and costs to execute similar leases. We also consider information obtained about each targeted facility as a result of our pre-acquisition due diligence, marketing, and leasing activities in estimating the fair value of the intangible assets acquired. In estimating carrying costs, management includes real estate taxes, insurance and other operating expenses and estimates of lost rentals at market rates during the expected lease-up periods, which we expect to be about six months. depending on specific local market conditions. Management also estimates costs to execute similar leases including leasing commissions, legal costs, and other related expenses to the extent that such costs are not already incurred in connection with a new lease origination as part of the transaction.
	Other intangible assets acquired, may include customer relationship intangible values which are based on management’s evaluation of the specific characteristics of each prospective tenant’s lease and our overall relationship with that tenant. Characteristics to be considered by management in allocating these values include the nature and extent of our existing business relationships with the tenant, growth prospects for developing new business with the tenant, the tenant’s credit quality and expectations of lease renewals, including those existing under the terms of the lease agreement, among other factors.
	We amortize the value of in-place leases, if any, to expense over the initial term of the respective leases. The value of customer relationship intangibles is amortized to expense over the initial term and any renewal periods in the respective leases, but in no event will the amortization period for intangible assets exceed the remaining depreciable life of the building. If a lease is terminated, the unamortized portion of the in-place lease value and customer relationship intangibles are charged to expense.
Real Estate and Depreciation	'
	Real Estate and Depreciation: Real estate, consisting of land, buildings and improvements, are recorded at cost. Although typically paid by our tenants, any expenditure for ordinary maintenance and repairs that we pay are expensed to operations as incurred. Significant renovations and improvements which improve and/or extend the useful life of the asset are capitalized and depreciated over their estimated useful lives. We record impairment losses on long-lived assets used in operations when events and circumstances indicate that the assets might be impaired and the undiscounted cash flows estimated to be generated by those assets, including an estimated liquidation amount, during the expected holding periods are less than the carrying amounts of those assets. Impairment losses are measured as the difference between carrying value and fair value of assets. For assets held for sale, we cease recording depreciation expense and adjust the assets’ value to the lower of its carrying value or fair value, less cost of disposal. Fair value is based on estimated cash flows discounted at a risk-adjusted rate of interest. We classify real estate assets as held for sale when we have commenced an active program to sell the assets, and in the opinion of management, it is probable the asset will be sold within the next 12 months. We record the results of operations from material property sales or planned sales (which include real property, loans and any receivables) as discontinued operations in the consolidated statements of income for all periods presented if we do not have any continuing involvement with the property subsequent to its sale. Results of discontinued operations include interest expense from debt which specifically collateralizes the property sold or held for sale.
	Construction in progress includes the cost of land, the cost of construction of buildings, improvements and fixed equipment, and costs for design and engineering. Other costs, such as interest, legal, property taxes and corporate project supervision, which can be directly associated with the project during construction, are also included in construction in progress. We commence capitalization of costs associated with a development project when the development of the future asset is probable and activities necessary to get the underlying property ready for its intended use have been initiated. We stop the capitalization of costs when the property is substantially complete and ready for its intended use.
	Depreciation is calculated on the straight-line method over the weighted average useful lives of the related real estate and other assets, as follows:
	Buildings and improvements			38.2 years
	Tenant lease intangibles			18.6 years
	Leasehold improvements			22.2 years
	Furniture, equipment and other			9.4 years
Losses from Rent Receivables	'
	Losses from Rent Receivables: For all leases, we continuously monitor the performance of our existing tenants including, but not limited to: admission levels and surgery/procedure volumes by type; current operating margins; ratio of our tenant’s operating margins both to facility rent and to facility rent plus other fixed costs; trends in revenue and patient mix; and the effect of evolving healthcare regulations on tenant’s profitability and liquidity.
	Losses from Operating Lease Receivables:  We utilize the information above along with the tenant’s payment and default history in evaluating (on a property-by-property basis) whether or not a provision for losses on outstanding rent receivables is needed. A provision for losses on rent receivables (including straight-line rent receivables) is ultimately recorded when it becomes probable that the receivable will not be collected in full. The provision is an amount which reduces the receivable to its estimated net realizable value based on a determination of the eventual amounts to be collected either from the debtor or from existing collateral, if any.
	Losses on DFL Receivables:  Allowances are established for DFLs based upon an estimate of probable losses for the individual DFLs deemed to be impaired. DFLs are impaired when it is deemed probable that we will be unable to collect all amounts due in accordance with the contractual terms of the lease. Like operating lease receivables, the need for an allowance is based upon our assessment of the lessee’s overall financial condition; economic resources and payment record; the prospects for support from any financially responsible guarantors; and, if appropriate, the realizable value of any collateral. These estimates consider all available evidence including the expected future cash flows discounted at the DFL’s effective interest rate, fair value of collateral, and other relevant factors, as appropriate. DFLs are placed on non-accrual status when we determine that the collectability of contractual amounts is not reasonably assured. While on non-accrual status, we generally account for the DFLs on a cash basis, in which income is recognized only upon receipt of cash.
Loans	'
	Loans: Loans consist of mortgage loans, working capital loans and other long-term loans. Mortgage loans are collateralized by interests in real property. Working capital and other long-term loans are generally collateralized by interests in receivables and corporate and individual guarantees. We record loans at cost. We evaluate the collectability of both interest and principal on a loan-by-loan basis (using the same process as we do for assessing the collectability of rents) to determine whether they are impaired. A loan is considered impaired when, based on current information and events, it is probable that we will be unable to collect all amounts due according to the existing contractual terms. When a loan is considered to be impaired, the amount of the allowance is calculated by comparing the recorded investment to either the value determined by discounting the expected future cash flows using the loan’s effective interest rate or to the fair value of the collateral if the loan is collateral dependent. When a loan is deemed to be impaired, we generally place the loan on non-accrual status and record interest income only upon receipt of cash.
Earnings Per Share/Units	'
	Earnings Per Share/Units: Basic earnings per common share/unit is computed by dividing net income applicable to common shares/units by the weighted number of shares/units of common stock/units outstanding during the period. Diluted earnings per common share/units is calculated by including the effect of dilutive securities.
	Certain of our unvested restricted and performance stock/unit awards contain non-forfeitable rights to dividends, and accordingly, these awards are deemed to be participating securities. These participating securities are included in the earnings allocation in computing both basic and diluted earnings per common share/unit.
Income Taxes	'
	Income Taxes: We conduct our business as a real estate investment trust (“REIT”) under Sections 856 through 860 of the Internal Revenue Code. To qualify as a REIT, we must meet certain organizational and operational requirements, including a requirement to distribute to stockholders at least 90% of our REIT’s ordinary taxable income. As a REIT, we generally are not subject to federal income tax on taxable income that we distribute to our stockholders. If we fail to qualify as a REIT in any taxable year, we will then be subject to federal income taxes on our taxable income at regular corporate rates and will not be permitted to qualify for treatment as a REIT for federal income tax purposes for four years following the year during which qualification is lost, unless the Internal Revenue Service grants us relief under certain statutory provisions. Such an event could materially adversely affect our net income and net cash available for distribution to stockholders. However, we intend to operate in such a manner so that we will remain qualified as a REIT for federal income tax purposes.
	Our financial statements include the operations of taxable REIT subsidiaries (“TRS”), including MPT Development Services, Inc. (“MDS”) and MPT Covington TRS, Inc. (“CVT”), along with 29 others, which are single member LLCs that are disregarded for tax purposes and are reflected in the tax returns of MDS. Our TRS entities are not entitled to a dividends paid deduction and are subject to federal, state, and local income taxes. Our TRS entities are authorized to provide property development, leasing, and management services for third-party owned properties, and they make loans to and/or investments in our lessees.
	With the property acquisitions in Germany, we will be subject to income taxes internationally. However, we do not expect to incur any additional income tazes in the United States as such income from our German properties will flow through our REIT income tax returns. For our TRS and international subsidiaries, we determine deferred tax assets and liabilities based on the differences between the financial reporting and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Any increase or decrease in the deferred tax liability that results from a change in circumstances, and that causes us to change our judgment about expected future tax consequences of events, is reflected in our tax provision when such changes occur. Deferred income taxes also reflect the impact of operating loss carryforwards. A valuation allowance is provided if we believe it is more likely than not that all or some portion of the deferred tax asset will not be realized. Any increase or decrease in the valuation allowance that results from a change in circumstances, and that causes us to change our judgment about the realizability of the related deferred tax asset, is reflected in our tax provision when such changes occur.
Stock-Based Compensation	'
	Stock-Based Compensation: We adopted the 2013 Equity Incentive Plan (the “Equity Incentive Plan”) during the second quarter of 2013, which replaced the 2004 Equity Incentive Plan. Awards of restricted stock, stock options and other equity-based awards with service conditions are amortized to compensation expense over the vesting periods (typically three years), using the straight-line method. Awards of deferred stock units vest when granted and are charged to expense at the date of grant. Awards that contain market conditions are amortized to compensation expense over the derived vesting periods, which correspond to the periods over which we estimate the awards will be earned, which generally range from three to five years, using the straight-line method. Awards with performance conditions are amortized using the straight-line method over the service period in which the performance conditions are measured, adjusted for the probability of achieving the performance conditions.
Deferred Costs	'
	Deferred Costs: Costs incurred prior to the completion of offerings of stock or other capital instruments that directly relate to the offering are deferred and netted against proceeds received from the offering. External costs incurred in connection with anticipated financings and refinancings of debt are generally capitalized as deferred financing costs in other assets and amortized over the lives of the related loans as an addition to interest expense. For debt with defined principal re-payment terms, the deferred costs are amortized to produce a constant effective yield on the loan (interest method). For debt without defined principal repayment terms, such as revolving credit agreements, the deferred costs are amortized on the straight-line method over the term of the debt. Leasing commissions and other leasing costs directly attributable to tenant leases are capitalized as deferred leasing costs and amortized on the straight-line method over the terms of the related lease agreements. Costs identifiable with loans made to borrowers are recognized as a reduction in interest income over the life of the loan.
Foreign Currency Translation and Transactions	'
	Foreign Currency Translation and Transactions: Certain of our subsidiaries’ functional currencies are the local currencies of their respective countries. We translate the results of operations of our foreign subsidiaries into U.S. dollars using average rates of exchange in effect during the period, and we translate balance sheet accounts using exchange rates in effect at the end of the period. We record resulting currency translation adjustments in accumulated other comprehensive income, a component of stockholders’ equity on our consolidated balance sheets.
	Certain of our U.S. subsidiaries will enter into transactions denominated in foreign currency from time to time. Gains or losses resulting from these foreign currency transactions are translated into U.S. dollars at the rates of exchange prevailing at the dates of the transactions. The effects of transaction gains or losses are included in other income in the consolidated statements of income.
Derivative Financial Investments and Hedging Activities	'
	Derivative Financial Investments and Hedging Activities: During our normal course of business, we may use certain types of derivative instruments for the purpose of managing interest rate and/or foreign currency risk. We record our derivative and hedging instruments at fair value on the balance sheet. Changes in the estimated fair value of derivative instruments that are not designated as hedges or that do not meet the criteria for hedge accounting are recognized in earnings. For derivatives designated as cash flow hedges, the change in the estimated fair value of the effective portion of the derivative is recognized in accumulated other comprehensive income (loss), whereas the change in the estimated fair value of the ineffective portion is recognized in earnings. For derivatives designated as fair value hedges, the change in the estimated fair value of the effective portion of the derivatives offsets the change in the estimated fair value of the hedged item, whereas the change in the estimated fair value of the ineffective portion is recognized in earnings.
	To qualify for hedge accounting, we formally document all relationships between hedging instruments and hedged items, as well as our risk management objective and strategy for undertaking the hedge prior to entering into a derivative transaction. This process includes specific identification of the hedging instrument and the hedge transaction, the nature of the risk being hedged and how the hedging instrument’s effectiveness in hedging the exposure to the hedged transaction’s variability in cash flows attributable to the hedged risk will be assessed. Both at the inception of the hedge and on an ongoing basis, we assess whether the derivatives that are used in hedging transactions are highly effective in offsetting changes in cash flows or fair values of hedged items. In addition, for cash flow hedges, we assess whether the underlying forecasted transaction will occur. We discontinue hedge accounting if a derivative is not determined to be highly effective as a hedge or that it is probable that the underlying forecasted transaction will not occur.
Fair Value Measurement	'
	Fair Value Measurement: We measure and disclose the estimated fair value of financial assets and liabilities utilizing a hierarchy of valuation techniques based on whether the inputs to a fair value measurement are considered to be observable or unobservable in a marketplace. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect our market assumptions. This hierarchy requires the use of observable market data when available. These inputs have created the following fair value hierarchy:
		•		Level 1 — quoted prices for identical instruments in active markets;
		•		Level 2 — quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which significant inputs and significant value drivers are observable in active markets; and
		•		Level 3 — fair value measurements derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
	We measure fair value using a set of standardized procedures that are outlined herein for all assets and liabilities which are required to be measured at their estimated fair value on either a recurring or non-recurring basis. When available, we utilize quoted market prices from an independent third party source to determine fair value and classify such items in Level 1. In some instances where a market price is available, but the instrument is in an inactive or over-the-counter market, we consistently apply the dealer (market maker) pricing estimate and classify the asset or liability in Level 2.
	If quoted market prices or inputs are not available, fair value measurements are based upon valuation models that utilize current market or independently sourced market inputs, such as interest rates, option volatilities, credit spreads, market capitalization rates, etc. Items valued using such internally-generated valuation techniques are classified according to the lowest level input that is significant to the fair value measurement. As a result, the asset or liability could be classified in either Level 2 or 3 even though there may be some significant inputs that are readily observable. Internal fair value models and techniques used by us include discounted cash flow and Monte Carlo valuation models. We also consider our counterparty’s and own credit risk on derivatives and other liabilities measured at their estimated fair value.
	Fair Value Option Election: For our equity interest in Ernest and related loans (as more fully described in Note 3), we have elected to account for these investments at fair value due to the size of the investments and because we believe this method is more reflective of current values. We have not made a similar election for other equity interest or loans made in or prior to 2012.
Recent Accounting Developments	'
	Recent Accounting Developments: In July 2013, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update No. 2013-10, Inclusion of the Fed Funds Effective Swap Rate (or Overnight Index Swap Rate) as a Benchmark Interest Rate for Hedge Accounting Purposes (a consensus of the FASB Emerging Issues Task Force) (“ASU 2013-10”). This update permits the Fed Funds Effective Swap Rate to be used as a U.S. benchmark interest rate for hedge accounting purposes under Topic 815, in addition to the interest rates on direct Treasury obligations of the U.S. government and the London Interbank Offered Rate (“LIBOR”). The amendments are effective prospectively for qualifying new or redesignated hedging relationships entered into on or after July 17, 2013. The adoption of ASU 2013-10 on July 17, 2013, did not have a material impact on our 2013 consolidated financial position or results of operations.
	In January 2013, the FASB issued Accounting Standards Update (“ASU”) No. 2013-02, Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income (“ASU 2013-02”). The amendments in this update require an entity to provide information about the amounts reclassified from accumulated other comprehensive income by component. In addition, an entity is required to present, either on the face of the income statement or in the notes, significant amounts reclassified from accumulated other comprehensive income by the net income line item. The adoption of ASU 2013-02 did not have an impact on our 2013 consolidated financial position or results of operations.
Reclassifications	'
	Reclassifications: Certain reclassifications have been made to the consolidated financial statements to conform to the 2013 consolidated financial statement presentation. Assets sold or held for sale have been reclassified to Real Estate Held for Sale on the consolidated balance sheets and related operating results have been reclassified from continuing operations to discontinued operations for all periods presented (see Note 11).

Summary_of_Significant_Account2

Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2013
Accounting Policies [Abstract]	'
Carrying Value and Classification of Related Assets and Maximum Exposure to Loss	'
	The carrying value and classification of the related assets and maximum exposure to loss as a result of our involvement with these VIEs are presented below at December 31, 2013 (in thousands):
	VIE	Maximum Loss		Asset Type	Carrying
	Type	Exposure(1)		Classification	Amount(2)
	Loans, net		$283,273	Mortgage and other loans	$	228,996
	Equity investments		$  19,308	Other assets	$	5,198
Useful Lives of Related Real Estate and Other Assets	'
	Depreciation is calculated on the straight-line method over the weighted average useful lives of the related real estate and other assets, as follows:
	Buildings and improvements		38.2 years
	Tenant lease intangibles		18.6 years
	Leasehold improvements		22.2 years
	Furniture, equipment and other		9.4 years

Real_Estate_and_Loans_Receivab1

Real Estate and Loans Receivable (Tables)	12 Months Ended
	Dec. 31, 2013
Text Block [Abstract]	'
Assets Acquired	'
	We acquired the following assets:
		2013			2012				2011
	Assets Acquired		(in thousands)
	Land	$	41,473		$	518			$	19,705
	Building		439,030			8,942				220,769
	Intangible lease assets — subject to amortization (weighted average useful life 21.0 years in 2013, 15.0 years in 2012 and 13.9 years in 2011)		38,589			1,040				20,630
	Net investments in direct financing leases		110,580			310,000				—
	Mortgage loans		20,000			200,000				—
	Other loans		5,250			95,690				27,283
	Equity investments		—			5,300				5,168
	Total assets acquired	$	654,922		$	621,490			$	293,555
	Total liabilities assumed		—			—				(14,592	)
	Net assets acquired	$	654,922		$	621,490			$	278,963
Supplemental Pro Forma Earnings Adjusted to Exclude Acquisition-Related Costs	'
		2013			2012
		(Amounts in thousands
		except per share/unit
		amounts)
	Total revenues	$	288,159		$	280,539
	Net income		133,258			135,402
	Net income per share/unit	$	0.82		$	0.85
Summary of Status Update on Current Development Projects	'
	See table below for a status update on our current development projects (in thousands):
	Property	Location		Property Type	Operator		Commitment				Costs Incurred				Estimated
											as of				Completion
											12/31/13				Date
	First Choice ER- Nacogdoches	San Antonio, TX		Acute Care Hospital	First Choice ER, LLC		$	5,100			$	2,681				1Q 2014
	First Choice ER- Brodie	Austin, TX		Acute Care Hospital	First Choice ER, LLC			5,470				1,950				2Q 2014
	First Choice ER- Alvin	Houston, TX		Acute Care Hospital	First Choice ER, LLC			5,240				1,328				2Q 2014
	Northern Utah Rehabilitation Hospital	South Ogden, UT		Inpatient Rehabilitation Hospital	Ernest Health, Inc.			19,153				16,391				2Q 2014
	First Choice ER- Briar Forest	Houston, TX		Acute Care Hospital	First Choice ER, LLC			5,833				1,386				3Q 2014
	First Choice ER- Cedar Hill	Cedar Hill, TX		Acute Care Hospital	First Choice ER, LLC			5,768				1,167				3Q 2014
	First Choice ER- Firestone	Firestone, CO		Acute Care Hospital	First Choice ER, LLC			5,172				544				3Q 2014
	Oakleaf Surgical Hospital	Altoona, WI		Acute Care Hospital	National Surgical			33,500				16,324				3Q 2014
					Hospitals
	First Choice Emergency Rooms	Various		Acute Care Hospital	First Choice			62,217				—				Various
							$	147,453			$	41,771
Amortization Expense from Lease Intangible Assets	'
	Amortization expense from existing lease intangible assets as follows: (amounts in thousands)
	For the Year Ended December 31:
	2014	$	5,086
	2015		4,896
	2016		4,855
	2017		4,845
	2018		4,784
Components of Net Investment in Direct Financing Leases	'
	The components of our net investment in DFLs consisted of the following (dollars in thousands):
		As of December 31,
		2013
	Minimum lease payments receivable	$	1,647,567
	Estimated residual values		211,863
	Less unearned income		(1,428,406	)
	Net investment in direct financing leases	$	431,024
Minimum Rental Payments Due under Operating Leases with Non-Cancelable Terms	'
	Minimum rental payments due to us in future periods under operating leases and DFL, which have non-cancelable terms extending beyond one year at December 31, 2013, are as follows: (amounts in thousands)
		Total Under			Total Under				Total
		Operating Leases			DFLs
	2014	$	166,602		$	42,535			$	209,137
	2015		164,754			43,386				208,140
	2016		165,517			44,254				209,771
	2017		165,418			45,139				210,557
	2018		165,679			46,041				211,720
	Thereafter		1,536,759			601,981				2,138,740
		$	2,364,729		$	823,336			$	3,188,065
Summary of Loans	'
	The following is a summary of our loans ($ amounts in thousands):
		As of December 31, 2013							As of December 31, 2012
		Balance			Weighted Average				Balance				Weighted Average
					Interest Rate								Interest Rate
	Mortgage loans	$	388,650			10.2	%		$	368,650				10	%
	Acquisition loans		103,266			14.5	%			98,433				14.7	%
	Working capital and other loans		57,724			10.9	%			60,810				10.8	%
		$	549,640						$	527,893

Debt_Tables

Debt (Tables)	12 Months Ended
	Dec. 31, 2013
Debt Disclosure [Abstract]	'
Summary of Debt	'
	The following is a summary of debt ($ amounts in thousands):
		As of December 31, 2013					As of December 31, 2012
		Balance		Interest Rate			Balance			Interest Rate
	Revolving credit facility	$	105,000		Variable		$	125,000			Variable
	2006 Senior Unsecured Notes		125,000		Various			125,000			Various
	2011 Senior Unsecured Notes		450,000		6.875	%		450,000			6.875	%
	2012 Senior Unsecured Notes:
	Principal amount		350,000		6.375	%		200,000			6.375	%
	Unamortized premium		2,873					—
			352,873					200,000
	Exchangeable senior notes:
	Principal amount		—					11,000			9.25	%
	Unamortized discount		—					(37	)
			—					10,963
	2013 Senior Unsecured Notes		274,860		5.75	%		—
	Term loans		113,948		Various			114,197			Various
		$	1,421,681				$	1,025,160
Principal Payments Due for Debt	'
	As of December 31, 2013, principal payments due on our debt (which exclude the effects of any discounts or premiums recorded) are as follows: (A)
	2014	$	265
	2015		105,283
	2016		225,299
	2017		320
	2018		12,781
	Thereafter		1,074,860
	Total	$	1,418,808

Income_Taxes_Tables

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2013
Income Tax Disclosure [Abstract]	'
Schedule of Income Tax Expense	'
	From our taxable REIT subsidiaries and our foreign operations (which realized a $12.9 million loss before income taxes in 2013 primarily due to the real estate transfer taxes), we incurred income tax expenses as follows (in thousands):
			For the Years Ended December 31,
			2013			2012			2011
	Domestic		$	568		$	19		$	128
	Foreign			158			—			—
			$	726		$	19		$	128
Schedule of Deferred Tax Assets And Liablities	'
	At December 31, 2013 and 2012, components of our deferred tax assets and liabilities were as follows (in thousands):
			2013			2012
	Deferred tax liabilities:
	Property and equipment		$	(2,870	)	$	(2,370	)
	Other			(2,923	)		(1,673	)
	Total deferred tax liabilities			(5,793	)		(4,043	)
	Deferred tax assets:
	Loan loss and other reserves			7,751			7,218
	Operating loss and interest deduction carry forwards			2,283			3,938
	Other			3,371			1,261
	Total deferred tax assets			13,405			12,417
	Valuation allowance			(7,843	)		(8,540	)
	Net deferred tax (liability)		$	(231	)	$	(166	)
Schedule of Per Share Distributions to Stockholders	'
	A schedule of per share distributions we paid and reported to our stockholders is set forth in the following:
			For the Years Ended December 31,
			2013			2012			2011
	Common share distribution		$	0.8		$	0.8		$	0.8
	Ordinary income			0.599384			0.601216			0.300844
	Capital gains(1)			0.04638			0.117584			0.031396
	Unrecaptured Sec. 1250 gain			0.026512			0.086976			0.031396
	Return of capital			0.154236			0.0812			0.46776
	Allocable to next year			—			—			—
	-1	Capital gains include unrecaptured Sec. 1250 gains.

Earnings_Per_ShareUnit_Tables

Earnings Per Share/Unit (Tables)	12 Months Ended
	Dec. 31, 2013
Earnings Per Share [Abstract]	'
Calculation of Earnings Per Share	'
	Medical Properties Trust, Inc.
	Our earnings per share were calculated based on the following (amounts in thousands):
		For the Years Ended December 31,
		2013			2012			2011
	Numerator:
	Income from continuing operations	$	89,301		$	72,870		$	12,120
	Non-controlling interests’ share in continuing operations		(224	)		(177	)		(178	)
	Participating securities’ share in earnings		(729	)		(887	)		(1,090	)
	Income from continuing operations, less participating securities’ share in earnings		88,348			71,806			10,852
	Income from discontinued operations attributable to MPT common stockholders		7,914			17,207			14,594
	Net income, less participating securities’ share in earnings	$	96,262		$	89,013		$	25,446
	Denominator:
	Basic weighted-average common shares		151,439			132,331			110,623
	Dilutive potential common shares		1,159			2			6
	Diluted weighted-average common shares		152,598			132,333			110,629
	MPT Operating Partnership, L.P.
	Our earnings per unit were calculated based on the following (amounts in thousands):
		For the Years Ended December 31,
		2013			2012			2011
	Numerator:
	Income from continuing operations	$	89,301		$	72,870		$	12,137
	Non-controlling interests’ share in continuing operations		(244	)		(177	)		(178	)
	Participating securities’ share in earnings		(729	)		(887	)		(1,090	)
	Income from continuing operations, less participating securities’ share in earnings		88,328			71,806			10,869
	Income from discontinued operations attributable to MPT Operating Partnership partners		7,914			17,207			14,594
	Net income, less participating securities’ share in earnings	$	96,242		$	89,013		$	25,463
	Denominator:
	Basic weighted-average units		151,439			132,331			110,623
	Dilutive potential units		1,159			2			6
	Diluted weighted-average units		152,598			132,333			110,629

Stock_Awards_Tables

Stock Awards (Tables)	12 Months Ended
	Dec. 31, 2013
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]	'
Restricted Equity Awards Activity	'
	The following summarizes restricted equity award activity in 2013 and 2012 (which includes awards granted in 2013, 2012, 2011, and any applicable prior years), respectively:
	For the Year Ended December 31, 2013:
		Vesting Based					Vesting Based on
		on Service					Market/Performance
							Conditions
		Shares			Weighted Average		Shares			Weighted Average
					Value at Award Date					Value at Award Date
	Nonvested awards at beginning of the year		466,883		$	10.72		1,879,889		$	6.48
	Awarded		240,425		$	12.26		754,255		$	6.13
	Vested		(381,309	)	$	11.15		(386,446	)	$	8.27
	Forfeited		—		$	—		(248,519	)	$	11.03
	Nonvested awards at end of year		325,999		$	11.36		1,999,179		$	5.44
	For the Year Ended December 31, 2012:
		Vesting Based					Vesting Based on
		on Service					Market/Performance
							Conditions
		Shares			Weighted Average		Shares			Weighted Average
					Value at Award Date					Value at Award Date
	Nonvested awards at beginning of the year		603,980		$	11.02		1,511,397		$	7.6
	Awarded		275,464		$	10.14		902,359		$	5.81
	Vested		(410,261	)	$	10.78		(513,693	)	$	8.63
	Forfeited		(2,300	)	$	10.24		(20,174	)	$	5.45
	Nonvested awards at end of year		466,883		$	10.72		1,879,889		$	6.48

Commitments_and_Contingencies_

Commitments and Contingencies (Tables)	12 Months Ended
	Dec. 31, 2013
Commitments And Contingencies Disclosure [Abstract]	'
Fixed Minimum Rental Payments Due under Operating Leases with Non-Cancelable Terms	'
	Fixed minimum payments due under operating leases with non-cancelable terms of more than one year at December 31, 2013 are as follows: (amounts in thousands)
	2014	$	2,471
	2015		2,644
	2016		2,659
	2017		2,620
	2018		2,614
	Thereafter		37,213
		$	50,221

Fair_Value_of_Financial_Instru1

Fair Value of Financial Instruments (Tables)	12 Months Ended
	Dec. 31, 2013
Fair Value Disclosures [Abstract]	'
Summary of Fair Value Information of Financial Instruments	'
	The following table summarizes fair value estimates for our financial instruments (in thousands):
			December 31,						December 31,
			2013						2012
	Asset (Liability)		Book			Fair			Book			Fair
			Value			Value			Value			Value
	Interest and rent receivables		$	58,499		$	44,349		$	45,289		$	36,700
	Loans(1)			351,607			358,277			334,693			335,595
	Debt, net			(1,421,681	)		(1,486,090	)		(1,025,160	)		(1,082,333	)
	-1	Excludes loans related to Ernest Transaction since they are recorded at fair value and discussed below.
Equity Interest in Ernest and Related Loans Measured at Fair Value on Recurring Basis	'
	At December 31, 2013. these amounts were as follows (in thousands):
	Asset (Liability)		Fair			Cost			Asset Type
			Value						Classification
	Mortgage loans		$	100,000		$	100,000		Mortgage loans
	Acquisition loan			98,033			98,033		Other loans
	Equity investments			3,300			3,300		Other assets
			$	201,333		$	201,333
Summary Showing Sensitivity Analysis by Using Basis Point Variations	'
	To illustrate the effect of movements in the DLOM, we performed a sensitivity analysis below by using basis point variations (dollars in thousands):
	Basis Point		Estimated Increase (Decrease)
	Change in		In Fair Value
	Marketability Discount
	+100 basis points		($320)
	- 100 basis points		320

Discontinued_Operations_Tables

Discontinued Operations (Tables)	12 Months Ended
	Dec. 31, 2013
Discontinued Operations And Disposal Groups [Abstract]	'
Discontinued Operations	'
	The following table presents the results of discontinued operations for the years ended December 31, 2013, 2012 and 2011 (in thousands except per share/unit amounts):
		For the Years Ended
		December 31,
		2013		2012		2011
	Revenues	$	988	$	3,470	$	14,531
	Gain on sale		7,659		16,369		5,431
	Income from discontinued operations		7,914		17,207		14,594
	Income from discontinued operations — diluted per share/unit	$	0.05	$	0.13	$	0.12

Quarterly_Financial_Data_unaud1

Quarterly Financial Data (unaudited) (Tables)	12 Months Ended
	Dec. 31, 2013
Medical Properties Trust, Inc. [Member]	'
Unaudited Quarterly Financial Information	'
	The following is a summary of the unaudited quarterly financial information for the years ended December 31, 2013 and 2012: (amounts in thousands, except for per share data)
		For the Three Month Periods in 2013 Ended
		March 31		June 30		September 30		December 31
	Revenues	$	57,614	$	57,124	$	60,106	$	67,679
	Income from continuing operations		25,570		25,031		25,391		13,309
	Income from discontinued operations		640		2,374		312		4,588
	Net income		26,210		27,405		25,703		17,897
	Net income attributable to MPT common stockholders		26,156		27,348		25,648		17,839
	Net income attributable to MPT common stockholders per share — basic	$	0.19	$	0.18	$	0.16	$	0.11
	Weighted average shares outstanding — basic		140,347		149,509		154,758		161,143
	Net income attributable to MPT common stockholders per share — diluted	$	0.18	$	0.18	$	0.16	$	0.11
	Weighted average shares outstanding — diluted		141,526		151,056		155,969		161,840
		For the Three Month Periods in 2012 Ended
		March 31		June 30		September 30		December 31
	Revenues	$	40,455	$	48,569	$	52,504	$	56,597
	Income (loss) from continuing operations		8,294		18,718		22,594		23,264
	Income from discontinued operations		2,312		642		8,914		5,339
	Net income		10,606		19,360		31,508		28,603
	Net income attributable to MPT common stockholders		10,564		19,316		31,464		28,556
	Net income attributable to MPT common stockholders per share — basic	$	0.08	$	0.14	$	0.23	$	0.21
	Weighted average shares outstanding — basic		124,906		134,715		134,781		134,923
	Net income attributable to MPT common stockholders per share — diluted	$	0.08	$	0.14	$	0.23	$	0.21
	Weighted average shares outstanding — diluted		124,906		134,715		134,782		134,930
MPT Operating Partnership, L.P. [Member]	'
Unaudited Quarterly Financial Information	'
	The following is a summary of the unaudited quarterly financial information for the years ended December 31, 2013 and 2012: (amounts in thousands, except for per unit data)
		For the Three Month Periods in 2013 Ended
		March 31		June 30		September 30		December 31
	Revenues	$	57,614	$	57,124	$	60,106	$	67,679
	Income from continuing operations		25,570		25,031		25,391		13,309
	Income from discontinued operations		640		2,374		312		4,588
	Net income		26,210		27,405		25,703		17,897
	Net income attributable to MPT Operating Partnership partners		26,156		27,348		25,648		17,839
	Net income attributable to MPT Operating Partnership partners per unit — basic	$	0.19	$	0.18	$	0.16	$	0.11
	Weighted average units outstanding — basic		140,347		149,509		154,758		161,143
	Net income attributable to MPT Operating Partnership partners per unit — diluted	$	0.18	$	0.18	$	0.16	$	0.11
	Weighted average units outstanding — diluted		141,526		151,056		155,969		161,840
		For the Three Month Periods in 2012 Ended
		March 31		June 30		September 30		December 31
	Revenues	$	40,455	$	48,569	$	52,504	$	56,597
	Income from continuing operations		8,294		18,718		22,594		23,264
	Income from discontinued operations		2,312		642		8,914		5,339
	Net income		10,606		19,360		31,508		28,603
	Net income attributable to MPT Operating Partnership partners		10,564		19,316		31,464		28,556
	Net income attributable to MPT Operating Partnership partners per unit — basic	$	0.08	$	0.14	$	0.23	$	0.21
	Weighted average units outstanding — basic		124,906		134,715		134,781		134,923
	Net income attributable to MPT Operating Partnership partners per unit — diluted	$	0.08	$	0.14	$	0.23	$	0.21
	Weighted average units outstanding — diluted		124,906		134,715		134,782		134,930

Condensed_Consolidating_Financ1

Condensed Consolidating Financial Information (Tables)	12 Months Ended
	Dec. 31, 2013
Condensed Financial Information Of Parent Company Only Disclosure [Abstract]	'
Condensed Consolidated Balance Sheets	'
	Condensed Consolidated Balance Sheets
	December 31, 2013
	(in thousands)
		Parent			Subsidiary			Subsidiary			Non-Guarantor			Eliminations			Total
					Issuers			Guarantors			Subsidiaries						Consolidated
	Assets
	Real estate assets
	Land, buildings and improvements and intangible lease assets	$	—		$	—		$	1,795,084		$	70,371		$	—		$	1,865,455
	Net investment in direct financing leases		—			—			212,543			218,481			—			431,024
	Mortgage loans		—			—			268,650			120,000			—			388,650
	Gross investment in real estate assets		—			—			2,276,277			408,852			—			2,685,129
	Accumulated depreciation and amortization		—			—			(151,624	)		(8,152	)		—			(159,776	)
	Net investment in real estate assets		—			—			2,124,653			400,700			—			2,525,353
	Cash and cash equivalents		—			18,815			27,094			70			—			45,979
	Interest and rent receivables		—			336			31,324			26,839			—			58,499
	Straight-line rent receivables		—			—			37,015			8,814			—			45,829
	Other loans		—			178			1,100			159,712			—			160,990
	Net intercompany receivable		35,363			1,907,474			—			—			(1,942,837	)		—
	Investment in subsidiaries		1,344,598			825,153			42,407			—			(2,212,158	)		—
	Other assets		—			37,311			1,168			29,441			—			67,920
	Total Assets	$	1,379,961		$	2,789,267		$	2,264,761		$	625,576		$	(4,154,995	)	$	2,904,570
	Liabilities and Equity
	Liabilities
	Debt, net	$	—		$	1,407,733		$	—		$	13,948		$	—		$	1,421,681
	Accounts payable and accrued expenses		35,753			36,887			20,367			1,304			—			94,311
	Net intercompany payable		—			—			1,538,934			403,903			(1,942,837	)		—
	Deferred revenue		—			49			17,772			5,966			—			23,787
	Lease deposits and other obligations to tenants		—			—			17,964			2,619			—			20,583
	Total liabilities		35,753			1,444,669			1,595,037			427,740			(1,942,837	)		1,560,362
	Total Equity		1,344,208			1,344,598			669,724			197,836			(2,212,158	)		1,344,208
	Total Liabilities and Equity	$	1,379,961		$	2,789,267		$	2,264,761		$	625,576		$	(4,154,995	)	$	2,904,570
	Condensed Consolidated Balance Sheets
	December 31, 2012
	(in thousands)
		Parent			Subsidiary			Subsidiary			Non-Guarantor			Eliminations			Total
					Issuers			Guarantors			Subsidiaries						Consolidated
	Assets
	Real estate assets
	Land, buildings and improvements and intangible lease assets	$	—		$	28		$	1,185,265		$	65,947		$	—		$	1,251,240
	Real estate held for sale		—			—			—			25,537			—			25,537
	Net investment in direct financing leases		—			—			110,155			204,257			—			314,412
	Mortgage loans		—			—			268,650			100,000			—			368,650
	Gross investment in real estate assets		—			28			1,564,070			395,741			—			1,959,839
	Accumulated depreciation and amortization		—			—			(116,344	)		(6,452	)		—			(122,796	)
	Net investment in real estate assets		—			28			1,447,726			389,289			—			1,837,043
	Cash and cash equivalents		—			35,483			1,565			263			—			37,311
	Interest and rent receivables		—			212			29,150			15,927			—			45,289
	Straight-line rent receivables		—			—			28,416			7,444			—			35,860
	Other loans		—			177			—			159,066			—			159,243
	Net intercompany receivable		27,393			1,373,941			—			—			(1,401,334	)		—
	Investment in subsidiaries		1,050,204			647,029			42,666			—			(1,739,899	)		—
	Other assets		—			31,097			1,522			31,521			—			64,140
	Total Assets	$	1,077,597		$	2,087,967		$	1,551,045		$	603,510		$	(3,141,233	)	$	2,178,886
	Liabilities and Equity
	Liabilities
	Debt, net	$	—		$	1,010,962		$	—		$	14,198		$	—		$	1,025,160
	Accounts payable and accrued expenses		27,783			26,658			10,492			1,028			—			65,961
	Net intercompany payable		—			—			997,231			404,103			(1,401,334	)		—
	Deferred revenue		—			143			19,431			1,035			—			20,609
	Lease deposits and other obligations to tenants		—			—			16,357			985			—			17,342
	Total liabilities		27,783			1,037,763			1,043,511			421,349			(1,401,334	)		1,129,072
	Total Equity		1,049,814			1,050,204			507,534			182,161			(1,739,899	)		1,049,814
	Total Liabilities and Equity	$	1,077,597		$	2,087,967		$	1,551,045		$	603,510		$	(3,141,233	)	$	2,178,886
Condensed Consolidated Statements of Income	'
	Condensed Consolidated Statements of Income
	For the Year Ended December 31, 2013
	(in thousands)
		Parent			Subsidiary			Subsidiary			Non-Guarantor			Eliminations			Total
					Issuers			Guarantors			Subsidiaries						Consolidated
	Revenues
	Rent billed	$	—		$	—		$	124,651		$	20,028		$	(12,101	)	$	132,578
	Straight-line rent		—			—			8,438			2,268			—			10,706
	Income from direct financing leases		—			—			38,522			22,577			(20,269	)		40,830
	Interest and fee income		—			21,797			38,696			29,834			(31,918	)		58,409
	Total revenues		—			21,797			210,307			74,707			(64,288	)		242,523
	Expenses
	Real estate depreciation and amortization		—			—			35,277			1,701			—			36,978
	Property-related		—			601			1,356			32,863			(32,370	)		2,450
	Acquisition expenses		—			7,356			12,138			—			—			19,494
	General and administrative		—			29,033			375			655			—			30,063
	Total operating expenses		—			36,990			49,146			35,219			(32,370	)		88,985
	Operating income		—			(15,193	)		161,161			39,488			(31,918	)		153,538
	Other income (expense)
	Interest and other (expense) income		—			(110	)		—			(209	)		—			(319	)
	Earnings from equity and other interests		—			—			948			2,606			—			3,554
	Interest expense		—			(67,484	)		(1,912	)		(29,268	)		31,918			(66,746	)
	Income tax expense		—			—			(158	)		(568	)		—			(726	)
	Net other expense		—			(67,594	)		(1,122	)		(27,439	)		31,918			(64,237	)
	Income (loss) from continuing operations		—			(82,787	)		160,039			12,049			—			89,301
	Income (loss) from discontinued operations		—			—			(4	)		7,918			—			7,914
	Equity in earnings of consolidated subsidiaries net of income taxes		97,215			180,002			4,477			—			(281,694	)		—
	Net income (loss)		97,215			97,215			164,512			19,967			(281,694	)		97,215
	Net income (loss) attributable to non-controlling interests		(224	)		(224	)		—			—			224			(224	)
	Net income attributable to MPT common stockholders	$	96,991		$	96,991		$	164,512		$	19,967		$	(281,470	)	$	96,991
	Condensed Consolidated Statements of Income
	For the Year Ended December 31, 2012
	(in thousands)
		Parent			Subsidiary			Subsidiary			Non-Guarantor			Eliminations			Total
					Issuers			Guarantors			Subsidiaries						Consolidated
	Revenues
	Rent billed	$	—		$	—		$	112,573		$	16,619		$	(9,309	)	$	119,883
	Straight-line rent		—			—			6,429			1,482			—			7,911
	Income from direct financing leases		—			—			19,870			18,090			(16,232	)		21,728
	Interest and fee income		—			18,341			29,606			25,387			(24,731	)		48,603
	Total revenues		—			18,341			168,478			61,578			(50,272	)		198,125
	Expenses
	Real estate depreciation and amortization		—			—			31,115			1,700			—			32,815
	Property-related		—			495			816			25,707			(25,541	)		1,477
	Acquisition expenses		—			5,420			—			—			—			5,420
	General and administrative		—			26,018			—			2,544			—			28,562
	Total operating expenses		—			31,933			31,931			29,951			(25,541	)		68,274
	Operating income		—			(13,592	)		136,547			31,627			(24,731	)		129,851
	Other income (expense)
	Interest and other (expense) income		—			(69	)		—			(1,593	)		—			(1,662	)
	Earnings from equity and other interests		—			—			1,061			1,882			—			2,943
	Interest expense		—			(58,729	)		1,408			(25,653	)		24,731			(58,243	)
	Income tax expense		—			—			—			(19	)		—			(19	)
	Net other expense		—			(58,798	)		2,469			(25,383	)		24,731			(56,981	)
	Income (loss) from continuing operations		—			(72,390	)		139,016			6,244			—			72,870
	Income (loss) from discontinued operations		—			—			103			17,104			—			17,207
	Equity in earnings of consolidated subsidiaries net of income taxes		90,077			162,467			4,481			—			(257,025	)		—
	Net income (loss)		90,077			90,077			143,600			23,348			(257,025	)		90,077
	Net income (loss) attributable to non-controlling interests		(177	)		(177	)		—			—			177			(177	)
	Net income attributable to MPT common stockholders	$	89,900		$	89,900		$	143,600		$	23,348		$	(256,848	)	$	89,900
	Condensed Consolidated Statements of Income
	For the Year Ended December 31, 2011
	(in thousands)
	Parent			Subsidiary			Subsidiary			Non-Guarantor			Eliminations			Total
				Issuers			Guarantors			Subsidiaries						Consolidated
Revenues
Rent billed	$	—		$	—		$	99,494		$	9,286		$	(3,092	)	$	105,688
Straight-line rent		—			—			3,515			1,762			—			5,277
Interest and fee income		—			6,124			17,543			3,926			(6,236	)		21,357
Total revenues		—			6,124			120,552			14,974			(9,328	)		132,322
Expenses
Real estate depreciation and amortization		—			—			28,489			1,658			—			30,147
Property-related		—			217			458			3,141			(3,092	)		724
Acquisition expenses		—			3,713			—			471			—			4,184
General and administrative		17			23,914			—			3,160			—			27,091
Total operating expenses		17			27,844			28,947			8,430			(3,092	)		62,146
Operating income		(17	)		(21,720	)		91,605			6,544			(6,236	)		70,176
Other income (expense)
Interest and other (expense) income		—			26			2			(10	)		—			18
Earnings from equity and other interests		—			—			345			(267	)		—			78
Debt refinancing costs		—			(14,109	)		(105	)		—			—			(14,214	)
Interest expense		—			(43,063	)		139			(7,122	)		6,236			(43,810	)
Income tax expense		—			—			—			(128	)		—			(128	)
Net other expense		—			(57,146	)		381			(7,527	)		6,236			(58,056	)
Income (loss) from continuing operations		(17	)		(78,866	)		91,986			(983	)		—			12,120
Income (loss) from discontinued operations		—			—			(1,969	)		16,563			—			14,594
Equity in earnings of consolidated subsidiaries net of income taxes		26,731			105,597			4,578			—			(136,906	)		—
Net income		26,714			26,731			94,595			15,580			(136,906	)		26,714
Net income attributable to non-controlling interests		(178	)		(178	)		—			—			178			(178	)
Net income attributable to MPT common stockholders	$	26,536		$	26,553		$	94,595		$	15,580		$	(136,728	)	$	26,536
Condensed Consolidated Statements of Comprehensive Income (Loss)	'
	Condensed Consolidated Statements of Comprehensive Income (Loss)
	For the Year Ended December 31, 2013
	(in thousands)
		Parent			Subsidiary			Subsidiary			Non-Guarantor			Eliminations			Total
					Issuers			Guarantors			Subsidiaries						Consolidated
	Net income	$	97,215		$	97,215		$	164,512		$	19,967		$	(281,694	)	$	97,215
	Other comprehensive income (loss):
	Unrealized gain (loss) on interest rate swap		3,474			3,474			—			—			(3,474	)		3,474
	Foreign currency translation gain (loss)		67			67			—			—			(67	)		67
	Total comprehensive income		100,756			100,756			164,512			19,967			(285,235	)		100,756
	Comprehensive income attributable to non-controlling interests		(224	)		(224	)		—			—			224			(224	)
	Comprehensive income attributable to MPT common stockholders	$	100,532		$	100,532		$	164,512		$	19,967		($	285,011	)	$	100,532
	Condensed Consolidated Statements of Comprehensive Income (Loss)
	For the Year Ended December 31, 2012
	(in thousands)
		Parent			Subsidiary			Subsidiary			Non-Guarantor			Eliminations			Total
					Issuers			Guarantors			Subsidiaries						Consolidated
	Net income	$	90,077		$	90,077		$	143,600		$	23,348		$	(257,025	)	$	90,077
	Other comprehensive income:
	Unrealized loss on interest rate swap		(251	)		(251	)		—			—			251			(251	)
	Total comprehensive income		89,826			89,826			143,600			23,348			(256,774	)		89,826
	Comprehensive income attributable to non-controlling interests		(177	)		(177	)		—			—			177			(177	)
	Comprehensive income attributable to MPT common stockholders	$	89,649		$	89,649		$	143,600		$	23,348		($	256,597	)	$	89,649
	Condensed Consolidated Statements of Comprehensive Income (Loss)
	For the Year Ended December 31, 2011
	(in thousands)
		Parent			Subsidiary			Subsidiary			Non-Guarantor			Eliminations			Total
					Issuers			Guarantors			Subsidiaries						Consolidated
	Net income	$	26,714		$	26,731		$	94,595		$	15,580		$	(136,906	)	$	26,714
	Other comprehensive income:
	Unrealized loss on interest rate swap		(8,590	)		(8,590	)		—			—			8,590			(8,590	)
	Total comprehensive income		18,124			18,141			94,595			15,580			(128,316	)		18,124
	Comprehensive income attributable to non-controlling interests		(178	)		(178	)		—			—			178			(178	)
	Comprehensive income attributable to MPT common stockholders	$	17,946		$	17,963		$	94,595		$	15,580		$	(128,138	)	$	17,946
Condensed Consolidated Statements of Cash Flows	'
	Condensed Consolidated Statements of Cash Flows
	For the Year Ended December 31, 2013
	(in thousands)
		Parent			Subsidiary			Subsidiary			Non-Guarantor			Eliminations			Total
					Issuers			Guarantors			Subsidiaries						Consolidated
	Operating Activities
	Net cash provided by (used in) operating activities	$	4		$	(53,846	)	$	196,883		$	(2,240	)	$	—		$	140,801
	Investing Activities
	Cash paid for acquisitions and other related investments		—			—			(619,092	)		(35,830	)		—			(654,922	)
	Net proceeds from sales of real estate		—			—			—			32,409			—			32,409
	Principal received on loans receivable		—			—			—			7,249			—			7,249
	Investments in loans receivable		—			—			(1,100	)		(2,646	)		—			(3,746	)
	Construction in progress and other		—			136			(94,737	)		1,034			—			(93,567	)
	Net cash provided by (used in) investing activities		—			136			(714,929	)		2,216			—			(712,577	)
	Financing Activities
	Additions to term debt		—			424,580			—			—			—			424,580
	Payments of term debt		—			(11,000	)		—			(249	)		—			(11,249	)
	Revolving credit facilities, net		—			(20,000	)		—			—			—			(20,000	)
	Distributions paid		(120,038	)		(120,309	)		—			—			120,038			(120,309	)
	Lease deposits and other obligations to tenants		—			—			1,606			1,625			—			3,231
	Net payments relating to intercompany financing		(193,297	)		(539,776	)		541,325			(1,545	)		193,293			—
	Proceeds from sale of common shares, net of offering costs		313,331			313,331			—			—			(313,331	)		313,331
	Debt issuance costs paid and other financing activities		—			(9,760	)		—			—			—			(9,760	)
	Net cash provided by (used in) financing activities		(4	)		37,066			542,931			(169	)		—			579,824
	Increase (decrease) in cash and cash equivalents for period		—			(16,644	)		24,885			(193	)		—			8,048
	Effect of exchange rate changes		—			(24	)		644			—			—			620
	Cash and cash equivalents at beginning of period		—			35,483			1,565			263			—			37,311
	Cash and cash equivalents at end of period	$	—		$	18,815		$	27,094		$	70		$	—		$	45,979
	Condensed Consolidated Statements of Cash Flows
	For the Year Ended December 31, 2012
	(in thousands)
		Parent			Subsidiary			Subsidiary			Non-Guarantor			Eliminations			Total
					Issuers			Guarantors			Subsidiaries						Consolidated
	Operating Activities
	Net cash provided by (used in) operating activities	$	57		$	(61,002	)	$	165,454		$	800		$	—		$	105,309
	Investing Activities
	Cash paid for acquisitions and other related investments		—			—			(420,500	)		(200,990	)		—			(621,490	)
	Net proceeds from sales of real estate		—			—			—			71,202			—			71,202
	Principal received on loans receivable		—			—			5,491			5,440			—			10,931
	Investments in loans receivable		—			—			—			(1,293	)		—			(1,293	)
	Construction in progress and other		—			(578	)		(66,467	)		(9,433	)		—			(76,478	)
	Net cash provided by (used in) investing activities		—			(578	)		(481,476	)		(135,074	)		—			(617,128	)
	Financing Activities
	Additions to term debt		—			300,000			—			—			—			300,000
	Payments of term debt		—			—			—			(232	)		—			(232	)
	Revolving credit facilities, net		—			75,000			(39,600	)		—			—			35,400
	Distributions paid		(103,684	)		(103,952	)		—			—			103,684			(103,952	)
	Lease deposits and other obligations to tenants		—			—			(10,031	)		(1,405	)		—			(11,436	)
	Net payments relating to intercompany financing		(129,421	)		(501,839	)		365,809			136,087			129,364			—
	Proceeds from sale of common shares, net of offering costs		233,048			233,048			—			—			(233,048	)		233,048
	Debt issuance costs paid and other financing activities		—			(6,424	)		—			—			—			(6,424	)
	Net cash provided by (used in) financing activities		(57	)		(4,167	)		316,178			134,450			—			446,404
	Increase (decrease) in cash and cash equivalents for period		—			(65,747	)		156			176			—			(65,415	)
	Cash and cash equivalents at beginning of period		—			101,230			1,409			87			—			102,726
	Cash and cash equivalents at end of period	$	—		$	35,483		$	1,565		$	263		$	—		$	37,311
	Condensed Consolidated Statements of Cash Flows
	For the Year Ended December 31, 2011
	(in thousands)
		Parent			Subsidiary			Subsidiary			Non-Guarantor			Eliminations			Total
					Issuers			Guarantors			Subsidiaries						Consolidated
	Operating Activities
	Net cash provided by (used in) operating activities	$	(209	)	$	(48,779	)	$	109,329		$	18,929		$	—		$	79,270
	Investing Activities
Cash paid for acquisitions and other related investments		—			—			(241,626	)		(37,337	)		—			(278,963	)
Net proceeds from sales of real estate		—			—			—			41,130			—			41,130
Principal received on loans receivable		—			—			230			4,059			—			4,289
Investments in loans receivable		—			—			(230	)		(631	)		—			(861	)
Construction in progress and other		—			(6,466	)		(24,081	)		(669	)		—			(31,216	)
Net cash provided by (used in) investing activities		—			(6,466	)		(265,707	)		6,552			—			(265,621	)
Financing Activities
Additions to term debt		—			450,000			—			—			—			450,000
Payments of term debt		—			(237,666	)		(8,433	)		(163	)		—			(246,262	)
Revolving credit facilities, net		—			50,000			39,600			—			—			89,600
Distributions paid		(89,342	)		(89,601	)		—			—			89,342			(89,601	)
Lease deposits and other obligations to tenants		—			—			10,986			(2,365	)		—			8,621
Net payments relating to intercompany financing		89,551			(92,052	)		114,247			(22,404	)		(89,342	)		—
Debt issuance costs paid and other financing activities		—			(21,028	)		—			(661	)		—			(21,689	)
Net cash provided by (used in) financing activities		209			59,653			156,400			(25,593	)		—			190,669
Increase (decrease) in cash and cash equivalents for period		—			4,408			22			(112	)		—			4,318
Cash and cash equivalents at beginning of period		—			96,822			1,387			199			—			98,408
Cash and cash equivalents at end of period	$	—		$	101,230		$	1,409		$	87		$	—		$	102,726

Summary_of_Significant_Account3

Summary of Significant Accounting Policies - Additional Information (Detail)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
	Y
	M
Summary Of Significant Accounting Policies [Line Items]	'	'	'
Equity method investment, ownership percentage	100.00%	'	'
Expected lease-up periods for estimating lost rentals, in months	6	'	'
Percentage of ordinary taxable income to be distributed for real estate investment trust qualification	90.00%	90.00%	90.00%
Number of years of federal income tax at corporate rates on failure to qualify as REIT	4	'	'
Maximum [Member]	'	'	'
Summary Of Significant Accounting Policies [Line Items]	'	'	'
Stock award vesting period in years, maximum	'10 years	'	'
Time-Based Awards [Member]	'	'	'
Summary Of Significant Accounting Policies [Line Items]	'	'	'
Stock award vesting period in years, maximum	'3 years	'	'
Market Conditions Based Awards [Member] | Minimum [Member]	'	'	'
Summary Of Significant Accounting Policies [Line Items]	'	'	'
Stock award vesting period in years, maximum	'3 years	'	'
Market Conditions Based Awards [Member] | Maximum [Member]	'	'	'
Summary Of Significant Accounting Policies [Line Items]	'	'	'
Stock award vesting period in years, maximum	'5 years	'	'

Summary_of_Significant_Account4

Summary of Significant Accounting Policies - Carrying Value and Classification of Related Assets and Maximum Exposure to Loss (Detail) (USD $)	Dec. 31, 2013
In Thousands, unless otherwise specified
Loans, net [Member]	'
Variable Interest Entity [Line Items]	'
Maximum Loss Exposure	$283,273
Equity investments [Member]	'
Variable Interest Entity [Line Items]	'
Maximum Loss Exposure	19,308
Mortgage and other loans [Member]	'
Variable Interest Entity [Line Items]	'
Carrying Amount	228,996
Other assets [Member]	'
Variable Interest Entity [Line Items]	'
Carrying Amount	$5,198

Summary_of_Significant_Account5

Summary of Significant Accounting Policies - Useful Lives of Related Real Estate and Other Assets (Detail)	12 Months Ended
	Dec. 31, 2013
Buildings and improvements [Member]	'
Property, Plant and Equipment [Line Items]	'
Weighted average useful lives of related real estate and other assets	'38 years 2 months 12 days
Tenant lease intangibles [Member]	'
Property, Plant and Equipment [Line Items]	'
Weighted average useful lives of related real estate and other assets	'18 years 7 months 6 days
Leasehold improvements [Member]	'
Property, Plant and Equipment [Line Items]	'
Weighted average useful lives of related real estate and other assets	'22 years 2 months 12 days
Furniture, equipment and other [Member]	'
Property, Plant and Equipment [Line Items]	'
Weighted average useful lives of related real estate and other assets	'9 years 4 months 24 days

Real_Estate_and_Loans_Receivab2

Real Estate and Loans Receivable - Assets Acquired (Detail) (USD $)	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
In Thousands, unless otherwise specified
Significant Acquisitions and Disposals [Line Items]	'	'	'
Total assets acquired	$654,922	$621,490	$293,555
Total liabilities assumed	'	'	-14,592
Net assets acquired	654,922	621,490	278,963
Land [Member]	'	'	'
Significant Acquisitions and Disposals [Line Items]	'	'	'
Total assets acquired	41,473	518	19,705
Building [Member]	'	'	'
Significant Acquisitions and Disposals [Line Items]	'	'	'
Total assets acquired	439,030	8,942	220,769
Intangible lease assets - subject to amortization [Member]	'	'	'
Significant Acquisitions and Disposals [Line Items]	'	'	'
Total assets acquired	38,589	1,040	20,630
Net investments in direct financing leases [Member]	'	'	'
Significant Acquisitions and Disposals [Line Items]	'	'	'
Total assets acquired	110,580	310,000	'
Mortgage loans [Member]	'	'	'
Significant Acquisitions and Disposals [Line Items]	'	'	'
Total assets acquired	20,000	200,000	'
Working capital and other loans [Member]	'	'	'
Significant Acquisitions and Disposals [Line Items]	'	'	'
Total assets acquired	5,250	95,690	27,283
Equity investments [Member]	'	'	'
Significant Acquisitions and Disposals [Line Items]	'	'	'
Total assets acquired	'	$5,300	$5,168

Real_Estate_and_Loans_Receivab3

Real Estate and Loans Receivable - Assets Acquired (Parenthetical) (Detail) (Intangible lease assets - subject to amortization [Member])	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Intangible lease assets - subject to amortization [Member]	'	'	'
Significant Acquisitions and Disposals [Line Items]	'	'	'
Weighted average useful life of acquired intangible lease assets (in years)	'21 years	'15 years	'13 years 10 months 24 days

Real_Estate_and_Loans_Receivab4

Real Estate and Loans Receivable - 2013 Activity - Additional Information (Detail)

12 Months Ended

12 Months Ended

12 Months Ended

0 Months Ended

12 Months Ended

0 Months Ended

12 Months Ended

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

4-May-12

Dec. 31, 2010

Jun. 13, 2012

Dec. 31, 2013

Dec. 31, 2013

Jul. 18, 2013

Jul. 18, 2013

Dec. 31, 2013

Nov. 29, 2013

Nov. 29, 2013

Dec. 12, 2013

Jun. 11, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Nov. 29, 2013

Nov. 29, 2013

Sep. 26, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

USD ($)

USD ($)

USD ($)

Bed

USD ($)

Ernest [Member]

Non U S [Member]

2013 Activity [Member]

2013 Activity [Member]

2013 Activity [Member]

2013 Activity [Member]

2013 Activity [Member]

2013 Activity [Member]

2013 Activity [Member]

2013 Activity [Member]

2013 Activity [Member]

2013 Activity [Member]

2013 Activity [Member]

2013 Activity [Member]

2013 Activity [Member]

2013 Activity [Member]

2013 Activity [Member]

2013 Activity [Member]

2013 Activity [Member]

2013 Activity [Member]

Bed

USD ($)

USD ($)

Corpus Christi Rehabilitation Hospital [Member]

Corpus Christi Rehabilitation Hospital [Member]

Ernest [Member]

RHM Portfolio Acquisition [Member]

RHM Portfolio Acquisition [Member]

Dallas Medical Center [Member]

Kansas [Member]

Kansas [Member]

Minimum [Member]

Maximum [Member]

From 2015 through 2017 [Member]

After 2017 [Member]

Acute Care Iasis Hospital [Member]

Acute Care Iasis Hospital [Member]

Acute Care Iasis Hospital [Member]

Business Acquisitions [Member]

Olympia Medical Center [Member]

USD ($)

Commitment [Member]

USD ($)

USD ($)

EUR (€)

USD ($)

USD ($)

Ernest [Member]

Ernest [Member]

RHM Portfolio Acquisition [Member]

RHM Portfolio Acquisition [Member]

USD ($)

Maximum [Member]

USD ($)

Bed

USD ($)

RenewalOptions

Hospital

Facility

RenewalOptions

Contract

Significant Acquisitions and Disposals [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Purchase price of Acquisition

'

'

'

'

'

'

'

'

$10,500,000

$500,000

'

$237,800,000

€ 175,000,000

'

$75,000,000

'

'

'

'

'

$281,300,000

'

'

'

'

Applicable transfer taxes on purchase price

'

'

'

'

'

'

'

'

'

'

'

'

9,000,000

'

'

'

'

'

'

'

'

'

'

'

'

Term of lease

'

'

'

'

'

'

'

'

'

'

'20 years

'27 years

'27 years

'10 years

'

'10 years

'

'

'

'

'

'

'

'

'

Rent escalations percentage

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

2.00%

0.50%

'

'

'

'

'

Cumulative increases in the German consumer price index

'

'

'

'

'

'

'

'

'

'

'

70.00%

70.00%

'

'

'

'

'

'

'

'

'

'

'

'

Real estate assets gross

1,733,194,000

1,189,552,000

[1]

1,191,096,000

[2]

'

990,635,000

'

240,500,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Revenue from real estate assets

'

'

'

'

'

'

1,800,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Purchase price of real estate

'

'

'

'

'

'

'

'

'

'

'

'

'

25,000,000

'

'

'

'

'

'

'

'

'

'

'

Number of lease extensions options in current lease contract

'

'

'

'

'

'

'

'

'

'

'

'

'

2

2

'

'

'

'

'

2

'

'

'

'

Term of lease extensions, Years

'

'

'

'

'

'

'

'

'

'

'5 years

'

'

'5 years

'

'5 years

'

'

'

'

'

'

'

'

'

Number of facilities acquired

'

'

'

'

'

'

'

'

'

'

'

'

'

'

2

'

'

'

'

'

3

'

'

'

'

Improvement costs

1,578,336,000

1,052,479,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

2,000,000

'

'

'

'

Initial leaseback term

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'15 years

'

'

'

Maximum rent increase percent

'

'

'

'

'

'

'

'

'

'

'

'

'

'

2.00%

'

2.00%

5.00%

'

'

'

'

2.50%

'

'

Lease renewal option

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'5 years

'

'

'

Lease maturity year

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'2019

'

'

'

Extended lease maturity year

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'2028

'

'

'

Loan on property

'

'

'

'

'

'

'

'

'

'

5.3

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Mortgage financing

20,000,000

203,650,000

'

'

'

'

'

20,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of beds

'

'

'

26

'

40

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

204

Revenue contributed by the acquired entity

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

13,600,000

'

Income contributed by the acquired entity

133,258,000

135,402,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

10,600,000

'

Acquisition related costs

19,494,000

5,420,000

4,184,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

19,500,000

'

Acquisition-related costs on consummated deals

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$18,000,000

'

[1]

Includes real estate cost included in real estate held for sale of $28,617 at December 31, 2012. Excludes intangible lease assets that are included in real estate held for sale of $858 for 2012.

[2]

Includes real estate cost included in real estate held for sale of $96,766 at December 31, 2011. Excludes intangible lease assets that are included in real estate held for sale of $3,012 for 2011.

Real_Estate_and_Loans_Receivab5

Real Estate and Loans Receivable - 2012 Activity - Additional Information (Detail) (USD $)

12 Months Ended

12 Months Ended

0 Months Ended

12 Months Ended

0 Months Ended

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Feb. 29, 2012

Dec. 31, 2013

Dec. 31, 2013

Dec. 14, 2012

Dec. 31, 2013

Dec. 14, 2012

Jul. 03, 2012

Jul. 03, 2012

Sep. 19, 2012

Sep. 19, 2012

2012 Activity [Member]

2012 Activity [Member]

2012 Activity [Member]

2012 Activity [Member]

2012 Activity [Member]

2012 Activity [Member]

2012 Activity [Member]

2012 Activity [Member]

2012 Activity [Member]

2012 Activity [Member]

2012 Activity [Member]

2012 Activity [Member]

2012 Activity [Member]

2012 Activity [Member]

2012 Activity [Member]

2012 Activity [Member]

Contract

Maximum [Member]

Minimum [Member]

Rehabilitation Hospital [Member]

Business Acquisitions [Member]

Ernest [Member]

Ernest [Member]

Ernest [Member]

Ernest [Member]

Acute Care Facility [Member]

Acute Care Facility [Member]

Acute Care Facility [Member]

Prime Health Care Services [Member]

Prime Health Care Services [Member]

St. Mary's Regional Medical Center [Member]

Roxborough Memorial Hospital [Member]

Ceiling [Member]

Floor Rate [Member]

Facility

Key Management Personnel [Member]

Minimum [Member]

Contract

Facility

Maximum [Member]

Property

Loans, net [Member]

Series of Individually Immaterial Business Acquisitions [Member]

Series of Individually Immaterial Business Acquisitions [Member]

Bed

State

Bed

Bed

Significant Acquisitions and Disposals [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Combined purchase price and investment amount

'

'

'

'

'

'

'

'

'

$396,500,000

'

'

'

'

'

'

'

'

'

Number of facilities acquired

'

'

'

'

'

'

5

'

'

'

'

'

'

7

'

'

'

'

'

Number of states

'

'

'

'

'

'

'

'

'

'

'

'

'

7

'

'

'

'

'

Aggregate purchase price

'

'

'

200,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Term of lease, years

'

'

'

'20 years

'

'

'

'

'

'

'

'

'15 years

'

'

'

'

'

'

Number of lease extension options in current lease contract

'

'

'

3

'

'

'

'

'

'

'

'

3

'

'

'

'

'

'

Term of lease extension, years

'

'

'

'5 years

'

'

'

'

'

'

'

'

'5 years

'

'

'

'

'

'

Percentage of rental rate

'

'

'

9.00%

5.00%

2.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

Loan secured by mortgage interest

'

'

'

100,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Total investment

'

'

'

'

'

'

'

'

96,500,000

'

'

'

'

'

'

'

'

'

'

Acquisition loan made

'

'

'

'

'

'

'

'

93,200,000

'

'

'

'

'

'

'

'

'

'

Capital contribution

'

'

'

'

'

'

'

'

'

'

3,300,000

'

'

'

'

'

'

'

'

Preferential rate of return on loan amount

'

'

'

'

'

'

'

'

15.00%

'

'

'

'

'

'

'

'

'

'

Coupon payable in cash, year one

'

'

'

'

'

'

'

'

'

'

'

6.00%

'

'

'

'

'

'

'

Coupon payable in cash, year two

'

'

'

'

'

'

'

'

'

'

'

7.00%

'

'

'

'

'

'

'

Coupon payable in cash in, thereafter

'

'

'

'

'

'

'

'

10.00%

'

'

'

'

'

'

'

'

'

'

Agreement terms

'

'

'

'

'

'

'

'

'Although there are provisions in the loan agreement that are expected to result in full payment of the 15% preference when funds are sufficient. Any of the 15% in excess of the minimum that is not paid may be accrued and paid upon the occurrence of a capital or liquidity event and is payable at maturity. The loan may be prepaid without penalty at any time.

'

'

'

'

'

'

'

'

'

'

New mortgage loan funded

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

100,000,000

'

'

Number of beds at Centinela Hospital Medical Center used to secure loan

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

369

'

'

'

Maturity of mortgage loan

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

31-Dec-22

'

'

'

Number of beds acquired

'

'

'

'

'

'

'

'

'

'

'

'

40

'

'

'

'

380

140

Business acquisition cost of acquired entity

'

'

'

'

'

'

'

'

'

'

'

'

10,500,000

'

'

'

'

80,000,000

30,000,000

Payments to acquire equity method investments

'

'

'

'

'

'

'

'

'

'

'

'

2,000,000

'

'

'

'

'

'

Ownership interest in equity

100.00%

'

'

'

'

'

'

'

'

'

'

'

25.00%

'

'

'

'

'

'

Working capital loan to the joint venture

'

'

'

'

'

'

'

'

'

'

'

'

2,500,000

'

'

'

'

'

'

Revolving loan

'

'

'

'

'

'

'

'

'

'

'

'

'

'

2,000,000

'

'

'

'

Date of properties acquired

'

'

'

'

'

'

'

'

'

'

'

'

14-Dec-12

'

'

'

'

'

'

Revenue contributed by the acquired entity

'

'

'

'

'

'

'

46,300,000

'

'

'

'

'

'

'

'

'

'

'

Income contributed by the acquired entity

133,258,000

135,402,000

'

'

'

'

'

46,100,000

'

'

'

'

'

'

'

'

'

'

'

Acquisition related costs

19,494,000

5,420,000

4,184,000

'

'

'

'

5,400,000

'

'

'

'

'

'

'

'

'

'

'

Acquisition-related costs on consummated deals

'

'

'

'

'

'

'

$5,100,000

'

'

'

'

'

'

'

'

'

'

'

Real_Estate_and_Loans_Receivab6

Real Estate and Loans Receivable - 2011 Activity - Additional Information (Detail) (USD $)

12 Months Ended

0 Months Ended

12 Months Ended

0 Months Ended

12 Months Ended

0 Months Ended

12 Months Ended

0 Months Ended

12 Months Ended

0 Months Ended

12 Months Ended

0 Months Ended

12 Months Ended

0 Months Ended

12 Months Ended

0 Months Ended

12 Months Ended

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2010

Nov. 04, 2011

Dec. 31, 2013

Dec. 31, 2012

Nov. 04, 2011

Jul. 18, 2011

Dec. 31, 2013

Dec. 31, 2013

Sep. 30, 2011

Dec. 31, 2013

Oct. 14, 2011

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Jan. 31, 2011

Jan. 04, 2011

Dec. 31, 2013

Jan. 31, 2011

Jan. 31, 2011

Jan. 31, 2011

Jan. 31, 2011

Feb. 04, 2011

Dec. 31, 2013

Feb. 09, 2011

Dec. 31, 2013

Feb. 14, 2011

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

2011 Activity [Member]

2011 Activity [Member]

2011 Activity [Member]

2011 Activity [Member]

2011 Activity [Member]

2011 Activity [Member]

2011 Activity [Member]

2011 Activity [Member]

2011 Activity [Member]

2011 Activity [Member]

2011 Activity [Member]

2011 Activity [Member]

2011 Activity [Member]

2011 Activity [Member]

2011 Activity [Member]

2011 Activity [Member]

2011 Activity [Member]

2011 Activity [Member]

2011 Activity [Member]

2011 Activity [Member]

2011 Activity [Member]

2011 Activity [Member]

2011 Activity [Member]

2011 Activity [Member]

2011 Activity [Member]

2011 Activity [Member]

2011 Activity [Member]

2011 Activity [Member]

2011 Activity [Member]

Hoboken, NJ [Member]

Hoboken, NJ [Member]

Hoboken, NJ [Member]

Maximum [Member]

Vibra Specialty Hospital [Member]

Vibra Specialty Hospital [Member]

Vibra Specialty Hospital [Member]

Acute Care Facility [Member]

Acute Care Facility [Member]

Acute Care Hospitals [Member]

Acute Care Hospitals [Member]

Acute Care Hospitals [Member]

Acute Care Hospitals [Member]

Series of Individually Immaterial Business Acquisitions [Member]

Series of Individually Immaterial Business Acquisitions [Member]

Series of Individually Immaterial Business Acquisitions [Member]

Series of Individually Immaterial Business Acquisitions [Member]

Series of Individually Immaterial Business Acquisitions [Member]

Series of Individually Immaterial Business Acquisitions [Member]

Series of Individually Immaterial Business Acquisitions [Member]

Series of Individually Immaterial Business Acquisitions [Member]

Series of Individually Immaterial Business Acquisitions [Member]

Series of Individually Immaterial Business Acquisitions [Member]

Series of Individually Immaterial Business Acquisitions [Member]

Series of Individually Immaterial Business Acquisitions [Member]

Series of Individually Immaterial Business Acquisitions [Member]

Business Acquisitions [Member]

Business Acquisitions [Member]

Business Acquisitions [Member]

Bed

Contract

Hoboken, NJ [Member]

Bed

Maximum [Member]

Bed

Contract

Hospital

Contract

Minimum [Member]

Maximum [Member]

Gilbert Hospital [Member]

Gilbert Hospital [Member]

Atrium Medical Center [Member]

Atrium Medical Center [Member]

Atrium Medical Center [Member]

Vibra [Member]

Bayonne Medical Center [Member]

Bayonne Medical Center [Member]

Alvarado Hospital [Member]

Alvarado Hospital [Member]

Northland Ltach Hospital [Member]

Northland Ltach Hospital [Member]

Hoboken, NJ [Member]

Hoboken, NJ [Member]

Hoboken, NJ [Member]

Y

Contract

Minimum [Member]

Maximum [Member]

Bed

Property

Bed

Bed

Bed

Bed

Significant Acquisitions and Disposals [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of beds acquired

'

'

'

'

350

'

'

'

40

'

'

40

'

'

'

'

'

'

19

'

60

'

'

'

278

'

306

'

35

'

'

'

'

Age of real estate acquired

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

4

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Business acquisition cost of acquired entity

'

'

'

'

'

'

'

'

$13,000,000

'

'

'

'

'

'

'

'

'

$17,100,000

'

$23,500,000

'

'

'

$58,000,000

'

$70,000,000

'

$19,500,000

'

'

'

'

Date of properties acquired

'

'

'

'

'

'

'

'

'

18-Jul-11

'

'

30-Sep-11

'

'

'

'

'

'

4-Jan-11

31-Jan-11

'

'

'

'

4-Feb-11

'

9-Feb-11

'

14-Feb-11

'

'

'

Lease expiration date

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'2022-05

'

'2024-06

'

'

'

'

'

'

'

'

'

'

'

'

Number of lease extension options in current lease contract

'

'

'

'

'

6

'

'

'

3

'

'

3

'

3

'

'

'

'

3

2

'

'

'

6

'

'

'

'

3

'

'

'

Term of lease extension, years

'

'

'

'

'

'5 years

'

'

'

'

'5 years

'

'5 years

'

'5 years

'

'

'

'

'5 years

'10 years

'

'

'

'

'5 years

'

'

'

'5 years

'

'

'

Rent escalations percentage

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1.00%

3.00%

'

'

2.50%

'

1.00%

5.00%

'

'

'

'

'

'

2.75%

'

'

'

Date of construction

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'2009

'

'

'

'

'

'

'

'

'

'

'

'

Payments to acquire equity method investments

'

'

'

'

'

'

'

'

2,500,000

'

'

1,400,000

'

'

'

'

'

'

'

'

'

'

'

1,300,000

'

'

'

'

'

'

'

'

'

Ownership interest in equity

100.00%

'

'

'

100.00%

'

'

'

25.00%

'

'

25.00%

'

'

'

'

'

51.00%

'

'

'

'

'

19.00%

'

'

'

'

'

'

'

'

'

Working capital loan to the joint venture

'

'

'

'

'

'

'

20,000,000

'

'

'

2,000,000

'

'

'

'

'

5,200,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Retained ownership in operating entity

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

49.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Term of lease, years

'

'

'

'

'

'15 years

'

'

'

'15 years

'

'

'15 years

'

'15 years

'

'

'

'

'

'

'

'

'

'

'15 years

'

'

'

'

'

'

'

Number of stories in building

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

6

'

'

'

'

'

'

'

Lease expiration year

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'2028

'

'

'

'

Construction completion date

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'2008-04

'

'

'

'

Existing mortgage loan

368,650,000

368,650,000

165,000,000

165,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

15,000,000

'

'

'

Mortgage loan, maturity date

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'2018-01

'

'

'

Business acquisition cost of acquired entity

'

'

'

'

75,000,000

'

'

'

'

'

'

10,000,000

'

30,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of leased hospital

'

'

'

'

'

'

'

'

'

'

'

'

'

3

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Agreement entry date

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

14-Oct-11

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Business acquisition cost of acquired entity

'

'

'

'

50,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Working capital loan outstanding

'

'

'

'

'

'

15,100,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Funding of convertible note

'

'

'

'

5,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Option to acquire percentage of hospital operator

'

'

'

'

25.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Revenue contributed by the acquired entity

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

21,200,000

'

Income contributed by the acquired entity

133,258,000

135,402,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

14,100,000

'

Acquisition related cost

19,494,000

5,420,000

4,184,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

18,000,000

5,100,000

4,200,000

Acquisition-related costs on consummated deals

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$1,900,000

'

Real_Estate_and_Loans_Receivab7

Real Estate and Loans Receivable - Supplemental Pro Forma Earnings Adjusted to Exclude Acquisition-Related Costs (Detail) (USD $)	12 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Business Combinations [Abstract]	'	'
Total revenues	$288,159	$280,539
Net income	$133,258	$135,402
Net income per share/unit	$0.82	$0.85

Real_Estate_and_Loans_Receivab8

Real Estate and Loans Receivable - Development Activities - Additional Information (Detail) (USD $)

Dec. 31, 2013

4-May-12

Mar. 02, 2012

Dec. 20, 2012

Oct. 02, 2012

Jun. 13, 2012

Dec. 31, 2013

Dec. 31, 2013

Jun. 11, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

20-May-13

Dec. 31, 2013

Mar. 04, 2013

In Millions, unless otherwise specified

Bed

Florence, AZ [Member]

Location Various [Member]

Ernest [Member]

Ernest [Member]

Development Activities [Member]

Development Activities [Member]

Development Activities [Member]

Development Activities [Member]

Development Activities [Member]

Development Activities [Member]

Development Activities [Member]

Development Activities [Member]

Development Activities [Member]

Bed

Twelve Oaks Facility [Member]

First Choice [Member]

Location Houston, TX [Member]

Emergency Room Facility One [Member]

Emergency Room Facility Two [Member]

Rehabilitation Facility in South Ogden [Member]

Rehabilitation Facility in South Ogden [Member]

Rehabilitation Facility in Post Falls, Idaho [Member]

Room

Significant Acquisitions and Disposals [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of freestanding emergency room facility

'

'

'

'

'

'

'

'

25

'

'

'

'

'

'

Estimated total development cost, funded

'

'

'

'

'

'

$9.10

'

$100

'

'

'

'

$16.40

'

Estimated total development cost

'

'

'

33.5

'

'

'

'

'

37.8

'

'

19.2

'

14.4

Expected facility completion date

'

'

'

'

'

'

'

'

'

'

'Fourth quarter of 2013

'2014

'

'Second quarter of 2014

'

Total development cost on inpatient rehabiliation hospital

'

'

'

'

16.9

'

'

'

'

'

'

'

'

'

'

Number of beds

'

26

'

'

'

40

'

'

'

'

'

'

'

'

'

Cost of land and building

$9.40

'

$30

'

'

$15.70

'

'

'

'

'

'

'

'

'

Lease agreement

'

'

'25 years

'

'

'

'

'15 years

'

'

'

'

'

'

'

Facility partially occupied date

'

'

'

'

'

'

'

23-Jan-13

'

'

'

'

'

'

'

Percentage of facility partially occupied

'

'

'

'

'

'

'

55.00%

'

'

'

'

'

'

'

Real_Estate_and_Loans_Receivab9

Real Estate and Loans Receivable - Summary of Status Update on Current Development Projects (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013
Business Acquisition [Line Items]	'
Original Commitment	$147,453
Costs Incurred as of December 31, 2013	41,771
Property First Choice ER- Nacogdoches [Member] | Location San Antonio, TX [Member] | Property Type Acute Care Hospital [Member] | Operator First Choice ER, LLC [Member]	'
Business Acquisition [Line Items]	'
Original Commitment	5,100
Costs Incurred as of December 31, 2013	2,681
Estimated Completion Date	'1Q 2014
Property First Choice ER - Brodie [Member] | Location Austin, TX [Member] | Property Type Acute Care Hospital [Member] | Operator First Choice ER, LLC [Member]	'
Business Acquisition [Line Items]	'
Original Commitment	5,470
Costs Incurred as of December 31, 2013	1,950
Estimated Completion Date	'2Q 2014
Property First Choice ER- Alvin [Member] | Location Houston, TX [Member] | Property Type Acute Care Hospital [Member] | Operator First Choice ER, LLC [Member]	'
Business Acquisition [Line Items]	'
Original Commitment	5,240
Costs Incurred as of December 31, 2013	1,328
Estimated Completion Date	'2Q 2014
Property Northern Utah Rehabilitation Hospital [Member] | Location South Ogden, UT [Member] | Property Type Inpatient Rehabilitation Hospital [Member] | Operator Ernest Health, Inc. [Member]	'
Business Acquisition [Line Items]	'
Original Commitment	19,153
Costs Incurred as of December 31, 2013	16,391
Estimated Completion Date	'2Q 2014
Property First Choice ER- Briar Forest [Member] | Location Houston, TX [Member] | Property Type Acute Care Hospital [Member] | Operator First Choice ER, LLC [Member]	'
Business Acquisition [Line Items]	'
Original Commitment	5,833
Costs Incurred as of December 31, 2013	1,386
Estimated Completion Date	'3Q 2014
Property First Choice ER- Cedar Hill [Member] | Location Cedar Hill, TX [Member] | Property Type Acute Care Hospital [Member] | Operator First Choice ER, LLC [Member]	'
Business Acquisition [Line Items]	'
Original Commitment	5,768
Costs Incurred as of December 31, 2013	1,167
Estimated Completion Date	'3Q 2014
Property First Choice ER- Firestone [Member] | Location Firestone, CO [Member] | Property Type Acute Care Hospital [Member] | Operator First Choice ER, LLC [Member]	'
Business Acquisition [Line Items]	'
Original Commitment	5,172
Costs Incurred as of December 31, 2013	544
Estimated Completion Date	'3Q 2014
Property Oakleaf Surgical Hospital [Member] | LocationAltoona, WI [Member] | Property Type Acute Care Hospital [Member] | Operator National Surgical Hospitals [Member]	'
Business Acquisition [Line Items]	'
Original Commitment	33,500
Costs Incurred as of December 31, 2013	16,324
Estimated Completion Date	'3Q 2014
Property First Choice Emergency Rooms [Member] | Location Various [Member] | Property Type Acute Care Hospital [Member] | Operator First Choice [Member]	'
Business Acquisition [Line Items]	'
Original Commitment	62,217
Costs Incurred as of December 31, 2013	'
Estimated Completion Date	'Various

Recovered_Sheet1

Real Estate and Loans Receivable - Disposals - Additional Information (Detail) (USD $)

12 Months Ended

3 Months Ended

0 Months Ended

3 Months Ended

0 Months Ended

12 Months Ended

0 Months Ended

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Sep. 30, 2012

Dec. 27, 2012

Sep. 28, 2012

Oct. 22, 2012

Dec. 31, 2012

Aug. 21, 2012

Jun. 15, 2012

Dec. 31, 2011

Dec. 30, 2011

Nov. 27, 2013

Apr. 17, 2013

Disposals [Member]

Disposals [Member]

Disposals [Member]

Disposals [Member]

Disposals [Member]

Disposals [Member]

Disposals [Member]

Disposals [Member]

Disposals [Member]

Disposals [Member]

Disposals [Member]

Huntington [Member]

Thornton [Member]

New Bedford [Member]

New Bedford [Member]

Denham Springs LTACH [Member]

HealthSouth Rehabilitation Hospital of Fayetteville [Member]

Mountain View Regional Rehabilitation Hospital [Member]

Sherman Oaks Hospital [Member]

San Antonio, TX [Member]

Summit Hospital of Southeast Arizona and Summit Hospital of Southeast Texas [Member]

Significant Acquisitions and Disposals [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Proceeds from sale of real estate

$32,409,000

$71,202,000

$41,130,000

$42,000,000

$12,500,000

'

'

'

$5,200,000

$16,000,000

$21,100,000

$20,000,000

$14,000,000

$18,500,000

Gain (loss) on sale of real estate

'

'

'

'

1,900,000

8,400,000

7,200,000

'

300,000

-1,400,000

2,300,000

3,100,000

5,600,000

2,100,000

Straight-line rent write-off

'

'

'

'

$700,000

$1,600,000

'

$4,100,000

'

'

'

$1,200,000

'

'

Recovered_Sheet2

Real Estate and Loans Receivable - Intangible Assets - Additional Information (Detail) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Significant Acquisitions and Disposals [Line Items]	'	'	'
Intangible lease assets	$90,490,000	$51,966,000	'
Intangible Assets [Member]	'	'	'
Significant Acquisitions and Disposals [Line Items]	'	'	'
Intangible lease assets	90,500,000	52,000,000	'
Accumulated amortization, net	75,000,000	40,100,000	'
Amortization expense related to intangible lease assets	$4,000,000	$3,900,000	$5,200,000
Capitalized lease intangibles, weighted average life (in years)	'18 years 7 months 6 days	'	'

Recovered_Sheet3

Real Estate and Loans Receivable - Amortization Expense from Existing Lease Intangible Assets (Detail) (USD $)	Dec. 31, 2013
In Thousands, unless otherwise specified
Business Combinations [Abstract]	'
2014	$5,086
2015	4,896
2016	4,855
2017	4,845
2018	$4,784

Recovered_Sheet4

Real Estate and Loans Receivable - Components of Net Investment in Direct Financing Leases (Detail) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Business Combinations [Abstract]	'	'
Minimum lease payments receivable	$1,647,567	'
Estimated residual values	211,863	'
Less unearned income	-1,428,406	'
Net investment in direct financing leases	$431,024	$314,412

Recovered_Sheet5

Real Estate and Loans Receivable - Minimum Rental Payments Due in Future Period under Operating Leases and Direct Finance Leases which have Non-Cancelable Terms (Detail) (USD $)	Dec. 31, 2013
In Thousands, unless otherwise specified
Leases User Charges And Commitments [Line Items]	'
2014	$2,471
2015	2,644
2016	2,659
2017	2,620
2018	2,614
Thereafter	37,213
Minimum rental payments, total	50,221
Minimum Rental Payments [Member]	'
Leases User Charges And Commitments [Line Items]	'
2014	209,137
2015	208,140
2016	209,771
2017	210,557
2018	211,720
Thereafter	2,138,740
Minimum rental payments, total	3,188,065
Minimum Rental Payments [Member] | Operating Leases [Member]	'
Leases User Charges And Commitments [Line Items]	'
2014	166,602
2015	164,754
2016	165,517
2017	165,418
2018	165,679
Thereafter	1,536,759
Minimum rental payments, total	2,364,729
Minimum Rental Payments [Member] | Direct Financing Leases [Member]	'
Leases User Charges And Commitments [Line Items]	'
2014	42,535
2015	43,386
2016	44,254
2017	45,139
2018	46,041
Thereafter	601,981
Minimum rental payments, total	$823,336

Recovered_Sheet6

Real Estate and Loans Receivable - Leasing Operations - Additional Information (Detail) (Leasing Operations [Member], USD $)	0 Months Ended	12 Months Ended	3 Months Ended
In Millions, unless otherwise specified	Jul. 03, 2012	Dec. 31, 2013	Dec. 31, 2011
	Prime Health Care Services [Member]	Prime Health Care Services [Member]	LTACH Facility [Member]
Significant Acquisitions and Disposals [Line Items]	'	'	'
Master lease term	'	'10 years	'
Master lease agreements, number of renewal options	2	'	'
Master lease, optional lease term	'	'5 years	'
Lease escalation percentage	100.00%	'	'
Wrote off in related straight-line rent receivables	'	'	$1.30
Amortization expense related to intangible lease assets	'	'	$0.60

Recovered_Sheet7

Real Estate and Loans Receivable - Monroe Facility - Additional Information (Detail) (USD $)	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2013	Mar. 31, 2012	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2010
					Olympia Medical Center [Member]	Monroe Facility [Member]	Monroe Facility [Member]	Monroe Facility [Member]	Monroe Facility [Member]	Monroe Facility [Member]	Monroe Facility [Member]
								Scenario, Forecast [Member]	Ernest Transaction and Other Acquisitions [Member]	Monroe Hospital [Member]	Monroe Hospital [Member]
Significant Acquisitions and Disposals [Line Items]	'	'	'	'	'	'	'	'	'	'	'
Lease advance	'	'	'	'	'	'	'	'	'	$31,100,000	'
Operating leases rent, interest and other charges outstanding	'	'	'	'	'	'	'	'	'	21,000,000	'
Advanced amount of working capital loan agreement	'	'	'	'	'	'	'	'	'	1,200,000	'
Interest receivables	'	'	'	'	'	'	'	'	'	6,000,000	'
Impairment of working capital loan recognized	'	'	'	'	'	'	'	'	'	'	12,000,000
Straight line rent receivables write-off	'	'	'	'	'	'	'	'	'	'	2,500,000
Number of days past due	'	'	'	'	'	'	'	'	'	'90 days	'
Net investment to maximum exposure	'	'	'	'	'	'	'	'	'	40,300,000	'
Impairment of working capital loan estimation-patient receivables considered for first priority secured interest	'	'	'	'	'	'	'	'	'	4,000,000	'
Impairment of working capital loan estimation-cash balance considered for first priority secured interest	'	'	'	'	'	'	'	'	'	100,000	'
Existing mortgage loan	368,650,000	368,650,000	165,000,000	165,000,000	20,000,000	'	'	'	98,000,000	'	'
Working capital loan outstanding	'	'	'	'	'	'	'	'	19,100,000	'	'
Amount of convertible note converted into equity interest	'	'	'	'	'	1,600,000	'	'	'	'	'
Convertible note	'	'	'	'	'	5,000,000	'	'	'	'	'
Percentage of equity shares from convertible debt	'	'	'	'	'	9.90%	15.10%	15.10%	'	'	'
Remaining convertible debt after conversion of part of debt	'	'	'	'	'	'	$3,400,000	'	'	'	'

Recovered_Sheet8

Real Estate and Loans Receivable - Florence Facility - Additional Information (Detail) (Florence acute care facility, USD $)	Dec. 31, 2013	Mar. 06, 2013
In Millions, unless otherwise specified
Significant Acquisitions and Disposals [Line Items]	'	'
Business acquisition cost of acquired entity	'	$29.40
Rent receivables	0.8	'
Letter of Credit	'	'
Significant Acquisitions and Disposals [Line Items]	'	'
Letter of credit outstanding	$1.20	'

Recovered_Sheet9

Real Estate and Loans Receivable - Gilbert Facility - Additional Information (Detail) (Gilbert, AZ [Member], USD $)	Dec. 31, 2013
In Millions, unless otherwise specified
Gilbert, AZ [Member]	'
Significant Acquisitions and Disposals [Line Items]	'
Business acquisition cost of acquired entity	$17.10
Rent receivables	$0.90

Recovered_Sheet10

Real Estate and Loans Receivable - Summary of Loans (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Loans [Line Items]	'	'
Loans, Balance	$549,640	$527,893
Mortgage loans [Member]	'	'
Loans [Line Items]	'	'
Loans, Balance	388,650	368,650
Loans, Weighted Average Interest Rate	10.20%	10.00%
Acquisition loans [Member]	'	'
Loans [Line Items]	'	'
Loans, Balance	103,266	98,433
Loans, Weighted Average Interest Rate	14.50%	14.70%
Working capital and other loans [Member]	'	'
Loans [Line Items]	'	'
Loans, Balance	$57,724	$60,810
Loans, Weighted Average Interest Rate	10.90%	10.80%

Recovered_Sheet11

Real Estate and Loans Receivable - Concentration of Credit Risks and Related Party Transactions - Additional Information (Detail) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Concentration of Credit Risks [Member]	'	'	'
Significant Acquisitions and Disposals [Line Items]	'	'	'
Maximum percentage of entity's total assets invested on single property	4.00%	'	'
Concentration of Credit Risks [Member] | California [Member]	'	'	'
Significant Acquisitions and Disposals [Line Items]	'	'	'
Percentage of total assets accounted	24.00%	'	'
Percentage of gross assets accounted	18.70%	'	'
Concentration of Credit Risks [Member] | Texas[Member]	'	'	'
Significant Acquisitions and Disposals [Line Items]	'	'	'
Percentage of total assets accounted	23.60%	'	'
Percentage of gross assets accounted	22.70%	'	'
Concentration of Credit Risks [Member] | Minimum [Member] | European	'	'	'
Significant Acquisitions and Disposals [Line Items]	'	'	'
Percentage of total assets accounted	9.00%	'	'
Concentration of Credit Risks [Member] | Prime Health Care Services [Member]	'	'	'
Significant Acquisitions and Disposals [Line Items]	'	'	'
Percentage of entity revenue from affiliates	32.00%	27.30%	'
Percentage of total assets accounted	24.50%	27.90%	'
Concentration of Credit Risks [Member] | Ernest [Member]	'	'	'
Significant Acquisitions and Disposals [Line Items]	'	'	'
Percentage of entity revenue from affiliates	20.20%	18.60%	'
Percentage of total assets accounted	15.90%	18.20%	'
Related Party Transactions [Member]	'	'	'
Significant Acquisitions and Disposals [Line Items]	'	'	'
Lease and interest revenue earned from tenants	$70	$54.30	$5.50

Debt_Summary_of_Debt_Detail

Debt - Summary of Debt (Detail) (USD $)

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Jul. 30, 2011

Dec. 31, 2013

Dec. 31, 2012

Apr. 26, 2011

Dec. 31, 2013

Aug. 20, 2013

Dec. 31, 2012

Feb. 17, 2012

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Oct. 10, 2013

In Thousands, unless otherwise specified

Revolving credit facilities [Member]

Revolving credit facilities [Member]

2006 Senior Unsecured Notes [Member]

2006 Senior Unsecured Notes [Member]

2006 Senior Unsecured Notes [Member]

2011 Senior Unsecured Notes [Member]

2011 Senior Unsecured Notes [Member]

2011 Senior Unsecured Notes [Member]

2012 Senior Unsecured Notes [Member]

2012 Senior Unsecured Notes [Member]

2012 Senior Unsecured Notes [Member]

2012 Senior Unsecured Notes [Member]

Exchangeable senior notes [Member]

2013 Senior Unsecured Notes [Member]

Term loans [Member]

Term loans [Member]

2013 Senior Unsecured Notes [Member]

2013 Senior Unsecured Notes [Member]

Debt Instrument [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Interest rate

'

'

'Variable

'Variable

'Various

'Various

'

'

'

'

'

'

'

'

'

'

'Various

'Various

'

'

Unsecured senior notes, interest rate

'

'

'

'

'

'

7.87%

6.88%

6.88%

6.88%

6.38%

6.38%

6.38%

6.38%

9.25%

5.75%

'

6.20%

5.75%

5.75%

Principal amount

'

'

$105,000

$125,000

$125,000

$125,000

'

$450,000

$450,000

$450,000

$350,000

'

$200,000

'

$11,000

'

'

$13,900

'

'

Unamortized discount

'

'

'

'

'

'

'

'

'

'

2,873

'

'

'

-37

'

'

'

'

'

Debt instrument, net

'

'

'

'

'

'

'

'

'

'

352,873

'

200,000

'

10,963

274,860

113,948

114,197

'

'

Debt

$1,421,681

$1,025,160

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Debt_Principal_Payments_Due_fo

Debt - Principal Payments Due for Debt (Detail) (USD $)	Dec. 31, 2013
In Thousands, unless otherwise specified
Debt Disclosure [Abstract]	'
2014	$265
2015	105,283
2016	225,299
2017	320
2018	12,781
Thereafter	1,074,860
Total	$1,418,808

Debt_2013_Senior_Unsecured_Not

Debt - 2013 Senior Unsecured Notes - Additional Information (Detail) (2013 Senior Unsecured Notes [Member])	0 Months Ended
In Millions, unless otherwise specified	Oct. 10, 2013	Oct. 10, 2013	Dec. 31, 2013
	USD ($)	EUR (€)
Debt Instrument [Line Items]	'	'	'
Unsecured senior notes, value of offering	$274.90	€ 200	'
Unsecured senior notes, interest rate	5.75%	5.75%	5.75%
Debt instrument, maturity date	1-Oct-20	1-Oct-20	'
Senior notes frequency of periodic payment	'Semi-annually	'Semi-annually	'
Senior notes, earliest redemption date	1-Oct-16	1-Oct-16	'
Senior notes, repurchase price percentage on principal amount plus accrued and unpaid interest	101.00%	101.00%	'

Debt_Additional_Information_De

Debt - Additional Information (Detail)	12 Months Ended			1 Months Ended		0 Months Ended	1 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011	Feb. 17, 2012	Dec. 31, 2013	Mar. 09, 2012	Mar. 09, 2012	Dec. 31, 2013
	USD ($)	USD ($)	USD ($)	Senior Notes 6.375% Due 2022 [Member]	Senior Notes 6.375% Due 2022 [Member]	2012 Term Loan [Member]	2012 Term Loan [Member]	5.750% Senior Notes due 2020 [Member]
				USD ($)	USD ($)	USD ($)	USD ($)	EUR (€)
Debt Instrument [Line Items]	'	'	'	'	'	'	'	'
Unsecured senior notes, value of offering	'	'	'	$200	$150	'	'	€ 200
Net proceeds, after underwriting discount	'	'	'	196.5	'	'	'	'
Unsecured senior notes, interest rate	'	'	'	6.38%	'	'	'	5.75%
Debt instrument, maturity date	'	'	'	15-Feb-22	'	9-Mar-16	'	'
Paid off term loan	'	'	'	'	'	100	100	'
Hedge ineffectiveness and income statement effect in period	0	0	0	'	'	'	'	'
Other assets, collateral	$5	$6.60	'	'	'	'	'	'

Debt_Revolving_Credit_Facility

Debt - Revolving Credit Facility - Additional Information (Detail) (Unsecured Revolving Credit Facility [Member], USD $)	1 Months Ended	12 Months Ended
	Mar. 31, 2012	Dec. 31, 2013	Dec. 31, 2012
Debt Instrument [Line Items]	'	'	'
Debt instrument face amount	$70,000,000	'	'
Credit facilities, amount outstanding	'	105,000,000	125,000,000
Credit facility, maturity date	'2015-10	'	'
Debt instrument, basis spread of interest rate	'	2.85%	2.85%
Revolving facility agreement, availability	'	295,000,000	'
Credit facilities, weighted average interest rate	'	3.20%	3.20%
Federal Funds Rate [Member]	'	'	'
Debt Instrument [Line Items]	'	'	'
Debt instrument, basis spread of interest rate	0.50%	'	'
Minimum [Member]	'	'	'
Debt Instrument [Line Items]	'	'	'
Credit facilities, amount outstanding	330,000,000	'	'
Debt instrument, basis spread of interest rate	1.60%	'	'
Credit facilities, percentage of commitment fee on unused capacity	0.38%	'	'
Minimum [Member] | London Interbank Offered Rate [Member]	'	'	'
Debt Instrument [Line Items]	'	'	'
Debt instrument, basis spread of interest rate	2.60%	'	'
Maximum [Member]	'	'	'
Debt Instrument [Line Items]	'	'	'
Credit facilities, amount outstanding	$400,000,000	'	'
Debt instrument, basis spread of interest rate	2.40%	'	'
Credit facilities, percentage of commitment fee on unused capacity	0.50%	'	'
Maximum [Member] | London Interbank Offered Rate [Member]	'	'	'
Debt Instrument [Line Items]	'	'	'
Debt instrument, basis spread of interest rate	3.40%	'	'

Debt_2012_Senior_Unsecured_Not

Debt - 2012 Senior Unsecured Notes - Additional Information (Detail) (2012 Senior Unsecured Notes [Member], USD $)	0 Months Ended		12 Months Ended
In Millions, unless otherwise specified	Aug. 20, 2013	Feb. 17, 2012	Dec. 31, 2013	Dec. 31, 2012
2012 Senior Unsecured Notes [Member]	'	'	'	'
Debt Instrument [Line Items]	'	'	'	'
Unsecured senior notes, value of offering	$150	$200	'	'
Unsecured senior notes, interest rate	6.38%	6.38%	6.38%	6.38%
Debt instrument, maturity date	'	15-Feb-20	15-Feb-22	'
Senior notes frequency of periodic payment	'	'	'Semi-annually	'
Net proceeds, after underwriting discount	$150.40	$196.50	'	'
Senior notes, earliest redemption date	'	'	15-Feb-17	'
Senior notes, repurchase price percentage on principal amount plus accrued and unpaid interest	101.00%	101.00%	'	'
Debt instrument redemption price	10200.00%	10200.00%	'	'
Debt instrument effective rate	'	'	6.00%	'

Debt_2011_Senior_Unsecured_Not

Debt - 2011 Senior Unsecured Notes - Additional Information (Detail) (2011 Senior Unsecured Notes [Member], USD $)	0 Months Ended
In Thousands, unless otherwise specified	Apr. 26, 2011	Dec. 31, 2013	Dec. 31, 2012
2011 Senior Unsecured Notes [Member]	'	'	'
Debt Instrument [Line Items]	'	'	'
Debt instrument face amount	$450,000	$450,000	$450,000
Interest rate	6.88%	6.88%	6.88%
Debt instrument, maturity date	1-May-21	'	'
Senior notes frequency of periodic payment	'Semi-annually	'	'
Senior notes, earliest redemption date	1-May-16	'	'
Senior notes, repurchase price percentage on principal amount plus accrued and unpaid interest	101.00%	'	'

Debt_2006_Senior_Unsecured_Not

Debt - 2006 Senior Unsecured Notes - Additional Information (Detail) (USD $)	Dec. 31, 2013	Dec. 31, 2012	Jun. 30, 2010	Oct. 31, 2011	Oct. 30, 2011	Jun. 30, 2010	Jul. 30, 2011	Dec. 31, 2006	Oct. 30, 2011	Jul. 30, 2011
In Millions, unless otherwise specified	Interest Rate Contract [Member]	Interest Rate Contract [Member]	Interest Rate Contract One [Member]	Interest Rate Contract Two [Member]	2006 Senior Unsecured Notes [Member]	2006 Senior Unsecured Notes [Member]	2006 Senior Unsecured Notes [Member]	2006 Senior Unsecured Notes [Member]	2006 Senior Unsecured Notes [Member]	2006 Senior Unsecured Notes [Member]
									London Interbank Offered Rate [Member]	London Interbank Offered Rate [Member]
Debt Instrument [Line Items]	'	'	'	'	'	'	'	'	'	'
Senior Unsecured Notes	'	'	'	'	'	'	'	$125	'	'
Credit facilities, periodic payments of interest	'	'	'	'	'	'	65	'	'	'
Senior notes frequency of periodic payment	'	'	'	'	'Quarterly	'	'Quarterly	'	'	'
Interest rate	'	'	'	'	'	'	7.87%	'	'	'
Debt instrument, basis spread of interest rate	'	'	'	'	'	'	'	'	2.30%	2.30%
Unsecured senior notes, year of maturity	'	'	'	'	'2016-07	'	'2016-07	'	'	'
Fixed rate, minimum	'	'	'	'	7.33%	'	'	'	'	'
Fixed rate, maximum	'	'	'	'	7.72%	'	'	'	'	'
Portion of debt instrument face amount	'	'	'	'	'	65	'	'	'	'
Fair value of the interest rate swaps	9	12.5	'	'	'	'	'	'	'	'
Interest rate of interest rate derivative instrument	'	'	5.51%	'	'	'	'	'	'	'
Maturity date of interest rate swap	'	'	'July 2016	'October 2016	'	'	'	'	'	'
Interest rate swap, amount fixed	'	'	'	$60	'	'	'	'	'	'
Interest rate of derivative instrument	'	'	'	5.68%	'	'	'	'	'	'

Debt_Exchangeable_Senior_Notes

Debt - Exchangeable Senior Notes - Additional Information (Detail) (USD $)	1 Months Ended
	Jul. 31, 2011	Apr. 30, 2008	Mar. 31, 2008	Dec. 31, 2013	Aug. 31, 2011
Debt Instrument [Line Items]	'	'	'	'	'
Unsecured senior notes, interest rate	'	'	'	$12,781,000	'
Exchangeable senior notes [Member]	'	'	'	'	'
Debt Instrument [Line Items]	'	'	'	'	'
Senior Notes	'	7,000,000	75,000,000	'	1,500,000
Proceeds from senior notes	'	6,800,000	72,800,000	'	'
Percentage of outstanding notes purchased from senior unsecured notes offering	85.00%	'	'	'	'
Price of principal amount plus accrued and unpaid interest, in percentage	118.50%	'	'	'	'
Price of principal amount plus accrued and unpaid interest, in amount	84,200,000	'	'	'	'
Unsecured senior notes, interest rate	'	'	'	$0.09	'

Debt_Term_Loans_Additional_Inf

Debt - Term Loans - Additional Information (Detail) (USD $)	0 Months Ended	1 Months Ended	0 Months Ended						0 Months Ended
	Mar. 09, 2012	Mar. 09, 2012	Mar. 09, 2012	Mar. 09, 2012	Mar. 09, 2012	Mar. 09, 2012	Dec. 31, 2013	Dec. 31, 2012	Feb. 14, 2011	Dec. 31, 2012
	2012 Term Loan [Member]	2012 Term Loan [Member]	2012 Term Loan [Member]	2012 Term Loan [Member]	2012 Term Loan [Member]	2012 Term Loan [Member]	Mortgages [Member]	Mortgages [Member]	Mortgages [Member]	Term loans [Member]
			London Interbank Offered Rate [Member]	Federal Funds Rate [Member]	Eurodollar Rate [Member]	Initial Spread [Member]			Northland Ltach Hospital [Member]
									Y
Debt Instrument [Line Items]	'	'	'	'	'	'	'	'	'	'
Paid off term loan	$100,000,000	$100,000,000	'	'	'	'	'	'	'	'
Debt instrument, basis spread of interest rate	'	'	2.25%	0.50%	1.00%	1.25%	'	'	'	'
Interest rate at end of period	2.43%	2.43%	'	'	'	'	'	'	'	'
Debt instrument maturity date	9-Mar-16	'	'	'	'	'	'	'	1-Jan-18	'
Term loan facility, potential term extension period	'1 year	'	'	'	'	'	'	'	'	'
Term loan facility, extension option maturity date	9-Mar-17	'	'	'	'	'	'	'	'	'
Liabilities acquired	'	'	'	'	'	'	'	'	14,600,000	'
Amortization period	'	'	'	'	'	'	'	'	30	'
Debt instrument face amount	'	'	'	'	'	'	'	'	'	13,900,000
Interest rate	'	'	'	'	'	'	'	'	6.20%	6.20%
Debt instrument earliest prepayment date	'	'	'	'	'	'	'	'	1-Jan-13	'
Collateralized real estate property	'	'	'	'	'	'	$18,000,000	$18,500,000	'	'

Debt_Covenants_Additional_Info

Debt - Covenants - Additional Information (Detail)	12 Months Ended
	Dec. 31, 2013
Debt Disclosure [Abstract]	'
Percentage of dividends which could be paid from adjusted operating funds	95.00%
Percentage of dividends which could be paid from operation funds	95.00%
Maximum percentage of total unencumbered assets	150.00%

Income_Taxes_Additional_Inform

Income Taxes - Additional Information (Detail) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Income Taxes [Line Items]	'	'	'
Percentage of ordinary taxable income to be distributed for real estate investment trust qualification	90.00%	90.00%	90.00%
Percentage of taxable income to be distributed for federal income tax assumption	100.00%	'	'
Loss before income taxes	$12.90	'	'
U.S federal NOLs	0.2	'	'
U.S. state NOLs	7.6	'	'
U.S. federal and state NOLs, expiration period	'2026 through 2032	'	'
Decrease in valuation allowance	2.6	'	'
Increased Valuation Allowances [Member]	'	'	'
Income Taxes [Line Items]	'	'	'
Acquisition-related costs on consummated deals	$1.90	'	'

Income_Taxes_Schedule_of_Incom

Income Taxes - Schedule of Income Tax Expense (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Income Tax Disclosure [Abstract]	'	'	'
Domestic	$568	$19	$128
Foreign	158	'	'
Total income tax expense	$726	$19	$128

Income_Taxes_Schedule_of_Defer

Income Taxes - Schedule of Deferred Tax Assets And liabilities (Detail) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Deferred tax liabilities:	'	'
Property and equipment	($2,870)	($2,370)
Other	-2,923	-1,673
Total deferred tax liabilities	-5,793	-4,043
Deferred tax assets:	'	'
Loan loss and other reserves	7,751	7,218
Operating loss and interest deduction carry forwards	2,283	3,938
Other	3,371	1,261
Total deferred tax assets	13,405	12,417
Valuation allowance	-7,843	-8,540
Net deferred tax (liability)	($231)	($166)

Income_Taxes_Schedule_of_Per_S

Income Taxes - Schedule of Per Share Distributions to Stockholders (Detail) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Income Tax Disclosure [Abstract]	'	'	'
Common share distribution	$0.80	$0.80	$0.80
Ordinary income	$0.60	$0.60	$0.30
Capital gains	$0.05	$0.12	$0.03
Unrecaptured Sec. 1250 gain	$0.03	$0.09	$0.03
Return of capital	$0.15	$0.08	$0.47
Allocable to next year	'	'	'

Earnings_Per_ShareUnit_Calcula

Earnings Per Share/Unit - Calculation of Earnings Per Share (Detail) (USD $)	3 Months Ended								12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2012	Mar. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]	'	'	'	'	'	'	'	'	'	'	'
Income from continuing operations	$13,309	$25,391	$25,031	$25,570	$23,264	$22,594	$18,718	$8,294	$89,301	$72,870	$12,120
Non-controlling interests' share in continuing operations	'	'	'	'	'	'	'	'	-224	-177	-178
Participating securities' share in earnings	'	'	'	'	'	'	'	'	-729	-887	-1,090
Income from continuing operations, less participating securities' share in earnings	'	'	'	'	'	'	'	'	88,348	71,806	10,852
Income from discontinued operations attributable to MPT common stockholders	'	'	'	'	'	'	'	'	7,914	17,207	14,594
Net income, less participating securities' share in earnings	'	'	'	'	'	'	'	'	96,262	89,013	25,446
Basic weighted-average common shares	161,143	154,758	149,509	140,347	134,923	134,781	134,715	124,906	151,439	132,331	110,623
Dilutive potential common shares	'	'	'	'	'	'	'	'	1,159	2	6
Diluted weighted-average common shares	161,840	155,969	151,056	141,526	134,930	134,782	134,715	124,906	152,598	132,333	110,629
MPT Operating Partnership, L.P. [Member]	'	'	'	'	'	'	'	'	'	'	'
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]	'	'	'	'	'	'	'	'	'	'	'
Income from continuing operations	13,309	25,391	25,031	25,570	23,264	22,594	18,718	8,294	89,301	72,870	12,137
Non-controlling interests' share in continuing operations	'	'	'	'	'	'	'	'	-244	-177	-178
Participating securities' share in earnings	'	'	'	'	'	'	'	'	-729	-887	-1,090
Income from continuing operations, less participating securities' share in earnings	'	'	'	'	'	'	'	'	88,328	71,806	10,869
Income from discontinued operations attributable to MPT common stockholders	'	'	'	'	'	'	'	'	7,914	17,207	14,594
Net income, less participating securities' share in earnings	'	'	'	'	'	'	'	'	$96,242	$89,013	$25,463
Basic weighted-average common shares	161,143	154,758	149,509	140,347	134,923	134,781	134,715	124,906	151,439	132,331	110,623
Dilutive potential common shares	'	'	'	'	'	'	'	'	1,159	2	6
Diluted weighted-average common shares	161,840	155,969	151,056	141,526	134,930	134,782	134,715	124,906	152,598	132,333	110,629

Earnings_Per_ShareUnit_Additio

Earnings Per Share/Unit - Additional Information (Detail) (Stock Options [Member])	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Stock Options [Member]	'	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'	'
Options excluded from earnings per share/unit	0.1	0.1	0.1

Stock_Awards_Additional_Inform

Stock Awards - Additional Information (Detail) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Number of stock options outstanding	20,000	'	'
Number of stock options exercisable	20,000	'	'
Stock options, weighted-average exercise price	$10	'	'
Stock options, intrinsic value of options exercisable and outstanding	$0	'	'
Stock options exercised	40,000	'	'
Stock options awarded, weighted average remaining contractual term (in years)	'3 months 18 days	'	'
Number of performance awards earned and vested	68,086	'	'
Number of performance awards to be earned	686,169	'	'
Stock-based compensation expense	8,900,000	7,600,000	7,000,000
Stock-based compensation expense, unrecognized cost	10,100,000	'	'
Stock-based compensation expense, unrecognized cost, reorganization period (in years)	'2 years 6 months	'	'
Restricted equity awards, fair value	$9,200,000	$9,200,000	$6,100,000
Maximum [Member]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Stock award vesting period (in years)	'10 years	'	'
30% of 2012 Performance Awards [Member]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Share based payment award, expected volatility rate	'	34.00%	'
Stock-based awards expiration date	'	31-Dec-16	'
Share based payment award, weighted average risk-free rate of return	'	0.93%	'
Common stock options awarded, dividend yield	'	8.60%	'
Percentage of performance award grant in period	'	30.00%	'
Percentage of shareholder return annually	'	9.00%	'
Percentage of shareholder return annually achieving period (in years)	'	3	'
Share-based compensation arrangement by share based payment award, expected term (in years)	'	'4 years	'
35% of 2012 Performance Awards [Member]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Share based payment award, expected volatility rate	'	35.00%	'
Share based payment award, weighted average risk-free rate of return	'	0.43%	'
Common stock options awarded, dividend yield	'	8.60%	'
Percentage of performance award grant in period	'	35.00%	'
Share-based compensation arrangement by share based payment award, expected term (in years)	'	'5 years	'
Percentage of performance award to be earned of shareholder return reaches shareholder limit	'	100.00%	'
35% of 2012 Performance Awards [Member] | If any shares are earned from this award [Member]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Share-based compensation award vesting rights	'	'Vest in equal annual amounts on January 1, 2015, 2016 and 2017	'
35% of 2012 Performance Awards [Member] | Minimum [Member]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Percentage of shareholder return to be earned	'	27.00%	'
35% of 2012 Performance Awards [Member] | Maximum [Member]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Percentage of shareholder return to be earned	'	35.00%	'
Remaining % of 2012 Performance Awards [Member]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Share based payment award, expected volatility rate	'	35.00%	'
Share based payment award, weighted average risk-free rate of return	'	0.43%	'
Common stock options awarded, dividend yield	'	8.60%	'
Share-based compensation arrangement by share based payment award, expected term (in years)	'	'5 years	'
Percentage of performance award to be earned of shareholder return reaches shareholder limit	'	100.00%	'
Percentage of shareholder return to be earned	'	6.00%	'
Remaining % of 2012 Performance Awards [Member] | If any shares are earned from this award [Member]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Share-based compensation award vesting rights	'	'Vest in equal annual amounts on January 1, 2015, 2016 and 2017	'
30% of 2011 Performance Awards [Member]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Share based payment award, expected volatility rate	'	'	33.00%
Stock-based awards expiration date	'	'	31-Dec-15
Share based payment award, weighted average risk-free rate of return	'	'	2.07%
Common stock options awarded, dividend yield	'	'	8.50%
Percentage of performance award grant in period	'	'	30.00%
Percentage of shareholder return annually	'	'	9.00%
Percentage of shareholder return annually achieving period (in years)	'	'	3
Share-based compensation arrangement by share based payment award, expected term (in years)	'	'	'4 years
18% of 2011 Performance Awards [Member]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Share based payment award, expected volatility rate	'	'	34.00%
Share based payment award, weighted average risk-free rate of return	'	'	1.07%
Common stock options awarded, dividend yield	'	'	8.50%
Percentage of performance award grant in period	'	'	18.00%
Share-based compensation arrangement by share based payment award, expected term (in years)	'	'	'5 years
Percentage of performance award to be earned of shareholder return reaches shareholder limit	'	'	100.00%
18% of 2011 Performance Awards [Member] | If any shares are earned from this award [Member]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Share-based compensation award vesting rights	'	'	'Vest in equal annual amounts on January 1, 2014, 2015 and 2016
18% of 2011 Performance Awards [Member] | Minimum [Member]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Percentage of shareholder return to be earned	'	'	27.00%
18% of 2011 Performance Awards [Member] | Maximum [Member]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Percentage of shareholder return to be earned	'	'	39.00%
Remaining % of 2011 Performance Awards [Member]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Share based payment award, expected volatility rate	'	'	34.00%
Share based payment award, weighted average risk-free rate of return	'	'	1.07%
Common stock options awarded, dividend yield	'	'	8.50%
Share-based compensation arrangement by share based payment award, expected term (in years)	'	'	'5 years
Percentage of performance award to be earned of shareholder return reaches shareholder limit	'	'	100.00%
Percentage of shareholder return to be earned	'	'	12.00%
Remaining % of 2011 Performance Awards [Member] | If any shares are earned from this award [Member]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Share-based compensation award vesting rights	'	'	'Vest in equal annual amounts on January 1, 2014, 2015 and 2016
Settled in Cash [Member]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Number of stock options settled for cash	'	'	20,000
Stock options granted	0	0	0
Stock options exercised	0	0	0
Service-Based Awards [Member] | Minimum [Member]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Stock award required service period (in years)	'3 years	'	'
Service-Based Awards [Member] | Maximum [Member]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Stock award required service period (in years)	'5 years	'	'
27% of 2013 Performance Awards [Member]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Share based payment award, expected volatility rate	27.00%	'	'
Stock-based awards expiration date	31-Dec-17	'	'
Share based payment award, weighted average risk-free rate of return	0.72%	'	'
Common stock options awarded, dividend yield	8.00%	'	'
Percentage of performance award grant in period	27.00%	'	'
Percentage of shareholder return annually	8.50%	'	'
Percentage of shareholder return annually achieving period (in years)	3	'	'
Share-based compensation arrangement by share based payment award, expected term (in years)	'3 years	'	'
Equity Incentive Plan [Member]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Reserved shares of common stock for awards under the Equity Incentive Plan	7,643,651	'	'
Common stock remaining for future stock awards transferred to the equity incentive plan	7,643,651	'	'
Maximum number of shares of common stock that may be awarded	5,000,000	'	'
36% of 2013 Performance Awards [Member]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Share based payment award, expected volatility rate	28.00%	'	'
Share based payment award, weighted average risk-free rate of return	0.38%	'	'
Common stock options awarded, dividend yield	8.00%	'	'
Percentage of performance award grant in period	36.00%	'	'
Share-based compensation arrangement by share based payment award, expected term (in years)	'5 years	'	'
Percentage of performance award to be earned of shareholder return reaches shareholder limit	100.00%	'	'
36% of 2013 Performance Awards [Member] | If any shares are earned from this award [Member]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Share-based compensation award vesting rights	'Vest in equal annual amounts on December 31, 2015, 2016 and 2017	'	'
36% of 2013 Performance Awards [Member] | Minimum [Member]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Percentage of shareholder return to be earned	25.50%	'	'
36% of 2013 Performance Awards [Member] | Maximum [Member]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Percentage of shareholder return to be earned	33.50%	'	'
Remaining % of 2013 Performance Awards [Member]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Share based payment award, expected volatility rate	28.00%	'	'
Share based payment award, weighted average risk-free rate of return	0.38%	'	'
Common stock options awarded, dividend yield	8.00%	'	'
Share-based compensation arrangement by share based payment award, expected term (in years)	'5 years	'	'
Percentage of performance award to be earned of shareholder return reaches shareholder limit	100.00%	'	'
Percentage of shareholder return to be earned	6.00%	'	'
Remaining % of 2013 Performance Awards [Member] | If any shares are earned from this award [Member]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Share-based compensation award vesting rights	'Vest in equal annual amounts on December 31, 2015, 2016 and 2017	'	'
2012 Performance Awards [Member]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Number of performance awards earned and vested	84,188	84,188	'
Number of performance awards to be earned	725,666	'	'
Number of performance awards forfeited	2,599	5,718	'
2011 Performance Awards [Member]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Number of performance awards earned and vested	81,359	155,162	0
Number of performance awards forfeited	8,062	14,456	'
Number of performance awards to be earned	587,344	'	'

Stock_Awards_Restricted_Equity

Stock Awards - Restricted Equity Awards Activity (Detail) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Vesting Based on Service [Member]	'	'
Employee Restricted Equity Awards Vesting Activity [Line Items]	'	'
Nonvested awards at beginning of the year, Shares	466,883	603,980
Awarded, Shares	240,425	275,464
Vested, Shares	-381,309	-410,261
Forfeited, Shares	'	-2,300
Nonvested awards at end of year, Shares	325,999	466,883
Nonvested awards at beginning of the year, Weighted Average Value at Award Date	$10.72	$11.02
Awarded, Weighted Average Value at Award Date	$12.26	$10.14
Vested, Weighted Average Value at Award Date	$11.15	$10.78
Forfeited, Weighted Average Value at Award Date	'	$10.24
Nonvested awards at end of year, Weighted Average Value at Award Date	$11.36	$10.72
Vesting Based on Market/Performance Conditions [Member]	'	'
Employee Restricted Equity Awards Vesting Activity [Line Items]	'	'
Nonvested awards at beginning of the year, Shares	1,879,889	1,511,397
Awarded, Shares	754,255	902,359
Vested, Shares	-386,446	-513,693
Forfeited, Shares	-248,519	-20,174
Nonvested awards at end of year, Shares	1,999,179	1,879,889
Nonvested awards at beginning of the year, Weighted Average Value at Award Date	$6.48	$7.60
Awarded, Weighted Average Value at Award Date	$6.13	$5.81
Vested, Weighted Average Value at Award Date	$8.27	$8.63
Forfeited, Weighted Average Value at Award Date	$11.03	$5.45
Nonvested awards at end of year, Weighted Average Value at Award Date	$5.44	$6.48

Commitments_and_Contingencies_1

Commitments and Contingencies - Additional Information (Detail) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Commitments And Contingencies Disclosure [Abstract]	'	'	'
Term of lease period	'50 years or more	'	'
Lease and Rental Expenses	$2,304,461	$2,195,835	$1,994,565
Sublease rental income	512,503	492,095	443,829
Total amount to be received in the future from non-cancellable subleases	$30,100,000	'	'

Commitments_and_Contingencies_2

Commitments and Contingencies - Fixed Minimum Payments Due under Operating Leases with Non-Cancelable Terms (Detail) (USD $)	Dec. 31, 2013
In Thousands, unless otherwise specified
Commitments And Contingencies Disclosure [Abstract]	'
2014	$2,471
2015	2,644
2016	2,659
2017	2,620
2018	2,614
Thereafter	37,213
Minimum rental payments, total	$50,221

Common_StockPartners_Capital_A

Common Stock/Partner's Capital - Additional Information (Detail) (USD $)

12 Months Ended

12 Months Ended

0 Months Ended

3 Months Ended

1 Months Ended

Dec. 31, 2013

Dec. 31, 2012

Feb. 29, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2013

Aug. 20, 2013

Feb. 28, 2013

Feb. 07, 2012

Dec. 31, 2012

Nov. 30, 2009

Feb. 28, 2014

Jan. 31, 2014

Jan. 31, 2014

Feb. 29, 2012

MPT Operating Partnership, L.P. [Member]

MPT Operating Partnership, L.P. [Member]

Employee [Member]

Director [Member]

Public Offering [Member]

Public Offering [Member]

Public Offering [Member]

Market Equity Offering Program [Member]

Market Equity Offering Program [Member]

Market Equity Offering Program [Member]

Market Equity Offering Program [Member]

Market Equity Offering Program [Member]

Before Amendment [Member]

Maximum [Member]

Subsequent Event

Subsequent Event

Subsequent Event

Maximum [Member]

Class of Stock [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Common stock, shares issued

136,335,000

136,335,000

'

'

'

'

'

11,500,000

12,650,000

23,575,000

1,100,000

'

'

'

'

'

Underwriters' purchase of shares pursuant to over allotment

'

'

'

'

'

'

'

1,500,000

1,650,000

3,075,000

'

'

'

'

'

'

Public offering price for common stock per share

'

'

'

'

'

'

'

$12.75

$14.25

$9.75

$11.84

'

'

'

'

'

Net proceed from issuance of common stock

$313,331,000

$233,048,000

'

$313,331,000

$233,048,000

'

'

$140,400,000

$172,900,000

$220,100,000

$13,200,000

'

$12,500,000

'

'

'

Number of shares can be sold out

'

'

'

'

'

'

'

'

'

'

'

50,000,000

'

'

'

'

Sales commission

'

'

'

'

'

'

'

'

'

'

2.00%

'

'

1.25%

'

'

Increased stock purchased amount

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$250,000,000

'

Common stock, shares authorized

250,000,000

250,000,000

250,000,000

'

'

'

'

'

'

'

'

'

'

'

'

150,000,000

Common stock, par value

$0.00

$0.00

$0.00

'

'

'

'

'

'

'

'

'

'

'

'

'

Percentage of ownership of general partner

'

'

'

100.00%

'

'

'

'

'

'

'

'

'

'

'

'

Ownership interest in equity

100.00%

'

'

99.80%

'

'

'

'

'

'

'

'

'

'

'

'

Number of other partners

'

'

'

3

'

'

'

'

'

'

'

'

'

'

'

'

Number of partners shared remaining ownership percentage

'

'

'

'

'

2

1

'

'

'

'

'

'

'

'

'

Fair_Value_of_Financial_Instru2

Fair Value of Financial Instruments - Summary of Fair Value Information of Financial Instruments (Detail) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]	'	'
Interest and rent receivables	$58,499	$45,289
Loans	351,607	334,693
Debt, net	-1,421,681	-1,025,160
Estimate of Fair Value, Fair Value Disclosure [Member]	'	'
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]	'	'
Interest and rent receivables	44,349	36,700
Loans	358,277	335,595
Debt, net	($1,486,090)	($1,082,333)

Fair_Value_of_Financial_Instru3

Fair Value of Financial Instruments - Equity Interest in Ernest and Related Loans Measured at Fair Value on Recurring Basis (Detail) (USD $)	Dec. 31, 2013
In Thousands, unless otherwise specified
Financial Instruments Measured At Fair Value On Recurring Basis [Line Items]	'
Fair Value	$201,333
Cost	201,333
Fair Value Measurements, Recurring [Member] | Mortgage loans [Member] | Mortgage Loans [Member]	'
Financial Instruments Measured At Fair Value On Recurring Basis [Line Items]	'
Fair Value	100,000
Cost	100,000
Fair Value Measurements, Recurring [Member] | Acquisition loans [Member] | Working capital and other loans [Member]	'
Financial Instruments Measured At Fair Value On Recurring Basis [Line Items]	'
Fair Value	98,033
Cost	98,033
Fair Value Measurements, Recurring [Member] | Equity investments [Member] | Other assets [Member]	'
Financial Instruments Measured At Fair Value On Recurring Basis [Line Items]	'
Fair Value	3,300
Cost	$3,300

Fair_Value_of_Financial_Instru4

Fair Value of Financial Instruments - Additional information (Detail)	12 Months Ended
	Dec. 31, 2013
Fair Value Disclosures [Abstract]	'
Adjustment for marketability discount	40.00%

Fair_Value_of_Financial_Instru5

Fair Value of Financial Instruments - Summary Showing Sensitivity Analysis by Using Basis Point Variations (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013
+100 basis points [Member]	'
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]	'
Estimated Increase (Decrease) In Fair Value of Financial Instruments	($320)
- 100 basis points [Member]	'
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]	'
Estimated Increase (Decrease) In Fair Value of Financial Instruments	$320

Discontinued_Operations_Additi

Discontinued Operations - Additional Information (Detail) (USD $)	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2013
In Thousands, unless otherwise specified		Allowance for Doubtful Accounts, Discontinued Operations [Member]	Allowance for Doubtful Accounts, Discontinued Operations [Member]	Allowance for Doubtful Accounts, Discontinued Operations [Member]	Allowance for Doubtful Accounts, Discontinued Operations [Member]	Allowance for Doubtful Accounts, Discontinued Operations [Member]	Allowance for Doubtful Accounts, Discontinued Operations [Member]
			Land [Member]	Building [Member]	Intangible Lease Assets [Member]	Accumulated Depreciation [Member]	Accumulated Amortization [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]	'	'	'	'	'	'	'
Real estate held for sale	$25,537	$25,500	$1,900	$26,700	$800	$3,500	$400

Discontinued_Operations_Discon

Discontinued Operations - Discontinued Operations (Detail) (USD $)	3 Months Ended								12 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2012	Mar. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Discontinued Operations And Disposal Groups [Abstract]	'	'	'	'	'	'	'	'	'	'	'
Revenues	'	'	'	'	'	'	'	'	$988	$3,470	$14,531
Gain on sale	'	'	'	'	'	'	'	'	7,659	16,369	5,431
Income from discontinued operations	$4,588	$312	$2,374	$640	$5,339	$8,914	$642	$2,312	$7,914	$17,207	$14,594
Income from discontinued operations - diluted per share/unit	'	'	'	'	'	'	'	'	$0.05	$0.13	$0.13

Recovered_Sheet12

Quarterly Financial Data (Unaudited) - Unaudited Quarterly Financial Information (Detail) (USD $)	3 Months Ended								12 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2012	Mar. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Quarterly Financial Information [Line Items]	'	'	'	'	'	'	'	'	'	'	'
Revenues	$67,679	$60,106	$57,124	$57,614	$56,597	$52,504	$48,569	$40,455	$242,523	$198,125	$132,322
Income (loss) from continuing operations	13,309	25,391	25,031	25,570	23,264	22,594	18,718	8,294	89,301	72,870	12,120
Income from discontinued operations	4,588	312	2,374	640	5,339	8,914	642	2,312	7,914	17,207	14,594
Net income	17,897	25,703	27,405	26,210	28,603	31,508	19,360	10,606	97,215	90,077	26,714
Net income attributable to MPT common stockholders	17,839	25,648	27,348	26,156	28,556	31,464	19,316	10,564	96,991	89,900	26,536
Net income attributable to MPT common stockholders per share - basic	$0.11	$0.16	$0.18	$0.19	$0.21	$0.23	$0.14	$0.08	$0.64	$0.67	$0.23
Weighted average shares outstanding - basic	161,143	154,758	149,509	140,347	134,923	134,781	134,715	124,906	151,439	132,331	110,623
Net income attributable to MPT common stockholders per share - diluted	$0.11	$0.16	$0.18	$0.18	$0.21	$0.23	$0.14	$0.08	$0.63	$0.67	$0.23
Weighted average shares outstanding - diluted	161,840	155,969	151,056	141,526	134,930	134,782	134,715	124,906	152,598	132,333	110,629
MPT Operating Partnership, L.P. [Member]	'	'	'	'	'	'	'	'	'	'	'
Quarterly Financial Information [Line Items]	'	'	'	'	'	'	'	'	'	'	'
Revenues	67,679	60,106	57,124	57,614	56,597	52,504	48,569	40,455	242,523	198,125	132,322
Income (loss) from continuing operations	13,309	25,391	25,031	25,570	23,264	22,594	18,718	8,294	89,301	72,870	12,137
Income from discontinued operations	4,588	312	2,374	640	5,339	8,914	642	2,312	7,914	17,207	14,594
Net income	17,897	25,703	27,405	26,210	28,603	31,508	19,360	10,606	97,215	90,077	26,731
Net income attributable to MPT common stockholders	$17,839	$25,648	$27,348	$26,156	$28,556	$31,464	$19,316	$10,564	$96,991	$89,900	$26,553
Net income attributable to MPT common stockholders per share - basic	$0.11	$0.16	$0.18	$0.19	$0.21	$0.23	$0.14	$0.08	$0.64	$0.67	$0.23
Weighted average shares outstanding - basic	161,143	154,758	149,509	140,347	134,923	134,781	134,715	124,906	151,439	132,331	110,623
Net income attributable to MPT common stockholders per share - diluted	$0.11	$0.16	$0.18	$0.18	$0.21	$0.23	$0.14	$0.08	$0.63	$0.67	$0.23
Weighted average shares outstanding - diluted	161,840	155,969	151,056	141,526	134,930	134,782	134,715	124,906	152,598	132,333	110,629

Condensed_Consolidating_Financ2

Condensed Consolidating Financial Information - Additional Information (Detail) (USD $)

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2012

Parent [Member]

Subsidiary of Common Parent [Member]

Subsidiary Guarantors [Member]

Subsidiary Guarantors [Member]

Subsidiary Guarantors [Member]

Non-Guarantor Subsidiaries [Member]

Non-Guarantor Subsidiaries [Member]

Non-Guarantor Subsidiaries [Member]

Restatement Adjustment [Member]

Restatement Adjustment [Member]

Subsidiary Issuer [Member]

Amounts Offset [Member]

Subsidiary Issuer [Member]

Amounts Offset [Member]

Subsidiaries Guarantor

Subsidiaries Non Guarantor

Prior Period Reclassification Adjustment

'

'

$129,400,000

$501,800,000

$365,800,000

$92,100,000

$89,600,000

$136,100,000

$22,400,000

$114,200,000

'

'

Total Assets

2,904,570,000

2,178,886,000

'

'

'

'

'

'

'

'

997,200,000

404,100,000

Total liabilities

$1,560,362,000

$1,129,072,000

'

'

'

'

'

'

'

'

$997,200,000

$404,100,000

Condensed_Consolidating_Financ3

Condensed Consolidating Financial Information - Condensed Consolidated Balance Sheets (Detail) (USD $)	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
In Thousands, unless otherwise specified
Condensed Financial Statements, Captions [Line Items]	'	'	'	'
Real estate held for sale	'	$25,537	'	'
Net investment in direct financing leases	431,024	314,412	'	'
Mortgage loans	388,650	368,650	'	'
Gross investment in real estate assets	2,685,129	1,959,839	'	'
Net investment in real estate assets	2,525,353	1,837,043	'	'
Cash and cash equivalents	45,979	37,311	102,726	98,408
Interest and rent receivables	58,499	45,289	'	'
Straight-line rent receivables	45,829	35,860	'	'
Other loans	160,990	159,243	'	'
Other assets	67,920	64,140	'	'
Total Assets	2,904,570	2,178,886	'	'
Debt, net	1,421,681	1,025,160	'	'
Accounts payable and accrued expenses	94,311	65,961	'	'
Deferred revenue	23,787	20,609	'	'
Lease deposits and other obligations to tenants	20,583	17,342	'	'
Total liabilities	1,560,362	1,129,072	'	'
Total Equity	1,344,208	1,049,814	'	'
Total Liabilities and Equity	2,904,570	2,178,886	'	'
Parent [Member]	'	'	'	'
Condensed Financial Statements, Captions [Line Items]	'	'	'	'
Land, buildings and improvements and intangible lease assets	'	'	'	'
Real estate held for sale	'	'	'	'
Net investment in direct financing leases	'	'	'	'
Mortgage loans	'	'	'	'
Gross investment in real estate assets	'	'	'	'
Accumulated depreciation and amortization	'	'	'	'
Net investment in real estate assets	'	'	'	'
Cash and cash equivalents	'	'	'	'
Interest and rent receivables	'	'	'	'
Straight-line rent receivables	'	'	'	'
Other loans	'	'	'	'
Net intercompany receivable	35,363	27,393	'	'
Investment in subsidiaries	1,344,598	1,050,204	'	'
Total Assets	1,379,961	1,077,597	'	'
Debt, net	'	'	'	'
Accounts payable and accrued expenses	35,753	27,783	'	'
Net intercompany payable	'	'	'	'
Deferred revenue	'	'	'	'
Lease deposits and other obligations to tenants	'	'	'	'
Total liabilities	35,753	27,783	'	'
Total Equity	1,344,208	1,049,814	'	'
Total Liabilities and Equity	1,379,961	1,077,597	'	'
Subsidiary Issuers [Member]	'	'	'	'
Condensed Financial Statements, Captions [Line Items]	'	'	'	'
Land, buildings and improvements and intangible lease assets	'	28	'	'
Real estate held for sale	'	'	'	'
Net investment in direct financing leases	'	'	'	'
Mortgage loans	'	'	'	'
Gross investment in real estate assets	'	28	'	'
Accumulated depreciation and amortization	'	'	'	'
Net investment in real estate assets	'	28	'	'
Cash and cash equivalents	18,815	35,483	101,230	96,822
Interest and rent receivables	336	212	'	'
Straight-line rent receivables	'	'	'	'
Other loans	178	177	'	'
Net intercompany receivable	1,907,477	1,373,941	'	'
Investment in subsidiaries	825,153	647,029	'	'
Other assets	37,311	31,097	'	'
Total Assets	2,789,267	2,087,967	'	'
Debt, net	1,407,733	1,010,962	'	'
Accounts payable and accrued expenses	36,887	26,658	'	'
Net intercompany payable	'	'	'	'
Deferred revenue	49	143	'	'
Lease deposits and other obligations to tenants	'	'	'	'
Total liabilities	1,444,669	1,037,763	'	'
Total Equity	1,344,598	1,050,204	'	'
Total Liabilities and Equity	2,789,267	2,087,967	'	'
Subsidiary Guarantors [Member]	'	'	'	'
Condensed Financial Statements, Captions [Line Items]	'	'	'	'
Land, buildings and improvements and intangible lease assets	1,795,084	1,185,265	'	'
Real estate held for sale	'	'	'	'
Net investment in direct financing leases	212,543	110,155	'	'
Mortgage loans	268,650	268,650	'	'
Gross investment in real estate assets	2,276,277	1,564,070	'	'
Accumulated depreciation and amortization	-151,624	-116,344	'	'
Net investment in real estate assets	2,124,653	1,447,726	'	'
Cash and cash equivalents	27,094	1,565	1,409	1,387
Interest and rent receivables	31,324	29,150	'	'
Straight-line rent receivables	37,015	28,416	'	'
Other loans	1,100	'	'	'
Net intercompany receivable	'	'	'	'
Investment in subsidiaries	42,407	42,666	'	'
Other assets	1,168	1,522	'	'
Total Assets	2,264,761	1,551,045	'	'
Debt, net	'	'	'	'
Accounts payable and accrued expenses	20,367	10,492	'	'
Net intercompany payable	1,538,934	997,231	'	'
Deferred revenue	17,772	19,431	'	'
Lease deposits and other obligations to tenants	17,964	16,357	'	'
Total liabilities	1,595,037	1,043,511	'	'
Total Equity	669,724	507,534	'	'
Total Liabilities and Equity	2,264,761	1,551,045	'	'
Non-Guarantor Subsidiaries [Member]	'	'	'	'
Condensed Financial Statements, Captions [Line Items]	'	'	'	'
Land, buildings and improvements and intangible lease assets	70,371	65,947	'	'
Real estate held for sale	'	25,537	'	'
Net investment in direct financing leases	218,481	204,257	'	'
Mortgage loans	120,000	100,000	'	'
Gross investment in real estate assets	408,852	395,741	'	'
Accumulated depreciation and amortization	-8,152	-6,452	'	'
Net investment in real estate assets	400,700	389,289	'	'
Cash and cash equivalents	70	263	87	199
Interest and rent receivables	26,839	15,927	'	'
Straight-line rent receivables	8,814	7,444	'	'
Other loans	159,712	159,066	'	'
Net intercompany receivable	'	'	'	'
Investment in subsidiaries	'	'	'	'
Other assets	29,441	31,521	'	'
Total Assets	625,576	603,510	'	'
Debt, net	13,948	14,198	'	'
Accounts payable and accrued expenses	1,304	1,028	'	'
Net intercompany payable	403,903	404,103	'	'
Deferred revenue	5,966	1,035	'	'
Lease deposits and other obligations to tenants	2,619	985	'	'
Total liabilities	427,740	421,349	'	'
Total Equity	197,836	182,161	'	'
Total Liabilities and Equity	625,576	603,510	'	'
Eliminations [Member]	'	'	'	'
Condensed Financial Statements, Captions [Line Items]	'	'	'	'
Land, buildings and improvements and intangible lease assets	'	'	'	'
Real estate held for sale	'	'	'	'
Net investment in direct financing leases	'	'	'	'
Mortgage loans	'	'	'	'
Gross investment in real estate assets	'	'	'	'
Accumulated depreciation and amortization	'	'	'	'
Net investment in real estate assets	'	'	'	'
Cash and cash equivalents	'	'	'	'
Interest and rent receivables	'	'	'	'
Straight-line rent receivables	'	'	'	'
Other loans	'	'	'	'
Net intercompany receivable	-1,942,837	-1,401,334	'	'
Investment in subsidiaries	-2,212,158	-1,739,899	'	'
Total Assets	-4,154,995	-3,141,233	'	'
Debt, net	'	'	'	'
Accounts payable and accrued expenses	'	'	'	'
Net intercompany payable	-1,942,837	-1,401,334	'	'
Deferred revenue	'	'	'	'
Lease deposits and other obligations to tenants	'	'	'	'
Total liabilities	-1,942,837	-1,401,334	'	'
Total Equity	-2,212,158	-1,739,899	'	'
Total Liabilities and Equity	-4,154,995	-3,141,233	'	'
Total Consolidated [Member]	'	'	'	'
Condensed Financial Statements, Captions [Line Items]	'	'	'	'
Land, buildings and improvements and intangible lease assets	1,865,455	1,251,240	'	'
Real estate held for sale	'	25,537	'	'
Net investment in direct financing leases	431,024	314,412	'	'
Mortgage loans	388,650	368,650	'	'
Gross investment in real estate assets	2,685,129	1,959,839	'	'
Accumulated depreciation and amortization	-159,776	-122,796	'	'
Net investment in real estate assets	2,525,353	1,837,043	'	'
Cash and cash equivalents	45,979	37,311	102,726	98,408
Interest and rent receivables	58,499	45,289	'	'
Straight-line rent receivables	45,829	35,860	'	'
Other loans	160,990	159,243	'	'
Net intercompany receivable	'	'	'	'
Investment in subsidiaries	'	'	'	'
Other assets	67,920	64,140	'	'
Total Assets	2,904,570	2,178,886	'	'
Debt, net	1,421,681	1,025,160	'	'
Accounts payable and accrued expenses	94,311	65,961	'	'
Net intercompany payable	'	'	'	'
Deferred revenue	23,787	20,609	'	'
Lease deposits and other obligations to tenants	20,583	17,342	'	'
Total liabilities	1,560,362	1,129,072	'	'
Total Equity	1,344,208	1,049,814	'	'
Total Liabilities and Equity	$2,904,570	$2,178,886	'	'

Condensed_Consolidating_Financ4

Condensed Consolidating Financial Information - Condensed Consolidated Statements of Income (Detail) (USD $)	3 Months Ended								12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2012	Mar. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Revenues	'	'	'	'	'	'	'	'	'	'	'
Rent billed	'	'	'	'	'	'	'	'	$132,578	$119,883	$105,688
Straight-line rent	'	'	'	'	'	'	'	'	10,706	7,911	5,277
Income from direct financing leases	'	'	'	'	'	'	'	'	40,830	21,728	'
Interest and fee income	'	'	'	'	'	'	'	'	58,409	48,603	21,357
Total revenues	67,679	60,106	57,124	57,614	56,597	52,504	48,569	40,455	242,523	198,125	132,322
Expenses	'	'	'	'	'	'	'	'	'	'	'
Real estate depreciation and amortization	'	'	'	'	'	'	'	'	36,978	32,815	30,147
Property-related	'	'	'	'	'	'	'	'	2,450	1,477	724
Acquisition expenses	'	'	'	'	'	'	'	'	19,494	5,420	4,184
General and administrative	'	'	'	'	'	'	'	'	30,063	28,562	27,091
Total operating expenses	'	'	'	'	'	'	'	'	88,985	68,274	62,146
Operating income	'	'	'	'	'	'	'	'	153,538	129,851	70,176
Other income (expense)	'	'	'	'	'	'	'	'	'	'	'
Interest and other (expense) income	'	'	'	'	'	'	'	'	-319	-1,662	18
Earnings from equity and other interests	'	'	'	'	'	'	'	'	3,554	2,943	78
Debt refinancing costs	'	'	'	'	'	'	'	'	'	'	-14,214
Interest expense	'	'	'	'	'	'	'	'	-66,746	-58,243	-43,810
Income tax expense	'	'	'	'	'	'	'	'	-726	-19	-128
Net other expense	'	'	'	'	'	'	'	'	-64,237	-56,981	-58,056
Income (loss) from continuing operations	13,309	25,391	25,031	25,570	23,264	22,594	18,718	8,294	89,301	72,870	12,120
Income (loss) from discontinued operations	4,588	312	2,374	640	5,339	8,914	642	2,312	7,914	17,207	14,594
Net income	17,897	25,703	27,405	26,210	28,603	31,508	19,360	10,606	97,215	90,077	26,714
Net income (loss) attributable to non-controlling interests	'	'	'	'	'	'	'	'	-224	-177	-178
Net income attributable to MPT common stockholders	17,839	25,648	27,348	26,156	28,556	31,464	19,316	10,564	96,991	89,900	26,536
Parent [Member]	'	'	'	'	'	'	'	'	'	'	'
Revenues	'	'	'	'	'	'	'	'	'	'	'
Rent billed	'	'	'	'	'	'	'	'	'	'	'
Straight-line rent	'	'	'	'	'	'	'	'	'	'	'
Income from direct financing leases	'	'	'	'	'	'	'	'	'	'	'
Interest and fee income	'	'	'	'	'	'	'	'	'	'	'
Total revenues	'	'	'	'	'	'	'	'	'	'	'
Expenses	'	'	'	'	'	'	'	'	'	'	'
Real estate depreciation and amortization	'	'	'	'	'	'	'	'	'	'	'
Property-related	'	'	'	'	'	'	'	'	'	'	'
Acquisition expenses	'	'	'	'	'	'	'	'	'	'	'
General and administrative	'	'	'	'	'	'	'	'	'	'	17
Total operating expenses	'	'	'	'	'	'	'	'	'	'	17
Operating income	'	'	'	'	'	'	'	'	'	'	-17
Other income (expense)	'	'	'	'	'	'	'	'	'	'	'
Interest and other (expense) income	'	'	'	'	'	'	'	'	'	'	'
Earnings from equity and other interests	'	'	'	'	'	'	'	'	'	'	'
Interest expense	'	'	'	'	'	'	'	'	'	'	'
Income tax expense	'	'	'	'	'	'	'	'	'	'	'
Net other expense	'	'	'	'	'	'	'	'	'	'	'
Income (loss) from continuing operations	'	'	'	'	'	'	'	'	'	'	-17
Equity in earnings of consolidated subsidiaries net of income taxes	'	'	'	'	'	'	'	'	97,215	90,077	26,731
Net income	'	'	'	'	'	'	'	'	97,215	90,077	26,714
Net income (loss) attributable to non-controlling interests	'	'	'	'	'	'	'	'	-224	-177	-178
Net income attributable to MPT common stockholders	'	'	'	'	'	'	'	'	96,991	89,900	26,536
Subsidiary Issuers [Member]	'	'	'	'	'	'	'	'	'	'	'
Revenues	'	'	'	'	'	'	'	'	'	'	'
Straight-line rent	'	'	'	'	'	'	'	'	'	'	'
Income from direct financing leases	'	'	'	'	'	'	'	'	'	'	'
Interest and fee income	'	'	'	'	'	'	'	'	21,797	18,341	6,124
Total revenues	'	'	'	'	'	'	'	'	21,797	18,341	6,124
Expenses	'	'	'	'	'	'	'	'	'	'	'
Real estate depreciation and amortization	'	'	'	'	'	'	'	'	'	'	'
Property-related	'	'	'	'	'	'	'	'	601	495	217
Acquisition expenses	'	'	'	'	'	'	'	'	7,356	5,420	3,713
General and administrative	'	'	'	'	'	'	'	'	29,033	26,018	23,914
Total operating expenses	'	'	'	'	'	'	'	'	36,990	31,933	27,844
Operating income	'	'	'	'	'	'	'	'	-15,193	-13,592	-21,720
Other income (expense)	'	'	'	'	'	'	'	'	'	'	'
Interest and other (expense) income	'	'	'	'	'	'	'	'	-110	-69	26
Earnings from equity and other interests	'	'	'	'	'	'	'	'	'	'	'
Debt refinancing costs	'	'	'	'	'	'	'	'	'	'	-14,109
Interest expense	'	'	'	'	'	'	'	'	-67,484	-58,729	-43,063
Income tax expense	'	'	'	'	'	'	'	'	'	'	'
Net other expense	'	'	'	'	'	'	'	'	-67,594	-58,798	-57,146
Income (loss) from continuing operations	'	'	'	'	'	'	'	'	-82,787	-72,390	-78,866
Income (loss) from discontinued operations	'	'	'	'	'	'	'	'	'	'	'
Equity in earnings of consolidated subsidiaries net of income taxes	'	'	'	'	'	'	'	'	180,002	162,467	105,597
Net income	'	'	'	'	'	'	'	'	97,215	90,077	26,731
Net income (loss) attributable to non-controlling interests	'	'	'	'	'	'	'	'	-224	-177	-178
Net income attributable to MPT common stockholders	'	'	'	'	'	'	'	'	96,991	89,900	26,553
Subsidiary Guarantors [Member]	'	'	'	'	'	'	'	'	'	'	'
Revenues	'	'	'	'	'	'	'	'	'	'	'
Rent billed	'	'	'	'	'	'	'	'	124,651	112,573	99,494
Straight-line rent	'	'	'	'	'	'	'	'	8,438	6,429	3,515
Income from direct financing leases	'	'	'	'	'	'	'	'	38,522	19,870	'
Interest and fee income	'	'	'	'	'	'	'	'	38,696	29,606	17,543
Total revenues	'	'	'	'	'	'	'	'	210,307	168,478	120,552
Expenses	'	'	'	'	'	'	'	'	'	'	'
Real estate depreciation and amortization	'	'	'	'	'	'	'	'	35,277	31,115	28,489
Property-related	'	'	'	'	'	'	'	'	1,356	816	458
Acquisition expenses	'	'	'	'	'	'	'	'	12,138	'	'
General and administrative	'	'	'	'	'	'	'	'	375	'	'
Total operating expenses	'	'	'	'	'	'	'	'	49,146	31,931	28,947
Operating income	'	'	'	'	'	'	'	'	161,161	136,547	91,605
Other income (expense)	'	'	'	'	'	'	'	'	'	'	'
Interest and other (expense) income	'	'	'	'	'	'	'	'	'	'	2
Earnings from equity and other interests	'	'	'	'	'	'	'	'	948	1,061	345
Debt refinancing costs	'	'	'	'	'	'	'	'	'	'	-105
Interest expense	'	'	'	'	'	'	'	'	-1,912	1,408	139
Income tax expense	'	'	'	'	'	'	'	'	-158	'	'
Net other expense	'	'	'	'	'	'	'	'	-1,122	2,469	381
Income (loss) from continuing operations	'	'	'	'	'	'	'	'	160,039	139,016	91,986
Income (loss) from discontinued operations	'	'	'	'	'	'	'	'	-4	103	-1,969
Equity in earnings of consolidated subsidiaries net of income taxes	'	'	'	'	'	'	'	'	4,477	4,481	4,578
Net income	'	'	'	'	'	'	'	'	164,512	143,600	15,580
Net income (loss) attributable to non-controlling interests	'	'	'	'	'	'	'	'	'	'	'
Net income attributable to MPT common stockholders	'	'	'	'	'	'	'	'	164,512	143,600	94,595
Non-Guarantor Subsidiaries [Member]	'	'	'	'	'	'	'	'	'	'	'
Revenues	'	'	'	'	'	'	'	'	'	'	'
Rent billed	'	'	'	'	'	'	'	'	20,028	16,619	9,286
Straight-line rent	'	'	'	'	'	'	'	'	2,268	1,482	1,762
Income from direct financing leases	'	'	'	'	'	'	'	'	22,577	18,090	'
Interest and fee income	'	'	'	'	'	'	'	'	29,834	25,387	3,926
Total revenues	'	'	'	'	'	'	'	'	74,707	61,578	14,974
Expenses	'	'	'	'	'	'	'	'	'	'	'
Real estate depreciation and amortization	'	'	'	'	'	'	'	'	1,701	1,700	1,658
Property-related	'	'	'	'	'	'	'	'	32,863	25,707	3,141
Acquisition expenses	'	'	'	'	'	'	'	'	'	'	471
General and administrative	'	'	'	'	'	'	'	'	655	2,544	3,160
Total operating expenses	'	'	'	'	'	'	'	'	35,219	29,951	8,430
Operating income	'	'	'	'	'	'	'	'	39,488	31,627	6,544
Other income (expense)	'	'	'	'	'	'	'	'	'	'	'
Interest and other (expense) income	'	'	'	'	'	'	'	'	-209	-1,593	10
Earnings from equity and other interests	'	'	'	'	'	'	'	'	2,606	1,882	-267
Interest expense	'	'	'	'	'	'	'	'	-29,268	-25,653	-7,122
Income tax expense	'	'	'	'	'	'	'	'	-568	-19	-128
Net other expense	'	'	'	'	'	'	'	'	-27,439	-25,383	-7,527
Income (loss) from continuing operations	'	'	'	'	'	'	'	'	12,049	6,244	-983
Income (loss) from discontinued operations	'	'	'	'	'	'	'	'	7,918	17,104	16,563
Equity in earnings of consolidated subsidiaries net of income taxes	'	'	'	'	'	'	'	'	'	'	'
Net income	'	'	'	'	'	'	'	'	19,967	23,348	15,580
Net income (loss) attributable to non-controlling interests	'	'	'	'	'	'	'	'	'	'	'
Net income attributable to MPT common stockholders	'	'	'	'	'	'	'	'	19,967	23,348	15,580
Eliminations [Member]	'	'	'	'	'	'	'	'	'	'	'
Revenues	'	'	'	'	'	'	'	'	'	'	'
Rent billed	'	'	'	'	'	'	'	'	-12,101	-9,309	-3,092
Income from direct financing leases	'	'	'	'	'	'	'	'	-20,269	-16,232	'
Interest and fee income	'	'	'	'	'	'	'	'	-31,918	-24,731	-6,236
Total revenues	'	'	'	'	'	'	'	'	-64,288	-50,272	-9,328
Expenses	'	'	'	'	'	'	'	'	'	'	'
Real estate depreciation and amortization	'	'	'	'	'	'	'	'	'	'	'
Property-related	'	'	'	'	'	'	'	'	-32,370	-25,541	-3,092
Acquisition expenses	'	'	'	'	'	'	'	'	'	'	'
General and administrative	'	'	'	'	'	'	'	'	'	'	'
Total operating expenses	'	'	'	'	'	'	'	'	-32,370	-25,541	-3,092
Operating income	'	'	'	'	'	'	'	'	-31,918	-24,731	-6,236
Other income (expense)	'	'	'	'	'	'	'	'	'	'	'
Interest and other (expense) income	'	'	'	'	'	'	'	'	'	'	'
Earnings from equity and other interests	'	'	'	'	'	'	'	'	'	'	'
Interest expense	'	'	'	'	'	'	'	'	31,918	24,731	6,236
Income tax expense	'	'	'	'	'	'	'	'	'	'	'
Net other expense	'	'	'	'	'	'	'	'	31,918	24,731	6,236
Income (loss) from continuing operations	'	'	'	'	'	'	'	'	'	'	'
Income (loss) from discontinued operations	'	'	'	'	'	'	'	'	'	'	'
Equity in earnings of consolidated subsidiaries net of income taxes	'	'	'	'	'	'	'	'	-281,694	-257,025	-136,906
Net income	'	'	'	'	'	'	'	'	-281,694	-257,025	-136,906
Net income (loss) attributable to non-controlling interests	'	'	'	'	'	'	'	'	224	177	178
Net income attributable to MPT common stockholders	'	'	'	'	'	'	'	'	($281,470)	($256,848)	($136,728)

Condensed_Consolidating_Financ5

Condensed Consolidating Financial Information - Condensed Consolidated Statements of Comprehensive Income (Loss) (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Comprehensive Income (Loss) [Line Items]	'	'	'
Net income	$97,215	$90,077	$26,714
Other comprehensive income (loss):	'	'	'
Unrealized gain (loss) on interest rate swap	3,474	-251	-8,590
Foreign currency translation gain (loss)	67	'	'
Total comprehensive income	100,756	89,826	18,124
Comprehensive income attributable to non-controlling interests	-224	-177	-178
Comprehensive income attributable to MPT common stockholders	100,532	89,649	17,946
Parent [Member]	'	'	'
Comprehensive Income (Loss) [Line Items]	'	'	'
Net income	97,215	90,077	26,714
Other comprehensive income (loss):	'	'	'
Unrealized gain (loss) on interest rate swap	3,474	-251	-8,590
Foreign currency translation gain (loss)	67	'	'
Total comprehensive income	100,756	89,826	18,124
Comprehensive income attributable to non-controlling interests	-224	-177	-178
Comprehensive income attributable to MPT common stockholders	100,532	89,649	17,946
Subsidiary Issuers [Member]	'	'	'
Comprehensive Income (Loss) [Line Items]	'	'	'
Net income	97,215	90,077	26,731
Other comprehensive income (loss):	'	'	'
Unrealized gain (loss) on interest rate swap	3,474	-251	-8,590
Foreign currency translation gain (loss)	67	'	'
Total comprehensive income	100,756	89,826	18,141
Comprehensive income attributable to non-controlling interests	-224	-177	-178
Comprehensive income attributable to MPT common stockholders	100,532	89,649	17,963
Subsidiary Guarantors [Member]	'	'	'
Comprehensive Income (Loss) [Line Items]	'	'	'
Net income	164,512	143,600	15,580
Other comprehensive income (loss):	'	'	'
Total comprehensive income	164,512	143,600	94,595
Comprehensive income attributable to MPT common stockholders	164,512	143,600	94,595
Non-Guarantor Subsidiaries [Member]	'	'	'
Comprehensive Income (Loss) [Line Items]	'	'	'
Net income	19,967	23,348	15,580
Other comprehensive income (loss):	'	'	'
Total comprehensive income	19,967	23,348	15,580
Comprehensive income attributable to MPT common stockholders	19,967	23,348	15,580
Eliminations [Member]	'	'	'
Comprehensive Income (Loss) [Line Items]	'	'	'
Net income	-281,694	-257,025	-136,906
Other comprehensive income (loss):	'	'	'
Unrealized gain (loss) on interest rate swap	-3,474	251	8,590
Foreign currency translation gain (loss)	-67	'	'
Total comprehensive income	-285,235	-256,774	-128,316
Comprehensive income attributable to non-controlling interests	224	177	178
Comprehensive income attributable to MPT common stockholders	($285,011)	($256,597)	($128,138)

Condensed_Consolidating_Financ6

Condensed Consolidating Financial Information - Condensed Consolidated Statements of Cash Flows (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Operating activities	'	'	'
Net cash provided by (used in) operating activities	$140,801	$105,309	$79,270
Investing Activities	'	'	'
Principal received on loans receivable	7,249	10,931	4,289
Investments in loans receivable	-3,746	-1,293	-861
Net cash (used for) provided by investing activities	-712,577	-617,128	-265,621
Financing Activities	'	'	'
Additions to term debt	424,580	300,000	450,000
Payments of term debt	-11,249	-232	-246,262
Revolving credit facilities, net	-20,000	35,400	89,600
Distributions paid	-120,309	-103,952	-89,601
Lease deposits and other obligations to tenants	3,231	-11,436	8,621
Proceeds from sale of common shares, net of offering costs	313,331	233,048	'
Debt issuance costs paid and other financing activities	'	-177	-6,235
Net cash provided by (used in) financing activities	579,824	446,404	190,669
Increase (decrease) in cash and cash equivalents for period	8,048	-65,415	4,318
Cash and cash equivalents at beginning of period	37,311	102,726	98,408
Cash and cash equivalents at end of period	45,979	37,311	102,726
Parent [Member]	'	'	'
Operating activities	'	'	'
Net cash provided by (used in) operating activities	4	57	-209
Investing Activities	'	'	'
Cash paid for acquisitions and other related investments	'	'	'
Net proceeds from sales of real estate	'	'	'
Principal received on loans receivable	'	'	'
Investments in loans receivable	'	'	'
Construction in progress and other	'	'	'
Net cash (used for) provided by investing activities	'	'	'
Financing Activities	'	'	'
Additions to term debt	'	'	'
Payments of term debt	'	'	'
Revolving credit facilities, net	'	'	'
Distributions paid	-120,038	-103,684	-89,342
Net payments relating to intercompany financing	-193,297	-129,421	89,551
Proceeds from sale of common shares, net of offering costs	313,331	233,048	'
Debt issuance costs paid and other financing activities	'	'	'
Net cash provided by (used in) financing activities	-4	-57	209
Increase (decrease) in cash and cash equivalents for period	'	'	'
Effect of exchange rate changes	'	'	'
Cash and cash equivalents at beginning of period	'	'	'
Cash and cash equivalents at end of period	'	'	'
Subsidiary Issuers [Member]	'	'	'
Operating activities	'	'	'
Net cash provided by (used in) operating activities	-53,846	-61,002	-48,779
Investing Activities	'	'	'
Cash paid for acquisitions and other related investments	'	'	'
Net proceeds from sales of real estate	'	'	'
Principal received on loans receivable	'	'	'
Investments in loans receivable	'	'	'
Construction in progress and other	136	-578	-6,466
Net cash (used for) provided by investing activities	136	-578	-6,466
Financing Activities	'	'	'
Additions to term debt	424,580	300,000	450,000
Payments of term debt	-11,000	'	-237,666
Revolving credit facilities, net	-20,000	75,000	50,000
Distributions paid	-120,309	-103,952	-89,601
Net payments relating to intercompany financing	-539,776	-501,839	92,052
Proceeds from sale of common shares, net of offering costs	313,331	233,048	'
Debt issuance costs paid and other financing activities	-9,760	-6,424	-21,028
Net cash provided by (used in) financing activities	37,066	-4,167	59,653
Increase (decrease) in cash and cash equivalents for period	-16,644	-65,747	4,408
Effect of exchange rate changes	-24	'	'
Cash and cash equivalents at beginning of period	35,483	101,230	96,822
Cash and cash equivalents at end of period	18,815	35,483	101,230
Subsidiary Guarantors [Member]	'	'	'
Operating activities	'	'	'
Net cash provided by (used in) operating activities	196,883	165,454	109,329
Investing Activities	'	'	'
Cash paid for acquisitions and other related investments	-619,092	-420,500	-241,626
Net proceeds from sales of real estate	'	'	'
Principal received on loans receivable	'	5,491	230
Investments in loans receivable	-1,100	'	-230
Construction in progress and other	-94,737	-66,467	-24,081
Net cash (used for) provided by investing activities	-714,929	-481,476	-265,707
Financing Activities	'	'	'
Additions to term debt	'	'	'
Payments of term debt	'	'	-8,433
Revolving credit facilities, net	'	-39,600	39,600
Distributions paid	'	'	'
Lease deposits and other obligations to tenants	1,606	-10,031	10,986
Net payments relating to intercompany financing	541,325	365,809	114,247
Proceeds from sale of common shares, net of offering costs	'	'	'
Debt issuance costs paid and other financing activities	'	'	'
Net cash provided by (used in) financing activities	542,931	316,178	156,400
Increase (decrease) in cash and cash equivalents for period	24,885	156	22
Effect of exchange rate changes	644	'	'
Cash and cash equivalents at beginning of period	1,565	1,409	1,387
Cash and cash equivalents at end of period	27,094	1,565	1,409
Non-Guarantor Subsidiaries [Member]	'	'	'
Operating activities	'	'	'
Net cash provided by (used in) operating activities	-2,240	800	18,929
Investing Activities	'	'	'
Cash paid for acquisitions and other related investments	-35,830	-200,990	-37,337
Net proceeds from sales of real estate	32,409	71,202	41,130
Principal received on loans receivable	7,249	5,440	4,059
Investments in loans receivable	-2,646	-1,293	-631
Construction in progress and other	1,034	-9,433	-669
Net cash (used for) provided by investing activities	2,216	-135,074	6,552
Financing Activities	'	'	'
Additions to term debt	'	'	'
Payments of term debt	-249	-232	-163
Revolving credit facilities, net	'	'	'
Distributions paid	'	'	'
Lease deposits and other obligations to tenants	1,625	-1,405	-2,365
Net payments relating to intercompany financing	-1,545	136,087	-22,404
Proceeds from sale of common shares, net of offering costs	'	'	'
Debt issuance costs paid and other financing activities	'	'	-661
Net cash provided by (used in) financing activities	-169	134,450	-25,593
Increase (decrease) in cash and cash equivalents for period	-193	176	-112
Effect of exchange rate changes	'	'	'
Cash and cash equivalents at beginning of period	263	87	199
Cash and cash equivalents at end of period	70	263	87
Eliminations [Member]	'	'	'
Operating activities	'	'	'
Net cash provided by (used in) operating activities	'	'	'
Investing Activities	'	'	'
Cash paid for acquisitions and other related investments	'	'	'
Net proceeds from sales of real estate	'	'	'
Principal received on loans receivable	'	'	'
Investments in loans receivable	'	'	'
Construction in progress and other	'	'	'
Net cash (used for) provided by investing activities	'	'	'
Financing Activities	'	'	'
Additions to term debt	'	'	'
Payments of term debt	'	'	'
Revolving credit facilities, net	'	'	'
Distributions paid	120,038	103,684	89,342
Lease deposits and other obligations to tenants	'	'	'
Net payments relating to intercompany financing	193,293	129,364	-89,342
Proceeds from sale of common shares, net of offering costs	-313,331	-233,048	'
Debt issuance costs paid and other financing activities	'	'	'
Net cash provided by (used in) financing activities	'	'	'
Increase (decrease) in cash and cash equivalents for period	'	'	'
Effect of exchange rate changes	'	'	'
Cash and cash equivalents at beginning of period	'	'	'
Cash and cash equivalents at end of period	'	'	'
Total Consolidated [Member]	'	'	'
Operating activities	'	'	'
Net cash provided by (used in) operating activities	140,801	105,309	79,270
Investing Activities	'	'	'
Cash paid for acquisitions and other related investments	-654,922	-621,490	-278,963
Net proceeds from sales of real estate	32,409	71,202	41,130
Principal received on loans receivable	7,249	10,931	4,289
Investments in loans receivable	-3,746	-1,293	-861
Construction in progress and other	-93,567	-76,478	-31,216
Net cash (used for) provided by investing activities	-712,577	-617,128	-265,621
Financing Activities	'	'	'
Additions to term debt	424,580	300,000	450,000
Payments of term debt	-11,249	-232	-246,262
Revolving credit facilities, net	-20,000	35,400	89,600
Distributions paid	-120,309	-103,952	-89,601
Lease deposits and other obligations to tenants	3,231	-11,436	8,621
Net payments relating to intercompany financing	'	'	'
Proceeds from sale of common shares, net of offering costs	313,331	233,048	'
Debt issuance costs paid and other financing activities	-9,760	-6,424	-21,689
Net cash provided by (used in) financing activities	579,824	446,404	190,669
Increase (decrease) in cash and cash equivalents for period	8,048	-65,415	4,318
Effect of exchange rate changes	620	'	'
Cash and cash equivalents at beginning of period	37,311	102,726	98,408
Cash and cash equivalents at end of period	$45,979	$37,311	$102,726

Schedule_II_Schedule_of_Valuat

Schedule II - Schedule of Valuation and Qualifying Accounts (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013		Dec. 31, 2012		Dec. 31, 2011
Valuation And Qualifying Accounts [Abstract]	'		'		'
Balance at Beginning of Year	$34,769	[1]	$32,618	[1]	$23,926	[1]
Additions charged against operations	9,397	[1],[2]	4,540	[1],[3]	8,692	[1],[4]
Net recoveries	-2,593	[1]	-2,389	[1]	'
Balance at end of year	$41,573	[1]	$34,769	[1]	$32,618	[1]
[1]	Includes allowance for doubtful accounts, straight-line rent reserves, allowance for loan losses, tax valuation allowances and other reserves.
[2]	Includes $4.8 million and $2.7 million in rent and interest reserves, respectively, related to our Monroe properties.
[3]	Includes $1.6 million and $2.9 million in rent and interest reserves, respectively, related to our Monroe properties.
[4]	Includes $3.7 million and $2.9 million in rent and interest reserves, respectively, related to our Denham Springs and Monroe properties and $2.1 million to fully reserve for the net deferred tax asset of one of our taxable REIT subsidiaries.

Schedule_II_Schedule_of_Valuat1

Schedule II - Schedule of Valuation and Qualifying Accounts (Parenthetical) (Detail) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Monroe Property [Member]	'	'
Rent reserves	$4.80	$1.60
Interest reserves	2.7	2.9
Acquisition-related costs on consummated deals	1.9	'
Denham Springs, LA [Member]	'	'
Rent reserves	'	3.7
Interest reserves	'	2.9
Full reserve for net deferred tax asset	'	$2.10

Recovered_Sheet13

Schedule III - Real Estate Investments and Accumulated Depreciation (Detail) (USD $)

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2010

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

In Thousands, unless otherwise specified

Baden-Wurttemburg, Germany [Member]

Saxony, Germany [Member]

Rhineland-Pflaz, Germany [Member]

Brandenburg, Germany [Member]

Hesse, Germany [Member]

Little Elm, TX [Member]

Port Arthur, TX [Member]

West Monroe, LA [Member]

Hausman, TX [Member]

Lafayette, IN [Member]

Mesa, AZ [Member]

Overlook, TX [Member]

Post Falls, ID [Member]

Spartanburg, SC [Member]

Victoria, TX [Member]

Covington, LA [Member]

Redding, CA [Member]

Bloomington, IN

Dallas, TX [Member]

La Palma, CA [Member]

Anaheim, CA [Member]

Luling, TX [Member]

Victoria, TX [Member]

Houston, TX [Member]

Bensalem, PA [Member]

Portland, OR [Member]

San Diego, CA [Member]

Redding, CA [Member]

Houston, TX [Member]

Bennettsville, SC [Member]

Bossier City, LA [Member]

Bristol, CT [Member]

Cheraw, SC [Member]

Detroit, MI [Member]

Enfield, CT [Member]

Fort Lauderdale, FL [Member]

Garden Grove, CA [Member]

Garden Grove, CA [Member]

Idaho Falls, ID [Member]

Newington, CT [Member]

Petersburg, VA [Member]

West Valley City, UT [Member]

Poplar Bluff, MO [Member]

East Providence, RI [Member]

San Dimas, CA [Member]

San Dimas, CA [Member]

West Springfield, MA [Member]

Warwick, RI [Member]

Wichita, KS [Member]

Addison, TX [Member]

Shenandoah, TX [Member]

Richardson, TX [Member]

Hill County, TX [Member]

Webster, TX [Member]

Tomball, TX [Member]

Gilbert, AZ [Member]

Corinth, TX [Member]

Bayonne, NJ [Member]

San Diego, CA [Member]

Northland, MO [Member]

DeSoto, TX [Member]

New Braunfels, TX [Member]

Hoboken, NJ [Member]

Florence, AZ [Member]

Hammond, LA [Member]

San Antonio, TX [Member]

1994 [Member]

1996 [Member]

1960 [Member]

1981 [Member]

1992 [Member]

1904 [Member]

1980 [Member]

Baden-Wurttemburg, Germany [Member]

Saxony, Germany [Member]

Rhineland-Pflaz, Germany [Member]

Hesse, Germany [Member]

Rhineland-Pflaz, Germany [Member]

Saxony, Germany [Member]

Rhineland-Pflaz, Germany [Member]

SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Encumbrances

$49,878

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$41,200

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$8,678

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Type of property

'

'

'

'

'Rehabilitation hospital

'Rehabilitation hospital

'Rehabilitation hospital

'Rehabilitation hospital

'Rehabilitation hospital

'Acute care general hospital

'Acute care general hospital

'Acute care general hospital

'Acute care general hospital

'Rehabilitation hospital

'Acute care general hospital

'Acute care general hospital

'Rehabilitation hospital

'Rehabilitation hospital

'Rehabilitation hospital

'Long term acute care hospital

'Long term acute care hospital

'Acute care general hospital

'Long term acute care hospital

'Acute care general hospital

'Acute care general hospital

'Long term acute care hospital

'Long term acute care hospital

'Acute care general hospital

'Acute care general hospital

'Long term acute care hospital

'Acute care general hospital

'Acute care general hospital

'Acute care general hospital

'Acute care general hospital

'Long term acute care hospital

'Wellness Center

'Acute care general hospital

'Long term acute care hospital

'Wellness Center

'Rehabilitaion hospital

'Acute care general hospital

'Medical Office Building

'Acute care general hospital

'Wellness Center

'Rehabilitaion hospital

'Acute care general hospital

'Acute care general hospital

'Wellness Center

'Acute care general hospital

'Medical Office Building

'Wellness Center

'Wellness Center

'Rehabilitaion hospital

'Rehabilitaion hospital

'Rehabilitaion hospital

'Rehabilitaion hospital

'Acute care general hospital

'Long term acute care hospital

'Long term acute care hospital

'Acute care general hospital

'Long term acute care hospital

'Acute care general hospital

'Acute care general hospital

'Long term acute care hospital

'Long term acute care hospital

'Long term acute care hospital

'Acute care general hospital

'Acute care general hospital

'Long term acute care hospital

'Acute care general hospital

'Rehabilitation hospital

'Rehabilitation hospital

'Rehabilitation hospital

'Rehabilitation hospital

'Rehabilitation hospital

'Rehabilitation hospital

'Rehabilitation hospital

Initial costs, land

151,814

'

'

'

4,327

682

7,382

438

3,894

1,241

2,178

10,555

1,500

800

3,875

2,452

417

1,135

'

821

'

2,457

1,000

937

1,875

811

625

4,757

6,911

3,085

6,550

1,555

3,501

794

900

485

657

1,220

384

3,499

5,502

862

1,822

270

1,302

5,516

2,659

209

6,160

1,915

583

1,265

1,019

2,013

2,033

2,219

1,120

663

1,298

150

1,288

2,003

12,663

834

1,067

1,100

1,387

900

519

2,248

'

471

4,017

116

'

682

921

Initial costs, buildings

1,547,919

'

'

'

7,372

18,907

20,382

22,615

18,730

2,963

74,225

71,429

8,958

14,968

101,248

9,666

12,175

15,717

9,355

10,238

19,952

31,209

13,589

10,907

21,814

9,345

7,197

56,238

38,185

17,859

15,653

53,863

34,530

15,772

17,818

2,267

19,576

8,687

2,257

21,939

10,748

7,888

37,467

1,615

9,121

58,314

38,694

1,265

6,839

5,085

3,185

759

18,373

22,531

21,943

17,419

17,882

33,751

23,982

15,553

21,175

51,495

52,431

17,182

10,701

7,883

44,351

28,636

8,941

5,390

11,968

25,956

18,989

6,625

37,579

18,907

8,281

Additions subsequent to acquisition, improvements

7,832

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

313

'

'

'

86

'

'

'

'

'

'

'

'

'

'

'

'

Additions subsequent to acquisition, carrying costs

25,629

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

14

4,361

408

368

3

10

'

'

1,259

-353

2,559

77

13

12,468

'

'

'

'

-365

'

1

51

28

4,665

'

'

'

1

'

34

18

'

'

1

'

'

'

'

'

'

'

'

'

'

'

8

'

'

'

'

'

'

'

'

'

'

'

'

Land at cost

154,858

'

'

'

4,327

682

7,382

438

3,894

1,241

2,178

10,555

1,500

800

3,875

2,452

417

1,135

'

821

1,629

2,576

1,421

937

1,875

811

625

5,464

6,911

3,071

6,550

1,555

3,274

794

900

485

657

1,220

384

3,499

5,502

862

1,822

270

1,302

5,516

2,660

209

6,160

1,915

583

1,265

1,019

2,013

2,033

2,219

1,120

663

1,298

150

1,601

2,003

12,663

834

1,161

1,100

1,387

900

519

2,249

'

471

4,017

116

'

682

921

Buildings at cost

1,578,336

'

'

'

7,372

18,907

20,382

22,615

18,730

2,963

74,225

71,429

8,958

14,968

101,248

9,666

12,175

15,717

9,355

10,252

22,684

31,498

13,536

10,910

21,824

9,345

7,197

56,790

37,832

20,432

15,730

53,876

54,658

15,772

17,818

2,267

19,576

8,322

2,257

21,940

10,799

7,916

42,132

1,615

9,121

58,314

38,694

1,265

6,873

5,103

3,185

759

18,374

22,531

21,943

17,419

17,882

33,751

23,982

15,553

21,175

51,495

52,432

17,182

10,701

7,883

44,351

28,462

8,941

5,879

11,968

25,956

18,989

6,625

37,579

18,907

8,281

Total at cost

1,733,194

1,189,552

[1]

1,191,096

[2]

990,635

11,699

19,589

27,764

23,053

22,624

4,204

76,403

81,984

10,458

15,768

105,123

12,118

12,592

16,852

9,355

11,073

24,313

34,074

14,957

11,847

23,699

10,156

7,822

62,254

44,743

23,503

22,280

55,431

57,932

16,566

18,718

2,752

20,233

9,542

2,641

25,439

16,301

8,778

43,954

1,885

10,423

63,830

41,354

1,474

13,033

7,018

3,768

2,024

19,393

24,544

23,976

19,638

19,002

34,414

25,280

15,703

22,776

53,498

65,094

18,016

11,862

8,983

45,738

29,362

9,460

8,128

11,968

26,427

23,006

6,741

37,579

19,589

9,202

Accumulated depreciation

$144,235

$110,888

[3]

$93,430

[4]

$68,662

$25

$48

$67

$68

$53

$6

$464

$449

$169

$328

$633

$203

$25

$145

'

$2,200

$4,621

$5,800

$2,481

$1,954

$3,910

$1,655

$1,275

$10,006

$6,602

$3,356

$2,619

$8,653

$4,948

$2,268

$2,559

$1,047

$2,814

$1,243

$1,043

$3,114

$1,385

$1,007

$5,913

$748

$1,254

$8,278

$5,493

$586

$874

$650

$1,475

$351

$2,641

$1,971

$1,920

$1,524

$3,897

$2,531

$1,799

$1,166

$1,570

$7,510

$3,823

$1,253

$655

$443

$4,730

$1,236

$242

$166

$29

$73

$48

$19

$103

$48

$21

Date of construction

'

'

'

'

'1986

'1995

'1930

'1994

'1977

'2013

'2005

'1962

'2013

'2013

'2007

'2012

'2013

'2013

'2013

'1984

'1991

'2006

'2006

'1971

'1964

'2002

'1998

'2006

'2006

'1964

'1964

'1974

'1960

'1984

'1982

'1975

'1982

'1956

'1974

'1985

'1982

'1982

'2002

'1979

'2006

'1980

'1980

'1979

'1972

'1979

'1976

'1979

'1992

'2008

'2008

'2008

'1980

'2004

'2005

'2005

'2008

'1918

'1973

'2007

'2008

'2007

'1863

'2012

'2003

'2012

'1994

'1996

'1960

'1981

'1992

'1904

'1980

Date acquired

'

'

'

'

29-Nov-13

29-Nov-13

29-Nov-13

29-Nov-13

29-Nov-13

1-Dec-13

26-Sep-13

26-Sep-13

1-Mar-13

1-Feb-13

26-Sep-13

1-Feb-13

31-Dec-13

1-Aug-13

31-Dec-13

9-Jun-05

30-Jun-05

8-Aug-06

5-Sep-06

8-Nov-06

8-Nov-06

1-Dec-06

1-Dec-06

1-Dec-06

19-Mar-07

18-Apr-07

9-May-07

10-Aug-07

10-Aug-07

1-Apr-08

1-Apr-08

22-Apr-08

1-Apr-08

22-May-08

22-Apr-08

22-Apr-08

25-Nov-08

25-Nov-08

1-Apr-08

22-Apr-08

1-Jul-08

22-Apr-08

22-Apr-08

22-Apr-08

25-Nov-08

25-Nov-08

22-Apr-08

22-Apr-08

4-Apr-08

17-Jun-10

17-Jun-10

17-Jun-10

17-Sep-10

21-Dec-10

21-Dec-10

4-Jan-11

31-Jan-11

4-Feb-11

9-Feb-11

14-Feb-11

18-Jul-11

30-Sep-11

4-Nov-11

4-Nov-10

14-Dec-12

14-Oct-11

29-Nov-13

29-Nov-13

29-Nov-13

29-Nov-13

29-Nov-13

29-Nov-13

29-Nov-13

Life on which depreci- ation in latest income state- ments is computed (Years)

'

'

'

'

'40 years

'40 years

'40 years

'40 years

'40 years

'40 years

'40 years

'40 years

'40 years

'40 years

'40 years

'40 years

'40 years

'40 years

'40 years

'40 years

'40 years

'40 years

'40 years

'40 years

'40 years

'40 years

'40 years

'40 years

'40 years

'40 years

'40 years

'40 years

'40 years

'40 years

'40 years

'10 years

'40 years

'40 years

'10 years

'40 years

'40 years

'40 years

'40 years

'10 years

'40 years

'40 years

'40 years

'10 years

'40 years

'40 years

'10 years

'10 years

'40 years

'40 years

'40 years

'40 years

'40 years

'40 years

'40 years

'40 years

'40 years

'20 years

'40 years

'40 years

'40 years

'40 years

'20 years

'40 years

'40 years

'40 years

'40 years

'40 years

'40 years

'40 years

'40 years

'40 years

'40 years

[1]

Includes real estate cost included in real estate held for sale of $28,617 at December 31, 2012. Excludes intangible lease assets that are included in real estate held for sale of $858 for 2012.

[2]

Includes real estate cost included in real estate held for sale of $96,766 at December 31, 2011. Excludes intangible lease assets that are included in real estate held for sale of $3,012 for 2011.

[3]

Includes in accumulated depreciation in real estate held for sale of $3,511 for 2012. Excludes accumulated amortization related to intangible lease assets that are included in real estate held for sale of $426 for 2012.

[4]

Includes accumulated depreciation in real estate held for sale of $11,807 for 2011. Excludes accumulated amortization related to intangible lease assets that are included in real estate held for sale of $1,949 for 2011.

Schedule_III_Changes_in_Total_

Schedule III - Changes in Total Real Estate Assets Including Real Estate Held for Sale (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013		Dec. 31, 2012		Dec. 31, 2011
Real Estate And Accumulated Depreciation Disclosure [Abstract]	'		'		'
Balance at beginning of period	$1,189,552	[1]	$1,191,096	[2]	$990,635
Acquisitions	483,162		9,460		240,474
Transfers from construction in progress	81,347		37,174		'
Additions	7,749		19,971		1,011
Dispositions	-28,616		-68,149		-40,460
Other	'		'		-564
Balance at end of period	$1,733,194		$1,189,552	[1]	$1,191,096	[2]
[1]	Includes real estate cost included in real estate held for sale of $28,617 at December 31, 2012. Excludes intangible lease assets that are included in real estate held for sale of $858 for 2012.
[2]	Includes real estate cost included in real estate held for sale of $96,766 at December 31, 2011. Excludes intangible lease assets that are included in real estate held for sale of $3,012 for 2011.

Schedule_III_Changes_in_Accumu

Schedule III - Changes in Accumulated Depreciation Including Real Estate Assets Held for Sale (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013		Dec. 31, 2012		Dec. 31, 2011
Real Estate And Accumulated Depreciation Disclosure [Abstract]	'		'		'
Balance at beginning of period	$110,888	[1]	$93,430	[2]	$68,662
Depreciation	33,349		31,026		29,523
Depreciation on disposed property	-3,513		-10,057		-4,755
Balance at end of period	$144,235		$110,888	[1]	$93,430	[2]
[1]	Includes in accumulated depreciation in real estate held for sale of $3,511 for 2012. Excludes accumulated amortization related to intangible lease assets that are included in real estate held for sale of $426 for 2012.
[2]	Includes accumulated depreciation in real estate held for sale of $11,807 for 2011. Excludes accumulated amortization related to intangible lease assets that are included in real estate held for sale of $1,949 for 2011.

Schedule_III_Changes_in_Accumu1

Schedule III - Changes in Accumulated Depreciation Including Real Estate Assets Held for Sale (Parenthetical) (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2012	Dec. 31, 2011
Real Estate And Accumulated Depreciation Disclosure [Abstract]	'	'
Real estate held for sale	'	$96,766
Intangible lease assets held for sale	'	3,012
Accumulated depreciation of real estate held for sale	'	11,807
Accumulated amortization of intangible lease assets	'	1,949
Real estate cost included in real estate held for sale	28,617	'
Excludes intangible lease assets that are included in real estate held for sale	858	'
Includes in accumulated depreciation in real estate held for sale	3,511	'
Excludes accumulated amortization related to intangible lease assets that are included in real estate held for sale	426	'
Aggregate cost for federal income tax purposes	$2,155,240	'

Schedule_IV_Schedule_of_Mortga

Schedule IV - Schedule of Mortgage Loan on Real Estate (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013
Mortgage Loans on Real Estate [Line Items]	'
Prior Liens	'	[1]
Face Amount of Mortgages	388,650
Carrying Amount of Mortgages	388,650	[2]
Principal Amount of Loans Subject to Delinquent Principal or Interest	'	[3]
Long-Term First Mortgage Loan [Member]	'
Mortgage Loans on Real Estate [Line Items]	'
Periodic Payment Terms	'Payable in monthly installments of interest plus principal payable in full at maturity
Long-Term First Mortgage Loan [Member] | Desert Valley Hospital [Member]	'
Mortgage Loans on Real Estate [Line Items]	'
Interest rate	10.70%
Final Maturity Date	'2022
Prior Liens	'	[1]
Face Amount of Mortgages	70,000
Carrying Amount of Mortgages	70,000	[2]
Principal Amount of Loans Subject to Delinquent Principal or Interest	'	[3]
Long-Term First Mortgage Loan [Member] | Desert Valley Hospital [Member]	'
Mortgage Loans on Real Estate [Line Items]	'
Interest rate	11.30%
Final Maturity Date	'2022
Prior Liens	'	[1]
Face Amount of Mortgages	20,000
Carrying Amount of Mortgages	20,000	[2]
Principal Amount of Loans Subject to Delinquent Principal or Interest	'	[3]
Long-Term First Mortgage Loan [Member] | Chino Valley Medical Center [Member]	'
Mortgage Loans on Real Estate [Line Items]	'
Interest rate	10.70%
Final Maturity Date	'2022
Prior Liens	'	[1]
Face Amount of Mortgages	50,000
Carrying Amount of Mortgages	50,000	[2]
Principal Amount of Loans Subject to Delinquent Principal or Interest	'	[3]
Long-Term First Mortgage Loan [Member] | Paradise Valley Hospital [Member]	'
Mortgage Loans on Real Estate [Line Items]	'
Interest rate	10.30%
Final Maturity Date	'2022
Prior Liens	'	[1]
Face Amount of Mortgages	25,000
Carrying Amount of Mortgages	25,000	[2]
Principal Amount of Loans Subject to Delinquent Principal or Interest	'	[3]
Long-Term First Mortgage Loan [Member] | Ernest Mortgage Loan [Member]	'
Mortgage Loans on Real Estate [Line Items]	'
Interest rate	9.20%	[4]
Final Maturity Date	'2032	[4]
Prior Liens	'	[1],[4]
Face Amount of Mortgages	100,000	[4]
Carrying Amount of Mortgages	100,000	[2],[4]
Principal Amount of Loans Subject to Delinquent Principal or Interest	'	[3],[4]
Long-Term First Mortgage Loan [Member] | Centinela Hospital Medical Center [Member]	'
Mortgage Loans on Real Estate [Line Items]	'
Interest rate	10.50%
Final Maturity Date	'2022
Prior Liens	'	[1]
Face Amount of Mortgages	100,000
Carrying Amount of Mortgages	100,000	[2]
Principal Amount of Loans Subject to Delinquent Principal or Interest	'	[3]
Long-Term First Mortgage Loan [Member] | Olympia Medical Center [Member]	'
Mortgage Loans on Real Estate [Line Items]	'
Interest rate	11.00%
Final Maturity Date	'2024
Prior Liens	'	[1]
Face Amount of Mortgages	20,000
Carrying Amount of Mortgages	20,000	[2]
Principal Amount of Loans Subject to Delinquent Principal or Interest	'	[3]
Long-Term First Mortgage Loan [Member] | Denham Springs LTACH [Member]	'
Mortgage Loans on Real Estate [Line Items]	'
Interest rate	6.00%
Final Maturity Date	'2014
Prior Liens	'	[1]
Face Amount of Mortgages	3,650
Carrying Amount of Mortgages	3,650	[2]
Principal Amount of Loans Subject to Delinquent Principal or Interest	'	[3]
[1]	There were no prior liens on loans as of December 31, 2013.
[2]	The aggregate cost for Federal income tax purposes is $388,650.
[3]	The mortgage loan was not delinquent with respect to principal or interest.
[4]	Mortgage loans on four properties.

Schedule_IV_Schedule_of_Mortga1

Schedule IV - Schedule of Mortgage Loan on Real Estate (Parenthetical) (Detail) (USD $)	Dec. 31, 2013
In Thousands, unless otherwise specified
Mortgage Loans on Real Estate [Line Items]	'
Carrying amount of mortgages, federal income tax purposes	$388,650
Ernest Mortgage Loan [Member] | Long-Term First Mortgage Loan [Member]	'
Mortgage Loans on Real Estate [Line Items]	'
Number of properties	4

Schedule_IV_Changes_in_Mortgag

Schedule IV - Changes in Mortgage Loans (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Mortgage Loans On Real Estate [Abstract]	'	'	'
Balance at beginning of year	$368,650	$165,000	$165,000
New mortgage loans and additional advances on existing loans	20,000	203,650	'
Mortgage loans on real estate including additions during year	368,650	368,650	165,000
Collection of principal	'	'	'
Deductions during year	'	'	'
Balance at end of year	$368,650	$368,650	$165,000